ID,Description,GeneRatio,BgRatio,pvalue,p.adjust,qvalue,geneID,Count
R-HSA-73933,Resolution of Abasic Sites (AP sites),2/22,39/10899,0.002754757316649585,0.19368368437579497,0.155499835805723,POLD4/MBD4,2
R-HSA-73884,Base Excision Repair,2/22,92/10899,0.014589408241012828,0.19368368437579497,0.155499835805723,POLD4/MBD4,2
R-HSA-877300,Interferon gamma signaling,2/22,92/10899,0.014589408241012828,0.19368368437579497,0.155499835805723,TRIM38/HLA-DRB1,2
R-HSA-1989781,PPARA activates gene expression,2/22,117/10899,0.02294453027767893,0.19368368437579497,0.155499835805723,PPARG/ACSL1,2
R-HSA-400206,Regulation of lipid metabolism by PPARalpha,2/22,119/10899,0.023681639720330588,0.19368368437579497,0.155499835805723,PPARG/ACSL1,2
R-HSA-2160916,Hyaluronan uptake and degradation,1/22,12/10899,0.02396725442356651,0.19368368437579497,0.155499835805723,HEXA,1
R-HSA-2022857,Keratan sulfate degradation,1/22,13/10899,0.025939581088642694,0.19368368437579497,0.155499835805723,HEXA,1
R-HSA-2046104,alpha-linolenic (omega3) and linoleic (omega6) acid metabolism,1/22,13/10899,0.025939581088642694,0.19368368437579497,0.155499835805723,ACSL1,1
R-HSA-2046106,alpha-linolenic acid (ALA) metabolism,1/22,13/10899,0.025939581088642694,0.19368368437579497,0.155499835805723,ACSL1,1
R-HSA-209543,p75NTR recruits signalling complexes,1/22,13/10899,0.025939581088642694,0.19368368437579497,0.155499835805723,MYD88,1
R-HSA-2024101,CS/DS degradation,1/22,14/10899,0.027908102971432203,0.19368368437579497,0.155499835805723,HEXA,1
R-HSA-5358565,Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha),1/22,14/10899,0.027908102971432203,0.19368368437579497,0.155499835805723,POLD4,1
R-HSA-5358606,Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta),1/22,14/10899,0.027908102971432203,0.19368368437579497,0.155499835805723,POLD4,1
R-HSA-69091,Polymerase switching,1/22,14/10899,0.027908102971432203,0.19368368437579497,0.155499835805723,POLD4,1
R-HSA-69109,Leading Strand Synthesis,1/22,14/10899,0.027908102971432203,0.19368368437579497,0.155499835805723,POLD4,1
R-HSA-69166,Removal of the Flap Intermediate,1/22,14/10899,0.027908102971432203,0.19368368437579497,0.155499835805723,POLD4,1
R-HSA-975110,TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling,1/22,14/10899,0.027908102971432203,0.19368368437579497,0.155499835805723,MYD88,1
R-HSA-5358508,Mismatch Repair,1/22,15/10899,0.029872827062808582,0.19368368437579497,0.155499835805723,POLD4,1
R-HSA-69183,Processive synthesis on the lagging strand,1/22,15/10899,0.029872827062808582,0.19368368437579497,0.155499835805723,POLD4,1
R-HSA-202733,Cell surface interactions at the vascular wall,2/22,137/10899,0.030745290123560524,0.19368368437579497,0.155499835805723,MERTK/ITGA4,2
R-HSA-139853,Elevation of cytosolic Ca2+ levels,1/22,16/10899,0.031833760341439254,0.19368368437579497,0.155499835805723,P2RX4,1
R-HSA-193639,p75NTR signals via NF-kB,1/22,16/10899,0.031833760341439254,0.19368368437579497,0.155499835805723,MYD88,1
R-HSA-174437,Removal of the Flap Intermediate from the C-strand,1/22,17/10899,0.03379090977380994,0.19368368437579497,0.155499835805723,POLD4,1
R-HSA-1810476,RIP-mediated NFkB activation via ZBP1,1/22,17/10899,0.03379090977380994,0.19368368437579497,0.155499835805723,MYD88,1
R-HSA-199220,Vitamin B5 (pantothenate) metabolism,1/22,17/10899,0.03379090977380994,0.19368368437579497,0.155499835805723,VNN1,1
R-HSA-2142845,Hyaluronan metabolism,1/22,17/10899,0.03379090977380994,0.19368368437579497,0.155499835805723,HEXA,1
R-HSA-5602498,MyD88 deficiency (TLR2/4),1/22,17/10899,0.03379090977380994,0.19368368437579497,0.155499835805723,MYD88,1
R-HSA-5603041,IRAK4 deficiency (TLR2/4),1/22,18/10899,0.035744282314241316,0.19368368437579497,0.155499835805723,MYD88,1
R-HSA-446652,Interleukin-1 family signaling,2/22,153/10899,0.037640527734934814,0.19368368437579497,0.155499835805723,MYD88/PTPN7,2
R-HSA-174414,Processive synthesis on the C-strand of the telomere,1/22,19/10899,0.03769388490491188,0.19368368437579497,0.155499835805723,POLD4,1
R-HSA-202430,Translocation of ZAP-70 to Immunological synapse,1/22,19/10899,0.03769388490491188,0.19368368437579497,0.155499835805723,HLA-DRB1,1
R-HSA-422085,"Synthesis, secretion, and deacylation of Ghrelin",1/22,19/10899,0.03769388490491188,0.19368368437579497,0.155499835805723,IGF1,1
R-HSA-5423646,Aflatoxin activation and detoxification,1/22,19/10899,0.03769388490491188,0.19368368437579497,0.155499835805723,MGST2,1
R-HSA-69186,Lagging Strand Synthesis,1/22,20/10899,0.03963972447587638,0.19368368437579497,0.155499835805723,POLD4,1
R-HSA-1606322,ZBP1(DAI) mediated induction of type I IFNs,1/22,21/10899,0.041581807945085925,0.19368368437579497,0.155499835805723,MYD88,1
R-HSA-189200,Cellular hexose transport,1/22,21/10899,0.041581807945085925,0.19368368437579497,0.155499835805723,SLC2A9,1
R-HSA-5651801,PCNA-Dependent Long Patch Base Excision Repair,1/22,21/10899,0.041581807945085925,0.19368368437579497,0.155499835805723,POLD4,1
R-HSA-9008059,Interleukin-37 signaling,1/22,21/10899,0.041581807945085925,0.19368368437579497,0.155499835805723,PTPN7,1
R-HSA-202427,Phosphorylation of CD3 and TCR zeta chains,1/22,22/10899,0.043520142218409164,0.19714769855583172,0.158280935504236,HLA-DRB1,1
R-HSA-389948,PD-1 signaling,1/22,23/10899,0.045454734189650736,0.19714769855583172,0.158280935504236,HLA-DRB1,1
R-HSA-75876,Synthesis of very long-chain fatty acyl-CoAs,1/22,24/10899,0.04738559074057236,0.19714769855583172,0.158280935504236,ACSL1,1
R-HSA-5696397,Gap-filling DNA repair synthesis and ligation in GG-NER,1/22,25/10899,0.04931271874091325,0.19714769855583172,0.158280935504236,POLD4,1
R-HSA-110373,Resolution of AP sites via the multiple-nucleotide patch replacement pathway,1/22,26/10899,0.05123612504840824,0.19714769855583172,0.158280935504236,POLD4,1
R-HSA-174411,Polymerase switching on the C-strand of the telomere,1/22,26/10899,0.05123612504840824,0.19714769855583172,0.158280935504236,POLD4,1
R-HSA-9660826,Purinergic signaling in leishmaniasis infection,1/22,26/10899,0.05123612504840824,0.19714769855583172,0.158280935504236,P2RX4,1
R-HSA-9664424,Cell recruitment (pro-inflammatory response),1/22,26/10899,0.05123612504840824,0.19714769855583172,0.158280935504236,P2RX4,1
R-HSA-380994,ATF4 activates genes in response to endoplasmic reticulum  stress,1/22,27/10899,0.05315581650880863,0.19817296083705568,0.15910407203688684,HERPUD1,1
R-HSA-110314,Recognition of DNA damage by PCNA-containing replication complex,1/22,30/10899,0.05889267008562338,0.19817296083705568,0.15910407203688684,POLD4,1
R-HSA-4090294,SUMOylation of intracellular receptors,1/22,30/10899,0.05889267008562338,0.19817296083705568,0.15910407203688684,PPARG,1
R-HSA-418360,Platelet calcium homeostasis,1/22,30/10899,0.05889267008562338,0.19817296083705568,0.15910407203688684,P2RX4,1
R-HSA-5260271,Diseases of Immune System,1/22,31/10899,0.060797570376185384,0.19817296083705568,0.15910407203688684,MYD88,1
R-HSA-5602358,Diseases associated with the TLR signaling cascade,1/22,31/10899,0.060797570376185384,0.19817296083705568,0.15910407203688684,MYD88,1
R-HSA-913531,Interferon Signaling,2/22,200/10899,0.06087090454064439,0.19817296083705568,0.15910407203688684,TRIM38/HLA-DRB1,2
R-HSA-381042,PERK regulates gene expression,1/22,32/10899,0.06269878986935096,0.19817296083705568,0.15910407203688684,HERPUD1,1
R-HSA-5656169,Termination of translesion DNA synthesis,1/22,32/10899,0.06269878986935096,0.19817296083705568,0.15910407203688684,POLD4,1
R-HSA-69190,DNA strand elongation,1/22,32/10899,0.06269878986935096,0.19817296083705568,0.15910407203688684,POLD4,1
R-HSA-1638074,Keratan sulfate/keratin metabolism,1/22,34/10899,0.06649021354871187,0.19947064064613562,0.16014592023329355,HEXA,1
R-HSA-174417,Telomere C-strand (Lagging Strand) Synthesis,1/22,34/10899,0.06649021354871187,0.19947064064613562,0.16014592023329355,POLD4,1
R-HSA-202433,Generation of second messenger molecules,1/22,34/10899,0.06649021354871187,0.19947064064613562,0.16014592023329355,HLA-DRB1,1
R-HSA-156590,Glutathione conjugation,1/22,36/10899,0.07026699517580814,0.20593584566046194,0.16533653978092397,MGST2,1
R-HSA-6798695,Neutrophil degranulation,3/22,482/10899,0.07097224059484847,0.20593584566046194,0.16533653978092397,ATP8B4/ATG7/VNN1,3
R-HSA-75105,Fatty acyl-CoA biosynthesis,1/22,38/10899,0.07402918861384356,0.21134139330081145,0.169676408537672,ACSL1,1
R-HSA-110313,Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template,1/22,39/10899,0.07590483154271732,0.21325643147715817,0.1712139057354526,POLD4,1
R-HSA-8853659,RET signaling,1/22,40/10899,0.07777684753775083,0.2135940615209394,0.17148497356721276,DOK1,1
R-HSA-3560782,Diseases associated with glycosaminoglycan metabolism,1/22,41/10899,0.07964524327899436,0.2135940615209394,0.17148497356721276,HEXA,1
R-HSA-5696400,Dual Incision in GG-NER,1/22,41/10899,0.07964524327899436,0.2135940615209394,0.17148497356721276,POLD4,1
R-HSA-5675221,Negative regulation of MAPK pathway,1/22,43/10899,0.08337120066189407,0.22024929130082463,0.17682815537086724,PTPN7,1
R-HSA-1660662,Glycosphingolipid metabolism,1/22,46/10899,0.08893315116301626,0.2314877611154982,0.18585101249237143,HEXA,1
R-HSA-73893,DNA Damage Bypass,1/22,48/10899,0.0926232050360678,0.23511037769904206,0.1887594468591774,POLD4,1
R-HSA-1793185,Chondroitin sulfate/dermatan sulfate metabolism,1/22,50/10899,0.09629898996732611,0.23511037769904206,0.1887594468591774,HEXA,1
R-HSA-180786,Extension of Telomeres,1/22,51/10899,0.09813154801145163,0.23511037769904206,0.1887594468591774,POLD4,1
R-HSA-2428928,IRS-related events triggered by IGF1R,1/22,52/10899,0.09996055851511587,0.23511037769904206,0.1887594468591774,IGF1,1
R-HSA-383280,Nuclear Receptor transcription pathway,1/22,52/10899,0.09996055851511587,0.23511037769904206,0.1887594468591774,PPARG,1
R-HSA-1257604,PIP3 activates AKT signaling,2/22,267/10899,0.1002453288288923,0.23511037769904206,0.1887594468591774,PPARG/MYD88,2
R-HSA-2428924,IGF1R signaling cascade,1/22,53/10899,0.10178602801937198,0.23511037769904206,0.1887594468591774,IGF1,1
R-HSA-2404192,Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R),1/22,54/10899,0.10360796305381514,0.23511037769904206,0.1887594468591774,IGF1,1
R-HSA-8848021,Signaling by PTK6,1/22,54/10899,0.10360796305381514,0.23511037769904206,0.1887594468591774,DOK1,1
R-HSA-9006927,Signaling by Non-Receptor Tyrosine Kinases,1/22,54/10899,0.10360796305381514,0.23511037769904206,0.1887594468591774,DOK1,1
R-HSA-936837,Ion transport by P-type ATPases,1/22,57/10899,0.10905262646274017,0.24433309979626594,0.19616395166515554,ATP8B4,1
R-HSA-110328,Recognition and association of DNA glycosylase with site containing an affected pyrimidine,1/22,61/10899,0.11626308922861384,0.2450356856942177,0.1967280259810847,MBD4,1
R-HSA-110329,Cleavage of the damaged pyrimidine ,1/22,61/10899,0.11626308922861384,0.2450356856942177,0.1967280259810847,MBD4,1
R-HSA-73928,Depyrimidination,1/22,61/10899,0.11626308922861384,0.2450356856942177,0.1967280259810847,MBD4,1
R-HSA-8943724,Regulation of PTEN gene transcription,1/22,61/10899,0.11626308922861384,0.2450356856942177,0.1967280259810847,PPARG,1
R-HSA-8986944,Transcriptional Regulation by MECP2,1/22,62/10899,0.11805698220120786,0.2450356856942177,0.1967280259810847,PPARG,1
R-HSA-73929,"Base-Excision Repair, AP Site Formation",1/22,63/10899,0.11984739895783525,0.2450356856942177,0.1967280259810847,MBD4,1
R-HSA-1834949,Cytosolic sensors of pathogen-associated DNA ,1/22,64/10899,0.1216343459145468,0.2450356856942177,0.1967280259810847,MYD88,1
R-HSA-1474244,Extracellular matrix organization,2/22,300/10899,0.12172721933905153,0.2450356856942177,0.1967280259810847,ITGA4/CRTAP,2
R-HSA-6782210,Gap-filling DNA repair synthesis and ligation in TC-NER,1/22,65/10899,0.12341782947614144,0.2450356856942177,0.1967280259810847,POLD4,1
R-HSA-6782135,Dual incision in TC-NER,1/22,66/10899,0.12519785603618672,0.2450356856942177,0.1967280259810847,POLD4,1
R-HSA-1650814,Collagen biosynthesis and modifying enzymes,1/22,67/10899,0.12697443197703429,0.2450356856942177,0.1967280259810847,CRTAP,1
R-HSA-6802952,Signaling by BRAF and RAF1 fusions,1/22,67/10899,0.12697443197703429,0.2450356856942177,0.1967280259810847,ATG7,1
R-HSA-9006925,Intracellular signaling by second messengers,2/22,309/10899,0.1277786079044313,0.2450356856942177,0.1967280259810847,PPARG/MYD88,2
R-HSA-5685942,HDR through Homologous Recombination (HRR),1/22,68/10899,0.1287475636698432,0.2450356856942177,0.1967280259810847,POLD4,1
R-HSA-388841,Costimulation by the CD28 family,1/22,69/10899,0.13051725747459475,0.24576121886173694,0.1973105236178084,HLA-DRB1,1
R-HSA-73894,DNA Repair,2/22,336/10899,0.1463599811910515,0.27269175442964333,0.21893182782040946,POLD4/MBD4,2
R-HSA-6781827,Transcription-Coupled Nucleotide Excision Repair (TC-NER),1/22,79/10899,0.1480265029208574,0.2729238647603308,0.21911817866574285,POLD4,1
R-HSA-381340,Transcriptional regulation of white adipocyte differentiation,1/22,84/10899,0.15665440878178882,0.2776146297052615,0.22288418085168188,PPARG,1
R-HSA-5696399,Global Genome Nucleotide Excision Repair (GG-NER),1/22,84/10899,0.15665440878178882,0.2776146297052615,0.22288418085168188,POLD4,1
R-HSA-6802957,Oncogenic MAPK signaling,1/22,84/10899,0.15665440878178882,0.2776146297052615,0.22288418085168188,ATG7,1
R-HSA-216083,Integrin cell surface interactions,1/22,85/10899,0.15836995228680917,0.2776146297052615,0.22288418085168188,ITGA4,1
R-HSA-418346,Platelet homeostasis,1/22,88/10899,0.16349661867599397,0.2776146297052615,0.22288418085168188,P2RX4,1
R-HSA-1236974,ER-Phagosome pathway,1/22,90/10899,0.16689782098151207,0.2776146297052615,0.22288418085168188,MYD88,1
R-HSA-1474290,Collagen formation,1/22,90/10899,0.16689782098151207,0.2776146297052615,0.22288418085168188,CRTAP,1
R-HSA-428157,Sphingolipid metabolism,1/22,90/10899,0.16689782098151207,0.2776146297052615,0.22288418085168188,HEXA,1
R-HSA-2980736,Peptide hormone metabolism,1/22,91/10899,0.16859346793667984,0.2776146297052615,0.22288418085168188,IGF1,1
R-HSA-163125,Post-translational modification: synthesis of GPI-anchored proteins,1/22,92/10899,0.1702858202410279,0.2776146297052615,0.22288418085168188,VNN1,1
R-HSA-381119,Unfolded Protein Response (UPR),1/22,94/10899,0.17366066527555724,0.2776146297052615,0.22288418085168188,HERPUD1,1
R-HSA-8878159,Transcriptional regulation by RUNX3,1/22,96/10899,0.17702240473458575,0.2776146297052615,0.22288418085168188,ITGA4,1
R-HSA-983169,Class I MHC mediated antigen processing & presentation,2/22,381/10899,0.17850822347489667,0.2776146297052615,0.22288418085168188,MYD88/ATG7,2
R-HSA-168142,Toll Like Receptor 10 (TLR10) Cascade,1/22,97/10899,0.17869837502948926,0.2776146297052615,0.22288418085168188,MYD88,1
R-HSA-168176,Toll Like Receptor 5 (TLR5) Cascade,1/22,97/10899,0.17869837502948926,0.2776146297052615,0.22288418085168188,MYD88,1
R-HSA-193704,p75 NTR receptor-mediated signalling,1/22,97/10899,0.17869837502948926,0.2776146297052615,0.22288418085168188,MYD88,1
R-HSA-975871,MyD88 cascade initiated on plasma membrane,1/22,97/10899,0.17869837502948926,0.2776146297052615,0.22288418085168188,MYD88,1
R-HSA-202424,Downstream TCR signaling,1/22,98/10899,0.18037108709663885,0.2776146297052615,0.22288418085168188,HLA-DRB1,1
R-HSA-5619102,SLC transporter disorders,1/22,98/10899,0.18037108709663885,0.2776146297052615,0.22288418085168188,SLC2A9,1
R-HSA-9679191,Potential therapeutics for SARS,1/22,99/10899,0.18204054696923155,0.2777687656340861,0.22300792959025645,ITGA4,1
R-HSA-975138,TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation,1/22,103/10899,0.18868598480684473,0.2831842862983683,0.22735580523508606,MYD88,1
R-HSA-975155,MyD88 dependent cascade initiated on endosome,1/22,104/10899,0.19033927383372984,0.2831842862983683,0.22735580523508606,MYD88,1
R-HSA-1236975,Antigen processing-Cross presentation,1/22,105/10899,0.19198934664296152,0.2831842862983683,0.22735580523508606,MYD88,1
R-HSA-168181,Toll Like Receptor 7/8 (TLR7/8) Cascade,1/22,105/10899,0.19198934664296152,0.2831842862983683,0.22735580523508606,MYD88,1
R-HSA-6811558,"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling",1/22,106/10899,0.19363620919380975,0.28325296716780435,0.22741094598664044,MYD88,1
R-HSA-168138,Toll Like Receptor 9 (TLR9) Cascade,1/22,108/10899,0.19692032730499642,0.28358007734774876,0.22767356789738974,MYD88,1
R-HSA-156580,Phase II - Conjugation of compounds,1/22,109/10899,0.19855759473148948,0.28358007734774876,0.22767356789738974,MGST2,1
R-HSA-5696398,Nucleotide Excision Repair,1/22,111/10899,0.20182257591335073,0.28358007734774876,0.22767356789738974,POLD4,1
R-HSA-157579,Telomere Maintenance,1/22,113/10899,0.20507485819498217,0.28358007734774876,0.22767356789738974,POLD4,1
R-HSA-166058,MyD88:MAL(TIRAP) cascade initiated on plasma membrane,1/22,113/10899,0.20507485819498217,0.28358007734774876,0.22767356789738974,MYD88,1
R-HSA-168188,Toll Like Receptor TLR6:TLR2 Cascade,1/22,113/10899,0.20507485819498217,0.28358007734774876,0.22767356789738974,MYD88,1
R-HSA-199418,Negative regulation of the PI3K/AKT network,1/22,113/10899,0.20507485819498217,0.28358007734774876,0.22767356789738974,MYD88,1
R-HSA-9020702,Interleukin-1 signaling,1/22,115/10899,0.2083144886245505,0.2836453023451489,0.2277259340862034,MYD88,1
R-HSA-168179,Toll Like Receptor TLR1:TLR2 Cascade,1/22,116/10899,0.20992957405205936,0.2836453023451489,0.2277259340862034,MYD88,1
R-HSA-181438,Toll Like Receptor 2 (TLR2) Cascade,1/22,116/10899,0.20992957405205936,0.2836453023451489,0.2277259340862034,MYD88,1
R-HSA-202403,TCR signaling,1/22,120/10899,0.21635852010628343,0.2898207019435244,0.23268388202423898,HLA-DRB1,1
R-HSA-69239,Synthesis of DNA,1/22,121/10899,0.21795793680149245,0.2898207019435244,0.23268388202423898,POLD4,1
R-HSA-2132295,MHC class II antigen presentation,1/22,123/10899,0.22114742700026946,0.2898207019435244,0.23268388202423898,HLA-DRB1,1
R-HSA-1630316,Glycosaminoglycan metabolism,1/22,124/10899,0.22273751206021664,0.2898207019435244,0.23268388202423898,HEXA,1
R-HSA-196849,Metabolism of water-soluble vitamins and cofactors,1/22,124/10899,0.22273751206021664,0.2898207019435244,0.23268388202423898,VNN1,1
R-HSA-381426,Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs),1/22,125/10899,0.2243244981144793,0.2898207019435244,0.23268388202423898,IGF1,1
R-HSA-114608,Platelet degranulation ,1/22,129/10899,0.23064156717756024,0.29582287964078374,0.23750275796316273,IGF1,1
R-HSA-5693567,HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA),1/22,132/10899,0.23534711028975697,0.299354530412785,0.24033816001026453,POLD4,1
R-HSA-198933,Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell,1/22,134/10899,0.23846886321018468,0.299354530412785,0.24033816001026453,ITGA4,1
R-HSA-76005,Response to elevated platelet cytosolic Ca2+,1/22,134/10899,0.23846886321018468,0.299354530412785,0.24033816001026453,IGF1,1
R-HSA-1632852,Macroautophagy,1/22,136/10899,0.2415784483896679,0.300176917132284,0.24099841696615132,ATG7,1
R-HSA-5693538,Homology Directed Repair,1/22,138/10899,0.24467591100472152,0.300176917132284,0.24099841696615132,POLD4,1
R-HSA-449147,Signaling by Interleukins,2/22,473/10899,0.24713656388994665,0.300176917132284,0.24099841696615132,MYD88/PTPN7,2
R-HSA-5663220,RHO GTPases Activate Formins,1/22,140/10899,0.24776129607248465,0.300176917132284,0.24099841696615132,FMNL1,1
R-HSA-6807070,PTEN Regulation,1/22,140/10899,0.24776129607248465,0.300176917132284,0.24099841696615132,PPARG,1
R-HSA-73886,Chromosome Maintenance,1/22,141/10899,0.24929947355054094,0.300176917132284,0.24099841696615132,POLD4,1
R-HSA-3781865,Diseases of glycosylation,1/22,143/10899,0.252366826357184,0.3018170828731187,0.2423152315662862,HEXA,1
R-HSA-166016,Toll Like Receptor 4 (TLR4) Cascade,1/22,146/10899,0.25694543378398393,0.303195611865101,0.24342198990061636,MYD88,1
R-HSA-73887,Death Receptor Signalling,1/22,146/10899,0.25694543378398393,0.303195611865101,0.24342198990061636,MYD88,1
R-HSA-9612973,Autophagy,1/22,151/10899,0.2645170244523104,0.31006300217257576,0.2489355057585354,ATG7,1
R-HSA-9013148,CDC42 GTPase cycle,1/22,155/10899,0.27052121427382014,0.3150148350425406,0.25291110752746343,FMNL1,1
R-HSA-69242,S Phase,1/22,163/10899,0.28238952593632327,0.3262547203824931,0.2619351011099409,POLD4,1
R-HSA-9658195,Leishmania infection,1/22,164/10899,0.2838600392028471,0.3262547203824931,0.2619351011099409,P2RX4,1
R-HSA-168898,Toll-like Receptor Cascades,1/22,168/10899,0.28971337937536235,0.32871325736819956,0.26390894882371063,MYD88,1
R-HSA-5693532,DNA Double-Strand Break Repair,1/22,168/10899,0.28971337937536235,0.32871325736819956,0.26390894882371063,POLD4,1
R-HSA-5619115,Disorders of transmembrane transporters,1/22,176/10899,0.30128334629128617,0.3391195411574554,0.27226368157155206,SLC2A9,1
R-HSA-8978868,Fatty acid metabolism,1/22,177/10899,0.3027168785473331,0.3391195411574554,0.27226368157155206,ACSL1,1
R-HSA-3108232,SUMO E3 ligases SUMOylate target proteins,1/22,182/10899,0.30984252891847774,0.34491904162622994,0.27691983716646473,PPARG,1
R-HSA-9013149,RAC1 GTPase cycle,1/22,185/10899,0.3140844981395178,0.3456403581695796,0.27749894946710235,FMNL1,1
R-HSA-983712,Ion channel transport,1/22,186/10899,0.3154929488620236,0.3456403581695796,0.27749894946710235,ATP8B4,1
R-HSA-2990846,SUMOylation,1/22,188/10899,0.3183015727776355,0.3456403581695796,0.27749894946710235,PPARG,1
R-HSA-69306,DNA Replication,1/22,188/10899,0.3183015727776355,0.3456403581695796,0.27749894946710235,POLD4,1
R-HSA-196854,Metabolism of vitamins and cofactors,1/22,190/10899,0.32109919430680745,0.3465521792213715,0.27823100918754173,VNN1,1
R-HSA-211859,Biological oxidations,1/22,222/10899,0.3643978742797126,0.3908995378636917,0.31383548981027887,MGST2,1
R-HSA-5668914,Diseases of metabolism,1/22,249/10899,0.3988684544810044,0.4240689248869407,0.34046568456578646,HEXA,1
R-HSA-425407,SLC-mediated transmembrane transport,1/22,250/10899,0.4001102285656446,0.4240689248869407,0.34046568456578646,SLC2A9,1
R-HSA-76002,"Platelet activation, signaling and aggregation",1/22,263/10899,0.416032117044115,0.43831955188576405,0.351906865920774,IGF1,1
R-HSA-5673001,RAF/MAP kinase cascade,1/22,280/10899,0.4362451788144597,0.45689583816662344,0.3668209227029091,PTPN7,1
R-HSA-5684996,MAPK1/MAPK3 signaling,1/22,286/10899,0.443218398149303,0.46146856748486254,0.3704921594436898,PTPN7,1
R-HSA-71387,Metabolism of carbohydrates,1/22,295/10899,0.4535240563718028,0.4694371811567784,0.37688979753889434,HEXA,1
R-HSA-983168,Antigen processing: Ubiquitination & Proteasome degradation,1/22,309/10899,0.4691939947568339,0.48283335506953257,0.3876449773082777,ATG7,1
R-HSA-5683057,MAPK family signaling cascades,1/22,325/10899,0.4865772780242512,0.4971376471162349,0.3991292438934982,PTPN7,1
R-HSA-195258,RHO GTPase Effectors,1/22,327/10899,0.4887115853007056,0.4971376471162349,0.3991292438934982,FMNL1,1
R-HSA-9679506,SARS-CoV Infections,1/22,413/10899,0.5728824706532061,0.5794296988892427,0.465197795718393,ITGA4,1
R-HSA-5663202,Diseases of signal transduction by growth factor receptors and second messengers,1/22,433/10899,0.5904674904220988,0.5938224193449516,0.4767530574580343,ATG7,1
R-HSA-9012999,RHO GTPase cycle,1/22,449/10899,0.604035722551127,0.604035722551127,0.48495285485817513,FMNL1,1
HALLMARK_IL6_JAK_STAT3_SIGNALING,HALLMARK_IL6_JAK_STAT3_SIGNALING,2/13,87/4383,0.026359553797909992,0.44154842411221995,0.44032529828365424,MYD88/ITGA4,2
HALLMARK_FATTY_ACID_METABOLISM,HALLMARK_FATTY_ACID_METABOLISM,2/13,158/4383,0.0776477698789256,0.44154842411221995,0.44032529828365424,ACSL1/VNN1,2
HALLMARK_INTERFERON_GAMMA_RESPONSE,HALLMARK_INTERFERON_GAMMA_RESPONSE,2/13,200/4383,0.1161969537137421,0.44154842411221995,0.44032529828365424,HLA-DRB1/MYD88,2
HALLMARK_MYOGENESIS,HALLMARK_MYOGENESIS,2/13,200/4383,0.1161969537137421,0.44154842411221995,0.44032529828365424,IGF1/ACSL1,2
HALLMARK_XENOBIOTIC_METABOLISM,HALLMARK_XENOBIOTIC_METABOLISM,2/13,200/4383,0.1161969537137421,0.44154842411221995,0.44032529828365424,IGF1/VNN1,2
HALLMARK_CHOLESTEROL_HOMEOSTASIS,HALLMARK_CHOLESTEROL_HOMEOSTASIS,1/13,74/4383,0.1988159005910275,0.4555689697149634,0.4543070058099358,PPARG,1
HALLMARK_ANDROGEN_RESPONSE,HALLMARK_ANDROGEN_RESPONSE,1/13,100/4383,0.2595170727490167,0.4555689697149634,0.4543070058099358,MERTK,1
HALLMARK_PEROXISOME,HALLMARK_PEROXISOME,1/13,104/4383,0.2684695657613998,0.4555689697149634,0.4543070058099358,ACSL1,1
HALLMARK_PI3K_AKT_MTOR_SIGNALING,HALLMARK_PI3K_AKT_MTOR_SIGNALING,1/13,105/4383,0.2706920232620076,0.4555689697149634,0.4543070058099358,MYD88,1
HALLMARK_BILE_ACID_METABOLISM,HALLMARK_BILE_ACID_METABOLISM,1/13,112/4383,0.28607556615311713,0.4555689697149634,0.4543070058099358,ACSL1,1
HALLMARK_UNFOLDED_PROTEIN_RESPONSE,HALLMARK_UNFOLDED_PROTEIN_RESPONSE,1/13,113/4383,0.28824859767735256,0.4555689697149634,0.4543070058099358,HERPUD1,1
HALLMARK_UV_RESPONSE_DN,HALLMARK_UV_RESPONSE_DN,1/13,144/4383,0.35266030113423097,0.4555689697149634,0.4543070058099358,PPARG,1
HALLMARK_DNA_REPAIR,HALLMARK_DNA_REPAIR,1/13,150/4383,0.36448769079044985,0.4555689697149634,0.4543070058099358,POLD4,1
HALLMARK_IL2_STAT5_SIGNALING,HALLMARK_IL2_STAT5_SIGNALING,1/13,199/4383,0.4538721096349573,0.4555689697149634,0.4543070058099358,P2RX4,1
HALLMARK_ADIPOGENESIS,HALLMARK_ADIPOGENESIS,1/13,200/4383,0.4555689697149634,0.4555689697149634,0.4543070058099358,PPARG,1
HALLMARK_GLYCOLYSIS,HALLMARK_GLYCOLYSIS,1/13,200/4383,0.4555689697149634,0.4555689697149634,0.4543070058099358,MERTK,1
HALLMARK_HEME_METABOLISM,HALLMARK_HEME_METABOLISM,1/13,200/4383,0.4555689697149634,0.4555689697149634,0.4543070058099358,HTATIP2,1
HALLMARK_HYPOXIA,HALLMARK_HYPOXIA,1/13,200/4383,0.4555689697149634,0.4555689697149634,0.4543070058099358,HEXA,1
HALLMARK_INFLAMMATORY_RESPONSE,HALLMARK_INFLAMMATORY_RESPONSE,1/13,200/4383,0.4555689697149634,0.4555689697149634,0.4543070058099358,P2RX4,1
VERHAAK_GLIOBLASTOMA_MESENCHYMAL,VERHAAK_GLIOBLASTOMA_MESENCHYMAL,7/25,216/21728,3.594494995184906e-9,3.3213133755508533e-6,2.0885907761495456e-6,POLD4/MGST2/TRIM38/HEXA/ACSL1/FMNL1/ITGA4,7
GERHOLD_ADIPOGENESIS_UP,GERHOLD_ADIPOGENESIS_UP,3/25,48/21728,2.2489585647278534e-5,0.010390188569042683,0.006533816461735659,PPARG/IGF1/ACSL1,3
MULLIGHAN_MLL_SIGNATURE_1_UP,MULLIGHAN_MLL_SIGNATURE_1_UP,5/25,386/21728,6.833989075496391e-5,0.014072216564989441,0.008849240765406894,POLD4/MGST2/TRIM38/ATP8B4/HTATIP2,5
WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP,WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP,5/25,392/21728,7.350704016639755e-5,0.014072216564989441,0.008849240765406894,SLC2A9/TRIM38/P2RX4/IGF1/ATP8B4,5
KEGG_LEISHMANIA_INFECTION,KEGG_LEISHMANIA_INFECTION,3/25,72/21728,7.614835803565714e-5,0.014072216564989441,0.008849240765406894,HLA-DRB1/MYD88/ITGA4,3
MULLIGHAN_MLL_SIGNATURE_2_UP,MULLIGHAN_MLL_SIGNATURE_2_UP,5/25,423/21728,1.0520017416259023e-4,0.015495668100969426,0.009744370917902853,POLD4/MGST2/TRIM38/ATP8B4/HTATIP2,5
JOHNSTONE_PARVB_TARGETS_3_UP,JOHNSTONE_PARVB_TARGETS_3_UP,5/25,433/21728,1.1739142500734414e-4,0.015495668100969426,0.009744370917902853,POLD4/HLA-DRB1/ACSL1/CRTAP/HTATIP2,5
VANLOO_SP3_TARGETS_DN,VANLOO_SP3_TARGETS_DN,3/25,88/21728,1.3841984433458869e-4,0.01598749202064499,0.010053651851670125,P2RX4/MYD88/CRTAP,3
LI_ADIPOGENESIS_BY_ACTIVATED_PPARG,LI_ADIPOGENESIS_BY_ACTIVATED_PPARG,2/25,17/21728,1.7103033298072678e-4,0.017559114186021282,0.011041958339808327,PPARG/ACSL1,2
SMID_BREAST_CANCER_NORMAL_LIKE_UP,SMID_BREAST_CANCER_NORMAL_LIKE_UP,5/25,484/21728,1.9740649199632897e-4,0.018240359860460797,0.011470356166523537,HLA-DRB1/IGF1/FMNL1/GIMAP5/ITGA4,5
HOSHIDA_LIVER_CANCER_SUBCLASS_S3,HOSHIDA_LIVER_CANCER_SUBCLASS_S3,4/25,266/21728,2.2684481640132613e-4,0.019054964577711393,0.011982616139093974,POLD4/MGST2/IGF1/ACSL1,4
STEGER_ADIPOGENESIS_UP,STEGER_ADIPOGENESIS_UP,2/25,21/21728,2.6334686772218395e-4,0.020277708814608164,0.012751532542337329,PPARG/ACSL1,2
WENG_POR_TARGETS_LIVER_DN,WENG_POR_TARGETS_LIVER_DN,2/25,22/21728,2.894773186870075e-4,0.02057515711283038,0.012938581369654102,IGF1/VNN1,2
DAVIES_MULTIPLE_MYELOMA_VS_MGUS_DN,DAVIES_MULTIPLE_MYELOMA_VS_MGUS_DN,2/25,26/21728,4.06126084962605e-4,0.025155479571142284,0.015818893510219346,MERTK/DOK1,2
GERY_CEBP_TARGETS,GERY_CEBP_TARGETS,3/25,131/21728,4.470290287830928e-4,0.025155479571142284,0.015818893510219346,PPARG/ACSL1/HTATIP2,3
WP_EBOLA_VIRUS_INFECTION_IN_HOST,WP_EBOLA_VIRUS_INFECTION_IN_HOST,3/25,131/21728,4.470290287830928e-4,0.025155479571142284,0.015818893510219346,HLA-DRB1/MERTK/ITGA4,3
RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN,RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN,4/25,321/21728,4.6281726483703335e-4,0.025155479571142284,0.015818893510219346,MYD88/ITGA4/HERPUD1/VNN1,4
WP_BASE_EXCISION_REPAIR,WP_BASE_EXCISION_REPAIR,2/25,31/21728,5.790279852262482e-4,0.029723436574947408,0.018691429698531523,POLD4/MBD4,2
APPEL_IMATINIB_RESPONSE,APPEL_IMATINIB_RESPONSE,2/25,33/21728,6.565507048827277e-4,0.030332642565582022,0.01907452574185609,PPARG/HEXA,2
ZHAN_LATE_DIFFERENTIATION_GENES_UP,ZHAN_LATE_DIFFERENTIATION_GENES_UP,2/25,33/21728,6.565507048827277e-4,0.030332642565582022,0.01907452574185609,IGF1/ITGA4,2
KEGG_BASE_EXCISION_REPAIR,KEGG_BASE_EXCISION_REPAIR,2/25,35/21728,7.388208278766504e-4,0.031996699837852416,0.02012095956994137,POLD4/MBD4,2
PACHER_TARGETS_OF_IGF1_AND_IGF2_UP,PACHER_TARGETS_OF_IGF1_AND_IGF2_UP,2/25,36/21728,7.817297611813962e-4,0.031996699837852416,0.02012095956994137,IGF1/HERPUD1,2
WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN,WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN,4/25,371/21728,7.964546496435125e-4,0.031996699837852416,0.02012095956994137,ACSL1/PTPN7/ITGA4/HERPUD1,4
REACTOME_RESOLUTION_OF_ABASIC_SITES_AP_SITES,REACTOME_RESOLUTION_OF_ABASIC_SITES_AP_SITES,2/25,38/21728,8.710825968093063e-4,0.03353667997715829,0.02108936813327794,POLD4/MBD4,2
TARTE_PLASMA_CELL_VS_PLASMABLAST_UP,TARTE_PLASMA_CELL_VS_PLASMABLAST_UP,4/25,398/21728,0.001034166224243074,0.03822278364802401,0.02403620024346008,MGST2/HEXA/MERTK/HERPUD1,4
JISON_SICKLE_CELL_DISEASE_UP,JISON_SICKLE_CELL_DISEASE_UP,3/25,182/21728,0.0011608179353103745,0.03891594348274228,0.024472090228382027,P2RX4/DOK1/HTATIP2,3
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP,2/25,44/21728,0.0011672376749744646,0.03891594348274228,0.024472090228382027,P2RX4/ACSL1,2
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP,LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP,3/25,183/21728,0.001179271014628554,0.03891594348274228,0.024472090228382027,MERTK/ACSL1/HERPUD1,3
YAMASHITA_LIVER_CANCER_STEM_CELL_UP,YAMASHITA_LIVER_CANCER_STEM_CELL_UP,2/25,47/21728,0.0013309941764566052,0.04076466325882638,0.025634648119015904,IGF1/MERTK,2
BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP,BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP,4/25,428/21728,0.0013526878291542027,0.04076466325882638,0.025634648119015904,PPARG/IGF1/ATP8B4/ITGA4,4
KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION,KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION,2/25,48/21728,0.001387885680404838,0.04076466325882638,0.025634648119015904,HLA-DRB1/ITGA4,2
BOCHKIS_FOXA2_TARGETS,BOCHKIS_FOXA2_TARGETS,4/25,433/21728,0.0014117632297429047,0.04076466325882638,0.025634648119015904,PPARG/MERTK/ACSL1/GIMAP5,4
MARTENS_BOUND_BY_PML_RARA_FUSION,MARTENS_BOUND_BY_PML_RARA_FUSION,4/25,456/21728,0.0017069986492871767,0.047795962180040945,0.030056244159697657,ATP8B4/ACSL1/FMNL1/ITGA4,4
BOQUEST_STEM_CELL_DN,BOQUEST_STEM_CELL_DN,3/25,218/21728,0.0019465635637951782,0.05151448624663153,0.03239461882905059,MGST2/HLA-DRB1/GIMAP5,3
ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_DN,ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_DN,2/25,57/21728,0.0019513062972208914,0.05151448624663153,0.03239461882905059,ACSL1/VNN1,2
SWEET_LUNG_CANCER_KRAS_UP,SWEET_LUNG_CANCER_KRAS_UP,4/25,482/21728,0.002089873334756663,0.05259750137248802,0.03307566730190635,PPARG/HEXA/HLA-DRB1/ITGA4,4
KYNG_DNA_DAMAGE_BY_4NQO_OR_UV,KYNG_DNA_DAMAGE_BY_4NQO_OR_UV,2/25,60/21728,0.0021594780000881125,0.05259750137248802,0.03307566730190635,IGF1/MYD88,2
LEE_LIVER_CANCER_MYC_DN,LEE_LIVER_CANCER_MYC_DN,2/25,63/21728,0.002377720881050024,0.05259750137248802,0.03307566730190635,IGF1/HERPUD1,2
ZWANG_EGF_PERSISTENTLY_DN,ZWANG_EGF_PERSISTENTLY_DN,2/25,63/21728,0.002377720881050024,0.05259750137248802,0.03307566730190635,POLD4/SLC2A9,2
LEE_LIVER_CANCER_E2F1_DN,LEE_LIVER_CANCER_E2F1_DN,2/25,64/21728,0.0024526950828322397,0.05259750137248802,0.03307566730190635,IGF1/ACSL1,2
LEE_LIVER_CANCER_MYC_E2F1_DN,LEE_LIVER_CANCER_MYC_E2F1_DN,2/25,64/21728,0.0024526950828322397,0.05259750137248802,0.03307566730190635,IGF1/ACSL1,2
WP_FERROPTOSIS,WP_FERROPTOSIS,2/25,65/21728,0.002528778490056869,0.05259750137248802,0.03307566730190635,ACSL1/ATG7,2
RUTELLA_RESPONSE_TO_HGF_DN,RUTELLA_RESPONSE_TO_HGF_DN,3/25,240/21728,0.0025577076612243264,0.05259750137248802,0.03307566730190635,MYD88/ITGA4/HERPUD1,3
BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP,BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP,2/25,66/21728,0.002605968659212061,0.05259750137248802,0.03307566730190635,HEXA/MERTK,2
URS_ADIPOCYTE_DIFFERENTIATION_UP,URS_ADIPOCYTE_DIFFERENTIATION_UP,2/25,66/21728,0.002605968659212061,0.05259750137248802,0.03307566730190635,PPARG/ACSL1,2
HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP,HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP,3/25,242/21728,0.0026184903280675855,0.05259750137248802,0.03307566730190635,P2RX4/HEXA/MYD88,3
WP_PPAR_SIGNALING_PATHWAY,WP_PPAR_SIGNALING_PATHWAY,2/25,67/21728,0.0026842631505531824,0.05277147130023704,0.03318506739317709,PPARG/ACSL1,2
GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP,GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP,3/25,247/21728,0.002774353955012705,0.05340631363399457,0.03358428471857485,MGST2/IGF1/ATG7,3
KEGG_PPAR_SIGNALING_PATHWAY,KEGG_PPAR_SIGNALING_PATHWAY,2/25,69/21728,0.002844155359621557,0.05363264392429222,0.033726611353621906,PPARG/ACSL1,2
ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN,ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN,2/25,74/21728,0.003263041461458531,0.05911637106575057,0.037175024867047525,PTPN7/HERPUD1,2
FOSTER_KDM1A_TARGETS_UP,FOSTER_KDM1A_TARGETS_UP,3/25,265/21728,0.003382622399954605,0.05911637106575057,0.037175024867047525,MGST2/HLA-DRB1/HTATIP2,3
HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_DN,HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_DN,2/25,76/21728,0.0034382073716160205,0.05911637106575057,0.037175024867047525,MGST2/HEXA,2
CAIRO_HEPATOBLASTOMA_DN,CAIRO_HEPATOBLASTOMA_DN,3/25,267/21728,0.0034548528544919165,0.05911637106575057,0.037175024867047525,IGF1/ACSL1/VNN1,3
ROZANOV_MMP14_TARGETS_UP,ROZANOV_MMP14_TARGETS_UP,3/25,267/21728,0.0034548528544919165,0.05911637106575057,0.037175024867047525,PPARG/HERPUD1/DOK1,3
RUAN_RESPONSE_TO_TNF_DN,RUAN_RESPONSE_TO_TNF_DN,2/25,79/21728,0.0037090512310359812,0.06231206068140449,0.039184617790083476,PPARG/ACSL1,2
HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN,HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN,3/25,282/21728,0.004026948645901425,0.06622302364855544,0.041644006668948054,FMNL1/ITGA4/HERPUD1,3
KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM,KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM,2/25,83/21728,0.004085186523774524,0.06622302364855544,0.041644006668948054,IGF1/ITGA4,2
NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN,NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN,2/25,85/21728,0.00427964419796378,0.06702358032065309,0.042147432600820815,PPARG/IGF1,2
SMID_BREAST_CANCER_LUMINAL_A_UP,SMID_BREAST_CANCER_LUMINAL_A_UP,2/25,85/21728,0.00427964419796378,0.06702358032065309,0.042147432600820815,PPARG/IGF1,2
KEGG_HEMATOPOIETIC_CELL_LINEAGE,KEGG_HEMATOPOIETIC_CELL_LINEAGE,2/25,87/21728,0.004478336581151765,0.06783578690138084,0.04265818451761474,HLA-DRB1/ITGA4,2
WP_TCELL_ACTIVATION_SARSCOV2,WP_TCELL_ACTIVATION_SARSCOV2,2/25,87/21728,0.004478336581151765,0.06783578690138084,0.04265818451761474,HLA-DRB1/MYD88,2
LIU_VAV3_PROSTATE_CARCINOGENESIS_UP,LIU_VAV3_PROSTATE_CARCINOGENESIS_UP,2/25,89/21728,0.004681244764622667,0.06801029343051984,0.042767922047900385,PPARG/IGF1,2
REACTOME_BASE_EXCISION_REPAIR,REACTOME_BASE_EXCISION_REPAIR,2/25,89/21728,0.004681244764622667,0.06801029343051984,0.042767922047900385,POLD4/MBD4,2
KEGG_DILATED_CARDIOMYOPATHY,KEGG_DILATED_CARDIOMYOPATHY,2/25,90/21728,0.004784273888510595,0.06801029343051984,0.042767922047900385,IGF1/ITGA4,2
UEDA_CENTRAL_CLOCK,UEDA_CENTRAL_CLOCK,2/25,90/21728,0.004784273888510595,0.06801029343051984,0.042767922047900385,HLA-DRB1/HERPUD1,2
WALLACE_PROSTATE_CANCER_RACE_UP,WALLACE_PROSTATE_CANCER_RACE_UP,3/25,303/21728,0.004920186460630167,0.06888261044882234,0.04331647410315554,HLA-DRB1/PTPN7/ITGA4,3
REACTOME_INTERFERON_GAMMA_SIGNALING,REACTOME_INTERFERON_GAMMA_SIGNALING,2/25,93/21728,0.005099633190259186,0.07032926966864908,0.04422619828787229,TRIM38/HLA-DRB1,2
HORIUCHI_WTAP_TARGETS_UP,HORIUCHI_WTAP_TARGETS_UP,3/25,309/21728,0.0051956866235527465,0.07060021235533438,0.044396579198159696,HEXA/ITGA4/HTATIP2,3
WIELAND_UP_BY_HBV_INFECTION,WIELAND_UP_BY_HBV_INFECTION,2/25,103/21728,0.006218068386499975,0.08326804621921706,0.05236268114947347,HLA-DRB1/GIMAP5,2
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4,PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4,2/25,108/21728,0.006815555276641655,0.08869821233263224,0.05577741308682274,PPARG/HLA-DRB1,2
WP_THERMOGENESIS,WP_THERMOGENESIS,2/25,108/21728,0.006815555276641655,0.08869821233263224,0.05577741308682274,PPARG/ACSL1,2
BOSCO_TH1_CYTOTOXIC_MODULE,BOSCO_TH1_CYTOTOXIC_MODULE,2/25,114/21728,0.007565686003747004,0.09709297038141988,0.061056413363572315,MERTK/GIMAP5,2
LAIHO_COLORECTAL_CANCER_SERRATED_UP,LAIHO_COLORECTAL_CANCER_SERRATED_UP,2/25,115/21728,0.007694191447264752,0.0973894917434607,0.061242879291854985,HLA-DRB1/MBD4,2
SANSOM_APC_TARGETS_DN,SANSOM_APC_TARGETS_DN,3/25,361/21728,0.0079769079927572,0.09960355385550881,0.06263518082506364,MGST2/MERTK/FMNL1,3
BURTON_ADIPOGENESIS_5,BURTON_ADIPOGENESIS_5,2/25,118/21728,0.008085634485034172,0.099615016855621,0.06264238927352792,PPARG/ACSL1,2
REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,2/25,120/21728,0.008351512901804891,0.10153681475352262,0.06385090196393768,PPARG/ACSL1,2
WP_DNA_REPAIR_PATHWAYS_FULL_NETWORK,WP_DNA_REPAIR_PATHWAYS_FULL_NETWORK,2/25,121/21728,0.008485920286805835,0.10183104344167002,0.06403592615607412,POLD4/MBD4,2
BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_DN,BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_DN,2/25,126/21728,0.009172549485479577,0.105953488960389,0.0666283047461093,HERPUD1/CRTAP,2
KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP,KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP,2/25,130/21728,0.009739229962708991,0.105953488960389,0.0666283047461093,MGST2/MYD88,2
LINDGREN_BLADDER_CANCER_CLUSTER_2B,LINDGREN_BLADDER_CANCER_CLUSTER_2B,3/25,389/21728,0.009777798058795141,0.105953488960389,0.0666283047461093,HLA-DRB1/PTPN7/ITGA4,3
WP_ADIPOGENESIS,WP_ADIPOGENESIS,2/25,131/21728,0.009883295093467552,0.105953488960389,0.0666283047461093,PPARG/IGF1,2
KEGG_CELL_ADHESION_MOLECULES_CAMS,KEGG_CELL_ADHESION_MOLECULES_CAMS,2/25,133/21728,0.010174283920717737,0.105953488960389,0.0666283047461093,HLA-DRB1/ITGA4,2
SERVITJA_LIVER_HNF1A_TARGETS_UP,SERVITJA_LIVER_HNF1A_TARGETS_UP,2/25,135/21728,0.01046906950839402,0.105953488960389,0.0666283047461093,PPARG/MGST2,2
REACTOME_INTERLEUKIN_1_FAMILY_SIGNALING,REACTOME_INTERLEUKIN_1_FAMILY_SIGNALING,2/25,140/21728,0.011222529304519469,0.105953488960389,0.0666283047461093,MYD88/PTPN7,2
PEDRIOLI_MIR31_TARGETS_DN,PEDRIOLI_MIR31_TARGETS_DN,3/25,412/21728,0.011421770931904022,0.105953488960389,0.0666283047461093,P2RX4/FMNL1/MYD88,3
WP_DEGRADATION_PATHWAY_OF_SPHINGOLIPIDS_INCLUDING_DISEASES,WP_DEGRADATION_PATHWAY_OF_SPHINGOLIPIDS_INCLUDING_DISEASES,1/25,10/21728,0.011448859008587053,0.105953488960389,0.0666283047461093,HEXA,1
LIM_MAMMARY_STEM_CELL_DN,LIM_MAMMARY_STEM_CELL_DN,3/25,416/21728,0.0117230788365912,0.105953488960389,0.0666283047461093,P2RX4/PRR13/HTATIP2,3
GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB,GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB,2/25,145/21728,0.0119993367205697,0.105953488960389,0.0666283047461093,ACSL1/MBD4,2
SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN,SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN,2/25,145/21728,0.0119993367205697,0.105953488960389,0.0666283047461093,ACSL1/VNN1,2
WP_NRF2_PATHWAY,WP_NRF2_PATHWAY,2/25,145/21728,0.0119993367205697,0.105953488960389,0.0666283047461093,SLC2A9/MGST2,2
KAUFFMANN_DNA_REPLICATION_GENES,KAUFFMANN_DNA_REPLICATION_GENES,2/25,146/21728,0.012157476077112482,0.105953488960389,0.0666283047461093,POLD4/IGF1,2
BIOCARTA_BBCELL_PATHWAY,BIOCARTA_BBCELL_PATHWAY,1/25,11/21728,0.012586798898299834,0.105953488960389,0.0666283047461093,HLA-DRB1,1
BIOCARTA_EOSINOPHILS_PATHWAY,BIOCARTA_EOSINOPHILS_PATHWAY,1/25,11/21728,0.012586798898299834,0.105953488960389,0.0666283047461093,HLA-DRB1,1
BIOCARTA_MONOCYTE_PATHWAY,BIOCARTA_MONOCYTE_PATHWAY,1/25,11/21728,0.012586798898299834,0.105953488960389,0.0666283047461093,ITGA4,1
WP_NAD_METABOLISM_SIRTUINS_AND_AGING,WP_NAD_METABOLISM_SIRTUINS_AND_AGING,1/25,11/21728,0.012586798898299834,0.105953488960389,0.0666283047461093,PPARG,1
WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR,WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR,2/25,150/21728,0.012799221260534914,0.105953488960389,0.0666283047461093,POLD4/MYD88,2
THUM_SYSTOLIC_HEART_FAILURE_UP,THUM_SYSTOLIC_HEART_FAILURE_UP,3/25,430/21728,0.012813951180517806,0.105953488960389,0.0666283047461093,HLA-DRB1/CRTAP/HTATIP2,3
BIDUS_METASTASIS_DN,BIDUS_METASTASIS_DN,2/25,155/21728,0.013621914548914673,0.105953488960389,0.0666283047461093,ATP8B4/DOK1,2
GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP,GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP,1/25,12/21728,0.013723481222172706,0.105953488960389,0.0666283047461093,ITGA4,1
MIZUSHIMA_AUTOPHAGOSOME_FORMATION,MIZUSHIMA_AUTOPHAGOSOME_FORMATION,1/25,12/21728,0.013723481222172706,0.105953488960389,0.0666283047461093,ATG7,1
PARK_TRETINOIN_RESPONSE,PARK_TRETINOIN_RESPONSE,1/25,12/21728,0.013723481222172706,0.105953488960389,0.0666283047461093,MERTK,1
REACTOME_HYALURONAN_UPTAKE_AND_DEGRADATION,REACTOME_HYALURONAN_UPTAKE_AND_DEGRADATION,1/25,12/21728,0.013723481222172706,0.105953488960389,0.0666283047461093,HEXA,1
MITSIADES_RESPONSE_TO_APLIDIN_UP,MITSIADES_RESPONSE_TO_APLIDIN_UP,3/25,445/21728,0.014045841748894613,0.105953488960389,0.0666283047461093,TRIM38/IGF1/HERPUD1,3
DESERT_PERIPORTAL_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP,DESERT_PERIPORTAL_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP,2/25,159/21728,0.014296312475344176,0.105953488960389,0.0666283047461093,IGF1/ACSL1,2
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP,2/25,159/21728,0.014296312475344176,0.105953488960389,0.0666283047461093,P2RX4/ACSL1,2
RODRIGUES_NTN1_TARGETS_DN,RODRIGUES_NTN1_TARGETS_DN,2/25,160/21728,0.014467150316802933,0.105953488960389,0.0666283047461093,HLA-DRB1/HTATIP2,2
FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN,FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN,3/25,453/21728,0.014729733310927336,0.105953488960389,0.0666283047461093,TRIM38/GIMAP5/MYD88,3
BIOCARTA_GHRELIN_PATHWAY,BIOCARTA_GHRELIN_PATHWAY,1/25,13/21728,0.014858907312126579,0.105953488960389,0.0666283047461093,IGF1,1
BIOCARTA_IL5_PATHWAY,BIOCARTA_IL5_PATHWAY,1/25,13/21728,0.014858907312126579,0.105953488960389,0.0666283047461093,HLA-DRB1,1
GERHOLD_RESPONSE_TO_TZD_DN,GERHOLD_RESPONSE_TO_TZD_DN,1/25,13/21728,0.014858907312126579,0.105953488960389,0.0666283047461093,PPARG,1
GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_2,GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_2,1/25,13/21728,0.014858907312126579,0.105953488960389,0.0666283047461093,HLA-DRB1,1
MATZUK_EARLY_ANTRAL_FOLLICLE,MATZUK_EARLY_ANTRAL_FOLLICLE,1/25,13/21728,0.014858907312126579,0.105953488960389,0.0666283047461093,IGF1,1
REACTOME_ALPHA_LINOLENIC_OMEGA3_AND_LINOLEIC_OMEGA6_ACID_METABOLISM,REACTOME_ALPHA_LINOLENIC_OMEGA3_AND_LINOLEIC_OMEGA6_ACID_METABOLISM,1/25,13/21728,0.014858907312126579,0.105953488960389,0.0666283047461093,ACSL1,1
REACTOME_KERATAN_SULFATE_DEGRADATION,REACTOME_KERATAN_SULFATE_DEGRADATION,1/25,13/21728,0.014858907312126579,0.105953488960389,0.0666283047461093,HEXA,1
REACTOME_P75NTR_RECRUITS_SIGNALLING_COMPLEXES,REACTOME_P75NTR_RECRUITS_SIGNALLING_COMPLEXES,1/25,13/21728,0.014858907312126579,0.105953488960389,0.0666283047461093,MYD88,1
REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION_IN_TLR7_8_OR_9_SIGNALING,REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION_IN_TLR7_8_OR_9_SIGNALING,1/25,13/21728,0.014858907312126579,0.105953488960389,0.0666283047461093,MYD88,1
WP_HOMOLOGOUS_RECOMBINATION,WP_HOMOLOGOUS_RECOMBINATION,1/25,13/21728,0.014858907312126579,0.105953488960389,0.0666283047461093,POLD4,1
WP_TRANSCRIPTIONAL_CASCADE_REGULATING_ADIPOGENESIS,WP_TRANSCRIPTIONAL_CASCADE_REGULATING_ADIPOGENESIS,1/25,13/21728,0.014858907312126579,0.105953488960389,0.0666283047461093,PPARG,1
FIRESTEIN_PROLIFERATION,FIRESTEIN_PROLIFERATION,2/25,166/21728,0.015510817497723728,0.105953488960389,0.0666283047461093,PPARG/MERTK,2
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2,SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2,2/25,168/21728,0.01586575729793335,0.105953488960389,0.0666283047461093,POLD4/VNN1,2
BIOCARTA_BLYMPHOCYTE_PATHWAY,BIOCARTA_BLYMPHOCYTE_PATHWAY,1/25,14/21728,0.01599307849873499,0.105953488960389,0.0666283047461093,HLA-DRB1,1
BIOCARTA_LYM_PATHWAY,BIOCARTA_LYM_PATHWAY,1/25,14/21728,0.01599307849873499,0.105953488960389,0.0666283047461093,ITGA4,1
BIOCARTA_MHC_PATHWAY,BIOCARTA_MHC_PATHWAY,1/25,14/21728,0.01599307849873499,0.105953488960389,0.0666283047461093,HLA-DRB1,1
BIOCARTA_TCRA_PATHWAY,BIOCARTA_TCRA_PATHWAY,1/25,14/21728,0.01599307849873499,0.105953488960389,0.0666283047461093,HLA-DRB1,1
KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_GLOBO_SERIES,KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_GLOBO_SERIES,1/25,14/21728,0.01599307849873499,0.105953488960389,0.0666283047461093,HEXA,1
PID_TCR_RAS_PATHWAY,PID_TCR_RAS_PATHWAY,1/25,14/21728,0.01599307849873499,0.105953488960389,0.0666283047461093,PTPN7,1
REACTOME_CS_DS_DEGRADATION,REACTOME_CS_DS_DEGRADATION,1/25,14/21728,0.01599307849873499,0.105953488960389,0.0666283047461093,HEXA,1
REACTOME_POLYMERASE_SWITCHING,REACTOME_POLYMERASE_SWITCHING,1/25,14/21728,0.01599307849873499,0.105953488960389,0.0666283047461093,POLD4,1
WP_CANCER_IMMUNOTHERAPY_BY_CTLA4_BLOCKADE,WP_CANCER_IMMUNOTHERAPY_BY_CTLA4_BLOCKADE,1/25,14/21728,0.01599307849873499,0.105953488960389,0.0666283047461093,HLA-DRB1,1
CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN,CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN,2/25,170/21728,0.016224194665530732,0.105953488960389,0.0666283047461093,SLC2A9/VNN1,2
UEDA_PERIFERAL_CLOCK,UEDA_PERIFERAL_CLOCK,2/25,171/21728,0.01640471974677783,0.105953488960389,0.0666283047461093,HERPUD1/HTATIP2,2
KIM_WT1_TARGETS_DN,KIM_WT1_TARGETS_DN,3/25,472/21728,0.016429459546428226,0.105953488960389,0.0666283047461093,POLD4/ITGA4/HTATIP2,3
KATSANOU_ELAVL1_TARGETS_UP,KATSANOU_ELAVL1_TARGETS_UP,2/25,174/21728,0.01695149574557433,0.105953488960389,0.0666283047461093,IGF1/VNN1,2
REACTOME_NEUTROPHIL_DEGRANULATION,REACTOME_NEUTROPHIL_DEGRANULATION,3/25,479/21728,0.017082587770802505,0.105953488960389,0.0666283047461093,ATP8B4/ATG7/VNN1,3
BIOCARTA_ASBCELL_PATHWAY,BIOCARTA_ASBCELL_PATHWAY,1/25,15/21728,0.017125996111221675,0.105953488960389,0.0666283047461093,HLA-DRB1,1
BIOCARTA_ERYTH_PATHWAY,BIOCARTA_ERYTH_PATHWAY,1/25,15/21728,0.017125996111221675,0.105953488960389,0.0666283047461093,IGF1,1
BIOCARTA_LONGEVITY_PATHWAY,BIOCARTA_LONGEVITY_PATHWAY,1/25,15/21728,0.017125996111221675,0.105953488960389,0.0666283047461093,IGF1,1
KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_GANGLIO_SERIES,KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_GANGLIO_SERIES,1/25,15/21728,0.017125996111221675,0.105953488960389,0.0666283047461093,HEXA,1
REACTOME_MISMATCH_REPAIR,REACTOME_MISMATCH_REPAIR,1/25,15/21728,0.017125996111221675,0.105953488960389,0.0666283047461093,POLD4,1
REACTOME_PROCESSIVE_SYNTHESIS_ON_THE_LAGGING_STRAND,REACTOME_PROCESSIVE_SYNTHESIS_ON_THE_LAGGING_STRAND,1/25,15/21728,0.017125996111221675,0.105953488960389,0.0666283047461093,POLD4,1
WP_OMEGA3_OMEGA6_FATTY_ACID_SYNTHESIS,WP_OMEGA3_OMEGA6_FATTY_ACID_SYNTHESIS,1/25,15/21728,0.017125996111221675,0.105953488960389,0.0666283047461093,ACSL1,1
BROWNE_HCMV_INFECTION_48HR_DN,BROWNE_HCMV_INFECTION_48HR_DN,3/25,485/21728,0.017653993876370743,0.105953488960389,0.0666283047461093,PPARG/ITGA4/DOK1,3
MATSUDA_NATURAL_KILLER_DIFFERENTIATION,MATSUDA_NATURAL_KILLER_DIFFERENTIATION,3/25,485/21728,0.017653993876370743,0.105953488960389,0.0666283047461093,HEXA/IGF1/MERTK,3
DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN,DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN,2/25,179/21728,0.01788000129333628,0.105953488960389,0.0666283047461093,CRTAP/DOK1,2
IGLESIAS_E2F_TARGETS_DN,IGLESIAS_E2F_TARGETS_DN,1/25,16/21728,0.018257661477463882,0.105953488960389,0.0666283047461093,IGF1,1
KEGG_OTHER_GLYCAN_DEGRADATION,KEGG_OTHER_GLYCAN_DEGRADATION,1/25,16/21728,0.018257661477463882,0.105953488960389,0.0666283047461093,HEXA,1
KEGG_PANTOTHENATE_AND_COA_BIOSYNTHESIS,KEGG_PANTOTHENATE_AND_COA_BIOSYNTHESIS,1/25,16/21728,0.018257661477463882,0.105953488960389,0.0666283047461093,VNN1,1
LUI_THYROID_CANCER_CLUSTER_5,LUI_THYROID_CANCER_CLUSTER_5,1/25,16/21728,0.018257661477463882,0.105953488960389,0.0666283047461093,HLA-DRB1,1
REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS,REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS,1/25,16/21728,0.018257661477463882,0.105953488960389,0.0666283047461093,P2RX4,1
REACTOME_P75NTR_SIGNALS_VIA_NF_KB,REACTOME_P75NTR_SIGNALS_VIA_NF_KB,1/25,16/21728,0.018257661477463882,0.105953488960389,0.0666283047461093,MYD88,1
WP_OMEGA9_FATTY_ACID_SYNTHESIS,WP_OMEGA9_FATTY_ACID_SYNTHESIS,1/25,16/21728,0.018257661477463882,0.105953488960389,0.0666283047461093,ACSL1,1
ZHAN_V1_LATE_DIFFERENTIATION_GENES_DN,ZHAN_V1_LATE_DIFFERENTIATION_GENES_DN,1/25,16/21728,0.018257661477463882,0.105953488960389,0.0666283047461093,PTPN7,1
KYNG_DNA_DAMAGE_DN,KYNG_DNA_DAMAGE_DN,2/25,182/21728,0.01844734171746264,0.105953488960389,0.0666283047461093,IGF1/MYD88,2
RODWELL_AGING_KIDNEY_UP,RODWELL_AGING_KIDNEY_UP,3/25,500/21728,0.01912942558247874,0.105953488960389,0.0666283047461093,HLA-DRB1/DOK1/HTATIP2,3
BIOCARTA_LAIR_PATHWAY,BIOCARTA_LAIR_PATHWAY,1/25,17/21728,0.019388075923994053,0.105953488960389,0.0666283047461093,ITGA4,1
PID_INTEGRIN5_PATHWAY,PID_INTEGRIN5_PATHWAY,1/25,17/21728,0.019388075923994053,0.105953488960389,0.0666283047461093,ITGA4,1
REACTOME_HYALURONAN_METABOLISM,REACTOME_HYALURONAN_METABOLISM,1/25,17/21728,0.019388075923994053,0.105953488960389,0.0666283047461093,HEXA,1
REACTOME_RIP_MEDIATED_NFKB_ACTIVATION_VIA_ZBP1,REACTOME_RIP_MEDIATED_NFKB_ACTIVATION_VIA_ZBP1,1/25,17/21728,0.019388075923994053,0.105953488960389,0.0666283047461093,MYD88,1
REACTOME_VITAMIN_B5_PANTOTHENATE_METABOLISM,REACTOME_VITAMIN_B5_PANTOTHENATE_METABOLISM,1/25,17/21728,0.019388075923994053,0.105953488960389,0.0666283047461093,VNN1,1
RUAN_RESPONSE_TO_TROGLITAZONE_DN,RUAN_RESPONSE_TO_TROGLITAZONE_DN,1/25,17/21728,0.019388075923994053,0.105953488960389,0.0666283047461093,PPARG,1
WP_CELLS_AND_MOLECULES_INVOLVED_IN_LOCAL_ACUTE_INFLAMMATORY_RESPONSE,WP_CELLS_AND_MOLECULES_INVOLVED_IN_LOCAL_ACUTE_INFLAMMATORY_RESPONSE,1/25,17/21728,0.019388075923994053,0.105953488960389,0.0666283047461093,ITGA4,1
WP_GLYCOSAMINOGLYCAN_DEGRADATION,WP_GLYCOSAMINOGLYCAN_DEGRADATION,1/25,17/21728,0.019388075923994053,0.105953488960389,0.0666283047461093,HEXA,1
WP_MITOCHONDRIAL_LONG_CHAIN_FATTY_ACID_BETAOXIDATION,WP_MITOCHONDRIAL_LONG_CHAIN_FATTY_ACID_BETAOXIDATION,1/25,17/21728,0.019388075923994053,0.105953488960389,0.0666283047461093,ACSL1,1
VERHAAK_AML_WITH_NPM1_MUTATED_UP,VERHAAK_AML_WITH_NPM1_MUTATED_UP,2/25,187/21728,0.019409794307546,0.105953488960389,0.0666283047461093,ACSL1/VNN1,2
REACTOME_IRAK4_DEFICIENCY_TLR2_4,REACTOME_IRAK4_DEFICIENCY_TLR2_4,1/25,18/21728,0.020517240775999812,0.105953488960389,0.0666283047461093,MYD88,1
SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_DN,SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_DN,1/25,18/21728,0.020517240775999812,0.105953488960389,0.0666283047461093,HERPUD1,1
SCHEIDEREIT_IKK_TARGETS,SCHEIDEREIT_IKK_TARGETS,1/25,18/21728,0.020517240775999812,0.105953488960389,0.0666283047461093,DOK1,1
WP_FATTY_ACID_TRANSPORTERS,WP_FATTY_ACID_TRANSPORTERS,1/25,18/21728,0.020517240775999812,0.105953488960389,0.0666283047461093,ACSL1,1
WP_GENES_ASSOCIATED_WITH_THE_DEVELOPMENT_OF_RHEUMATOID_ARTHRITIS,WP_GENES_ASSOCIATED_WITH_THE_DEVELOPMENT_OF_RHEUMATOID_ARTHRITIS,1/25,18/21728,0.020517240775999812,0.105953488960389,0.0666283047461093,HLA-DRB1,1
WP_TRANSCRIPTION_COFACTORS_SKI_AND_SKIL_PROTEIN_PARTNERS,WP_TRANSCRIPTION_COFACTORS_SKI_AND_SKIL_PROTEIN_PARTNERS,1/25,18/21728,0.020517240775999812,0.105953488960389,0.0666283047461093,MERTK,1
REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,2/25,194/21728,0.02079226233789053,0.105953488960389,0.0666283047461093,MERTK/ITGA4,2
ABE_VEGFA_TARGETS,ABE_VEGFA_TARGETS,1/25,19/21728,0.02164515735732586,0.105953488960389,0.0666283047461093,HERPUD1,1
BIOCARTA_IGF1MTOR_PATHWAY,BIOCARTA_IGF1MTOR_PATHWAY,1/25,19/21728,0.02164515735732586,0.105953488960389,0.0666283047461093,IGF1,1
CEBALLOS_TARGETS_OF_TP53_AND_MYC_UP,CEBALLOS_TARGETS_OF_TP53_AND_MYC_UP,1/25,19/21728,0.02164515735732586,0.105953488960389,0.0666283047461093,ACSL1,1
KOBAYASHI_RESPONSE_TO_ROMIDEPSIN,KOBAYASHI_RESPONSE_TO_ROMIDEPSIN,1/25,19/21728,0.02164515735732586,0.105953488960389,0.0666283047461093,MERTK,1
LANDIS_ERBB2_BREAST_PRENEOPLASTIC_UP,LANDIS_ERBB2_BREAST_PRENEOPLASTIC_UP,1/25,19/21728,0.02164515735732586,0.105953488960389,0.0666283047461093,DOK1,1
REACTOME_AFLATOXIN_ACTIVATION_AND_DETOXIFICATION,REACTOME_AFLATOXIN_ACTIVATION_AND_DETOXIFICATION,1/25,19/21728,0.02164515735732586,0.105953488960389,0.0666283047461093,MGST2,1
REACTOME_PROCESSIVE_SYNTHESIS_ON_THE_C_STRAND_OF_THE_TELOMERE,REACTOME_PROCESSIVE_SYNTHESIS_ON_THE_C_STRAND_OF_THE_TELOMERE,1/25,19/21728,0.02164515735732586,0.105953488960389,0.0666283047461093,POLD4,1
REACTOME_SYNTHESIS_SECRETION_AND_DEACYLATION_OF_GHRELIN,REACTOME_SYNTHESIS_SECRETION_AND_DEACYLATION_OF_GHRELIN,1/25,19/21728,0.02164515735732586,0.105953488960389,0.0666283047461093,IGF1,1
VERNOCHET_ADIPOGENESIS,VERNOCHET_ADIPOGENESIS,1/25,19/21728,0.02164515735732586,0.105953488960389,0.0666283047461093,PPARG,1
WP_GENES_TARGETED_BY_MIRNAS_IN_ADIPOCYTES,WP_GENES_TARGETED_BY_MIRNAS_IN_ADIPOCYTES,1/25,19/21728,0.02164515735732586,0.105953488960389,0.0666283047461093,IGF1,1
WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_AUTOPHAGY,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_AUTOPHAGY,1/25,19/21728,0.02164515735732586,0.105953488960389,0.0666283047461093,ATG7,1
WP_MYD88_DISTINCT_INPUTOUTPUT_PATHWAY,WP_MYD88_DISTINCT_INPUTOUTPUT_PATHWAY,1/25,19/21728,0.02164515735732586,0.105953488960389,0.0666283047461093,MYD88,1
KEGG_FOCAL_ADHESION,KEGG_FOCAL_ADHESION,2/25,199/21728,0.02180442311711553,0.105953488960389,0.0666283047461093,IGF1/ITGA4,2
EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP,EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP,2/25,200/21728,0.022009297747470458,0.105953488960389,0.0666283047461093,ACSL1/DOK1,2
WP_FOCAL_ADHESION,WP_FOCAL_ADHESION,2/25,202/21728,0.022421473647354754,0.105953488960389,0.0666283047461093,IGF1/ITGA4,2
REACTOME_INTERFERON_SIGNALING,REACTOME_INTERFERON_SIGNALING,2/25,203/21728,0.022628770972254887,0.105953488960389,0.0666283047461093,TRIM38/HLA-DRB1,2
BIOCARTA_GSK3_PATHWAY,BIOCARTA_GSK3_PATHWAY,1/25,20/21728,0.022771826990476973,0.105953488960389,0.0666283047461093,MYD88,1
LAMB_CCND1_TARGETS,LAMB_CCND1_TARGETS,1/25,20/21728,0.022771826990476973,0.105953488960389,0.0666283047461093,HEXA,1
LEE_NAIVE_T_LYMPHOCYTE,LEE_NAIVE_T_LYMPHOCYTE,1/25,20/21728,0.022771826990476973,0.105953488960389,0.0666283047461093,GIMAP5,1
REACTOME_LAGGING_STRAND_SYNTHESIS,REACTOME_LAGGING_STRAND_SYNTHESIS,1/25,20/21728,0.022771826990476973,0.105953488960389,0.0666283047461093,POLD4,1
WP_LTF_DANGER_SIGNAL_RESPONSE_PATHWAY,WP_LTF_DANGER_SIGNAL_RESPONSE_PATHWAY,1/25,20/21728,0.022771826990476973,0.105953488960389,0.0666283047461093,MYD88,1
BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP,BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP,2/25,207/21728,0.023465976897701874,0.105953488960389,0.0666283047461093,PRR13/HERPUD1,2
GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN,GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN,2/25,207/21728,0.023465976897701874,0.105953488960389,0.0666283047461093,PPARG/DOK1,2
AMIT_EGF_RESPONSE_240_MCF10A,AMIT_EGF_RESPONSE_240_MCF10A,1/25,21/21728,0.02389725099661455,0.105953488960389,0.0666283047461093,HERPUD1,1
BIOCARTA_IGF1_PATHWAY,BIOCARTA_IGF1_PATHWAY,1/25,21/21728,0.02389725099661455,0.105953488960389,0.0666283047461093,IGF1,1
BIOCARTA_NFKB_PATHWAY,BIOCARTA_NFKB_PATHWAY,1/25,21/21728,0.02389725099661455,0.105953488960389,0.0666283047461093,MYD88,1
HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_UP,HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_UP,1/25,21/21728,0.02389725099661455,0.105953488960389,0.0666283047461093,PTPN7,1
KEGG_GLYCOSAMINOGLYCAN_DEGRADATION,KEGG_GLYCOSAMINOGLYCAN_DEGRADATION,1/25,21/21728,0.02389725099661455,0.105953488960389,0.0666283047461093,HEXA,1
LUI_THYROID_CANCER_CLUSTER_4,LUI_THYROID_CANCER_CLUSTER_4,1/25,21/21728,0.02389725099661455,0.105953488960389,0.0666283047461093,HLA-DRB1,1
REACTOME_CELLULAR_HEXOSE_TRANSPORT,REACTOME_CELLULAR_HEXOSE_TRANSPORT,1/25,21/21728,0.02389725099661455,0.105953488960389,0.0666283047461093,SLC2A9,1
REACTOME_INTERLEUKIN_37_SIGNALING,REACTOME_INTERLEUKIN_37_SIGNALING,1/25,21/21728,0.02389725099661455,0.105953488960389,0.0666283047461093,PTPN7,1
REACTOME_PCNA_DEPENDENT_LONG_PATCH_BASE_EXCISION_REPAIR,REACTOME_PCNA_DEPENDENT_LONG_PATCH_BASE_EXCISION_REPAIR,1/25,21/21728,0.02389725099661455,0.105953488960389,0.0666283047461093,POLD4,1
REACTOME_ZBP1_DAI_MEDIATED_INDUCTION_OF_TYPE_I_IFNS,REACTOME_ZBP1_DAI_MEDIATED_INDUCTION_OF_TYPE_I_IFNS,1/25,21/21728,0.02389725099661455,0.105953488960389,0.0666283047461093,MYD88,1
SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_DN,SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_DN,1/25,21/21728,0.02389725099661455,0.105953488960389,0.0666283047461093,IGF1,1
VERRECCHIA_RESPONSE_TO_TGFB1_C5,VERRECCHIA_RESPONSE_TO_TGFB1_C5,1/25,21/21728,0.02389725099661455,0.105953488960389,0.0666283047461093,ITGA4,1
WP_GALANIN_RECEPTOR_PATHWAY,WP_GALANIN_RECEPTOR_PATHWAY,1/25,21/21728,0.02389725099661455,0.105953488960389,0.0666283047461093,PPARG,1
WP_PATHOGENESIS_OF_SARSCOV2_MEDIATED_BY_NSP9NSP10_COMPLEX,WP_PATHOGENESIS_OF_SARSCOV2_MEDIATED_BY_NSP9NSP10_COMPLEX,1/25,21/21728,0.02389725099661455,0.105953488960389,0.0666283047461093,HLA-DRB1,1
CAIRO_HEPATOBLASTOMA_CLASSES_DN,CAIRO_HEPATOBLASTOMA_CLASSES_DN,2/25,214/21728,0.024961650197982008,0.105953488960389,0.0666283047461093,IGF1/GIMAP5,2
BIOCARTA_CSK_PATHWAY,BIOCARTA_CSK_PATHWAY,1/25,22/21728,0.02502143069556395,0.105953488960389,0.0666283047461093,HLA-DRB1,1
BIOCARTA_CTLA4_PATHWAY,BIOCARTA_CTLA4_PATHWAY,1/25,22/21728,0.02502143069556395,0.105953488960389,0.0666283047461093,HLA-DRB1,1
DESERT_EXTRACELLULAR_MATRIX_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP,DESERT_EXTRACELLULAR_MATRIX_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP,1/25,22/21728,0.02502143069556395,0.105953488960389,0.0666283047461093,VNN1,1
FERRARI_RESPONSE_TO_FENRETINIDE_UP,FERRARI_RESPONSE_TO_FENRETINIDE_UP,1/25,22/21728,0.02502143069556395,0.105953488960389,0.0666283047461093,HERPUD1,1
SESTO_RESPONSE_TO_UV_C3,SESTO_RESPONSE_TO_UV_C3,1/25,22/21728,0.02502143069556395,0.105953488960389,0.0666283047461093,MYD88,1
WENG_POR_DOSAGE,WENG_POR_DOSAGE,1/25,22/21728,0.02502143069556395,0.105953488960389,0.0666283047461093,VNN1,1
WP_FATTY_ACID_BIOSYNTHESIS,WP_FATTY_ACID_BIOSYNTHESIS,1/25,22/21728,0.02502143069556395,0.105953488960389,0.0666283047461093,ACSL1,1
WP_TRANSCRIPTION_FACTOR_REGULATION_IN_ADIPOGENESIS,WP_TRANSCRIPTION_FACTOR_REGULATION_IN_ADIPOGENESIS,1/25,22/21728,0.02502143069556395,0.105953488960389,0.0666283047461093,PPARG,1
IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM,IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM,2/25,215/21728,0.02517846206310546,0.105953488960389,0.0666283047461093,P2RX4/VNN1,2
KIM_WT1_TARGETS_12HR_DN,KIM_WT1_TARGETS_12HR_DN,2/25,217/21728,0.02561442464109847,0.105953488960389,0.0666283047461093,PTPN7/HERPUD1,2
BIOCARTA_NTHI_PATHWAY,BIOCARTA_NTHI_PATHWAY,1/25,23/21728,0.026144367405810276,0.105953488960389,0.0666283047461093,MYD88,1
BIOCARTA_TH1TH2_PATHWAY,BIOCARTA_TH1TH2_PATHWAY,1/25,23/21728,0.026144367405810276,0.105953488960389,0.0666283047461093,HLA-DRB1,1
KEGG_MISMATCH_REPAIR,KEGG_MISMATCH_REPAIR,1/25,23/21728,0.026144367405810276,0.105953488960389,0.0666283047461093,POLD4,1
MOOTHA_FFA_OXYDATION,MOOTHA_FFA_OXYDATION,1/25,23/21728,0.026144367405810276,0.105953488960389,0.0666283047461093,ACSL1,1
PARK_TRETINOIN_RESPONSE_AND_RARA_PLZF_FUSION,PARK_TRETINOIN_RESPONSE_AND_RARA_PLZF_FUSION,1/25,23/21728,0.026144367405810276,0.105953488960389,0.0666283047461093,PPARG,1
TERAO_AOX4_TARGETS_SKIN_DN,TERAO_AOX4_TARGETS_SKIN_DN,1/25,23/21728,0.026144367405810276,0.105953488960389,0.0666283047461093,IGF1,1
WP_CANCER_IMMUNOTHERAPY_BY_PD1_BLOCKADE,WP_CANCER_IMMUNOTHERAPY_BY_PD1_BLOCKADE,1/25,23/21728,0.026144367405810276,0.105953488960389,0.0666283047461093,HLA-DRB1,1
WP_DNA_MISMATCH_REPAIR,WP_DNA_MISMATCH_REPAIR,1/25,23/21728,0.026144367405810276,0.105953488960389,0.0666283047461093,POLD4,1
WP_PROGERIAASSOCIATED_LIPODYSTROPHY,WP_PROGERIAASSOCIATED_LIPODYSTROPHY,1/25,23/21728,0.026144367405810276,0.105953488960389,0.0666283047461093,PPARG,1
WP_NETWORK_MAP_OF_SARSCOV2_SIGNALING_PATHWAY,WP_NETWORK_MAP_OF_SARSCOV2_SIGNALING_PATHWAY,2/25,221/21728,0.026495651338244972,0.10608286801052245,0.06670966409410846,HLA-DRB1/MYD88,2
ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP,ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP,2/25,223/21728,0.026940884796963185,0.10608286801052245,0.06670966409410846,TRIM38/HERPUD1,2
PID_TOLL_ENDOGENOUS_PATHWAY,PID_TOLL_ENDOGENOUS_PATHWAY,1/25,24/21728,0.027266062444504136,0.10608286801052245,0.06670966409410846,MYD88,1
REACTOME_SYNTHESIS_OF_VERY_LONG_CHAIN_FATTY_ACYL_COAS,REACTOME_SYNTHESIS_OF_VERY_LONG_CHAIN_FATTY_ACYL_COAS,1/25,24/21728,0.027266062444504136,0.10608286801052245,0.06670966409410846,ACSL1,1
RUAN_RESPONSE_TO_TROGLITAZONE_UP,RUAN_RESPONSE_TO_TROGLITAZONE_UP,1/25,24/21728,0.027266062444504136,0.10608286801052245,0.06670966409410846,ACSL1,1
WENG_POR_TARGETS_GLOBAL_DN,WENG_POR_TARGETS_GLOBAL_DN,1/25,24/21728,0.027266062444504136,0.10608286801052245,0.06670966409410846,VNN1,1
WP_NANOPARTICLE_TRIGGERED_AUTOPHAGIC_CELL_DEATH,WP_NANOPARTICLE_TRIGGERED_AUTOPHAGIC_CELL_DEATH,1/25,24/21728,0.027266062444504136,0.10608286801052245,0.06670966409410846,ATG7,1
PHONG_TNF_RESPONSE_VIA_P38_COMPLETE,PHONG_TNF_RESPONSE_VIA_P38_COMPLETE,2/25,225/21728,0.027389177970723558,0.10608286801052245,0.06670966409410846,MBD4/HTATIP2,2
THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN,THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN,2/25,227/21728,0.027840515651966116,0.10608286801052245,0.06670966409410846,MBD4/HTATIP2,2
BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_UP,BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_UP,1/25,25/21728,0.028386517127460764,0.10608286801052245,0.06670966409410846,IGF1,1
BIOCARTA_BAD_PATHWAY,BIOCARTA_BAD_PATHWAY,1/25,25/21728,0.028386517127460764,0.10608286801052245,0.06670966409410846,IGF1,1
BIOCARTA_HDAC_PATHWAY,BIOCARTA_HDAC_PATHWAY,1/25,25/21728,0.028386517127460764,0.10608286801052245,0.06670966409410846,IGF1,1
BIOCARTA_TOLL_PATHWAY,BIOCARTA_TOLL_PATHWAY,1/25,25/21728,0.028386517127460764,0.10608286801052245,0.06670966409410846,MYD88,1
PID_LYMPH_ANGIOGENESIS_PATHWAY,PID_LYMPH_ANGIOGENESIS_PATHWAY,1/25,25/21728,0.028386517127460764,0.10608286801052245,0.06670966409410846,ITGA4,1
REACTOME_GAP_FILLING_DNA_REPAIR_SYNTHESIS_AND_LIGATION_IN_GG_NER,REACTOME_GAP_FILLING_DNA_REPAIR_SYNTHESIS_AND_LIGATION_IN_GG_NER,1/25,25/21728,0.028386517127460764,0.10608286801052245,0.06670966409410846,POLD4,1
REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_MULTIPLE_NUCLEOTIDE_PATCH_REPLACEMENT_PATHWAY,REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_MULTIPLE_NUCLEOTIDE_PATCH_REPLACEMENT_PATHWAY,1/25,25/21728,0.028386517127460764,0.10608286801052245,0.06670966409410846,POLD4,1
WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_DN,WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_DN,1/25,25/21728,0.028386517127460764,0.10608286801052245,0.06670966409410846,HLA-DRB1,1
WP_DIFFERENTIATION_OF_WHITE_AND_BROWN_ADIPOCYTE,WP_DIFFERENTIATION_OF_WHITE_AND_BROWN_ADIPOCYTE,1/25,25/21728,0.028386517127460764,0.10608286801052245,0.06670966409410846,PPARG,1
WP_IL1_AND_MEGAKARYOCYTES_IN_OBESITY,WP_IL1_AND_MEGAKARYOCYTES_IN_OBESITY,1/25,25/21728,0.028386517127460764,0.10608286801052245,0.06670966409410846,MYD88,1
KAUFFMANN_DNA_REPAIR_GENES,KAUFFMANN_DNA_REPAIR_GENES,2/25,230/21728,0.028523197478952895,0.10608286801052245,0.06670966409410846,POLD4/MBD4,2
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_SCP2_QTL_TRANS,BYSTRYKH_HEMATOPOIESIS_STEM_CELL_SCP2_QTL_TRANS,1/25,26/21728,0.029505732769160464,0.10608286801052245,0.06670966409410846,POLD4,1
FINAK_BREAST_CANCER_SDPP_SIGNATURE,FINAK_BREAST_CANCER_SDPP_SIGNATURE,1/25,26/21728,0.029505732769160464,0.10608286801052245,0.06670966409410846,GIMAP5,1
FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_DN,FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_DN,1/25,26/21728,0.029505732769160464,0.10608286801052245,0.06670966409410846,ITGA4,1
GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_UP,GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_UP,1/25,26/21728,0.029505732769160464,0.10608286801052245,0.06670966409410846,TRIM38,1
PID_INTEGRIN_CS_PATHWAY,PID_INTEGRIN_CS_PATHWAY,1/25,26/21728,0.029505732769160464,0.10608286801052245,0.06670966409410846,ITGA4,1
PID_RXR_VDR_PATHWAY,PID_RXR_VDR_PATHWAY,1/25,26/21728,0.029505732769160464,0.10608286801052245,0.06670966409410846,PPARG,1
REACTOME_POLYMERASE_SWITCHING_ON_THE_C_STRAND_OF_THE_TELOMERE,REACTOME_POLYMERASE_SWITCHING_ON_THE_C_STRAND_OF_THE_TELOMERE,1/25,26/21728,0.029505732769160464,0.10608286801052245,0.06670966409410846,POLD4,1
REACTOME_PURINERGIC_SIGNALING_IN_LEISHMANIASIS_INFECTION,REACTOME_PURINERGIC_SIGNALING_IN_LEISHMANIASIS_INFECTION,1/25,26/21728,0.029505732769160464,0.10608286801052245,0.06670966409410846,P2RX4,1
WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,1/25,26/21728,0.029505732769160464,0.10608286801052245,0.06670966409410846,HLA-DRB1,1
IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_UP,IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_UP,1/25,27/21728,0.030623710682752714,0.1084149757504349,0.06817619801120992,ACSL1,1
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_UP,LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_UP,1/25,27/21728,0.030623710682752714,0.1084149757504349,0.06817619801120992,IGF1,1
REACTOME_ATF4_ACTIVATES_GENES_IN_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS,REACTOME_ATF4_ACTIVATES_GENES_IN_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS,1/25,27/21728,0.030623710682752714,0.1084149757504349,0.06817619801120992,HERPUD1,1
WANG_CLASSIC_ADIPOGENIC_TARGETS_OF_PPARG,WANG_CLASSIC_ADIPOGENIC_TARGETS_OF_PPARG,1/25,27/21728,0.030623710682752714,0.1084149757504349,0.06817619801120992,ACSL1,1
KEGG_HOMOLOGOUS_RECOMBINATION,KEGG_HOMOLOGOUS_RECOMBINATION,1/25,28/21728,0.03174045218005406,0.11025630757281936,0.06933411002528626,POLD4,1
LOPES_METHYLATED_IN_COLON_CANCER_UP,LOPES_METHYLATED_IN_COLON_CANCER_UP,1/25,28/21728,0.03174045218005406,0.11025630757281936,0.06933411002528626,ITGA4,1
REACTOME_PD_1_SIGNALING,REACTOME_PD_1_SIGNALING,1/25,28/21728,0.03174045218005406,0.11025630757281936,0.06933411002528626,HLA-DRB1,1
REACTOME_PLATELET_CALCIUM_HOMEOSTASIS,REACTOME_PLATELET_CALCIUM_HOMEOSTASIS,1/25,28/21728,0.03174045218005406,0.11025630757281936,0.06933411002528626,P2RX4,1
WP_EXTRACELLULAR_VESICLES_IN_THE_CROSSTALK_OF_CARDIAC_CELLS,WP_EXTRACELLULAR_VESICLES_IN_THE_CROSSTALK_OF_CARDIAC_CELLS,1/25,28/21728,0.03174045218005406,0.11025630757281936,0.06933411002528626,IGF1,1
BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_UP,BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_UP,1/25,29/21728,0.03285595857155155,0.1105228647808358,0.06950173314994458,PRR13,1
BIOCARTA_INFLAM_PATHWAY,BIOCARTA_INFLAM_PATHWAY,1/25,29/21728,0.03285595857155155,0.1105228647808358,0.06950173314994458,HLA-DRB1,1
GENTLES_LEUKEMIC_STEM_CELL_UP,GENTLES_LEUKEMIC_STEM_CELL_UP,1/25,29/21728,0.03285595857155155,0.1105228647808358,0.06950173314994458,VNN1,1
KEGG_THYROID_CANCER,KEGG_THYROID_CANCER,1/25,29/21728,0.03285595857155155,0.1105228647808358,0.06950173314994458,PPARG,1
YANAGIHARA_ESX1_TARGETS,YANAGIHARA_ESX1_TARGETS,1/25,29/21728,0.03285595857155155,0.1105228647808358,0.06950173314994458,CRTAP,1
HSIAO_LIVER_SPECIFIC_GENES,HSIAO_LIVER_SPECIFIC_GENES,2/25,249/21728,0.03300186689520464,0.1105228647808358,0.06950173314994458,MGST2/ACSL1,2
RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN,RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN,2/25,250/21728,0.03324486119688085,0.1105228647808358,0.06950173314994458,ITGA4/HERPUD1,2
GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_UP,GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_UP,1/25,30/21728,0.033970231166404075,0.1105228647808358,0.06950173314994458,TRIM38,1
GUILLAUMOND_KLF10_TARGETS_DN,GUILLAUMOND_KLF10_TARGETS_DN,1/25,30/21728,0.033970231166404075,0.1105228647808358,0.06950173314994458,VNN1,1
KEGG_ASTHMA,KEGG_ASTHMA,1/25,30/21728,0.033970231166404075,0.1105228647808358,0.06950173314994458,HLA-DRB1,1
KIM_LRRC3B_TARGETS,KIM_LRRC3B_TARGETS,1/25,30/21728,0.033970231166404075,0.1105228647808358,0.06950173314994458,HLA-DRB1,1
NEMETH_INFLAMMATORY_RESPONSE_LPS_DN,NEMETH_INFLAMMATORY_RESPONSE_LPS_DN,1/25,30/21728,0.033970231166404075,0.1105228647808358,0.06950173314994458,ITGA4,1
REACTOME_RECOGNITION_OF_DNA_DAMAGE_BY_PCNA_CONTAINING_REPLICATION_COMPLEX,REACTOME_RECOGNITION_OF_DNA_DAMAGE_BY_PCNA_CONTAINING_REPLICATION_COMPLEX,1/25,30/21728,0.033970231166404075,0.1105228647808358,0.06950173314994458,POLD4,1
REACTOME_SUMOYLATION_OF_INTRACELLULAR_RECEPTORS,REACTOME_SUMOYLATION_OF_INTRACELLULAR_RECEPTORS,1/25,30/21728,0.033970231166404075,0.1105228647808358,0.06950173314994458,PPARG,1
VALK_AML_CLUSTER_4,VALK_AML_CLUSTER_4,1/25,30/21728,0.033970231166404075,0.1105228647808358,0.06950173314994458,ITGA4,1
WIKMAN_ASBESTOS_LUNG_CANCER_DN,WIKMAN_ASBESTOS_LUNG_CANCER_DN,1/25,30/21728,0.033970231166404075,0.1105228647808358,0.06950173314994458,ITGA4,1
WP_AUTOPHAGY,WP_AUTOPHAGY,1/25,30/21728,0.033970231166404075,0.1105228647808358,0.06950173314994458,ATG7,1
WP_TLR4_SIGNALING_AND_TOLERANCE,WP_TLR4_SIGNALING_AND_TOLERANCE,1/25,30/21728,0.033970231166404075,0.1105228647808358,0.06950173314994458,MYD88,1
QI_PLASMACYTOMA_UP,QI_PLASMACYTOMA_UP,2/25,254/21728,0.03422396642490936,0.1109577016723377,0.06977517808513377,IGF1/DOK1,2
BIOCARTA_IL1R_PATHWAY,BIOCARTA_IL1R_PATHWAY,1/25,31/21728,0.03508327127244326,0.1113984283702322,0.07005232679467781,MYD88,1
BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN,BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN,1/25,31/21728,0.03508327127244326,0.1113984283702322,0.07005232679467781,IGF1,1
REACTOME_DISEASES_OF_IMMUNE_SYSTEM,REACTOME_DISEASES_OF_IMMUNE_SYSTEM,1/25,31/21728,0.03508327127244326,0.1113984283702322,0.07005232679467781,MYD88,1
WP_FAMILIAL_PARTIAL_LIPODYSTROPHY_FPLD,WP_FAMILIAL_PARTIAL_LIPODYSTROPHY_FPLD,1/25,31/21728,0.03508327127244326,0.1113984283702322,0.07005232679467781,PPARG,1
WP_OLIGODENDROCYTE_SPECIFICATION_AND_DIFFERENTIATION_LEADING_TO_MYELIN_COMPONENTS_FOR_CNS,WP_OLIGODENDROCYTE_SPECIFICATION_AND_DIFFERENTIATION_LEADING_TO_MYELIN_COMPONENTS_FOR_CNS,1/25,31/21728,0.03508327127244326,0.1113984283702322,0.07005232679467781,IGF1,1
WP_TYPE_I_INTERFERON_INDUCTION_AND_SIGNALING_DURING_SARSCOV2_INFECTION,WP_TYPE_I_INTERFERON_INDUCTION_AND_SIGNALING_DURING_SARSCOV2_INFECTION,1/25,31/21728,0.03508327127244326,0.1113984283702322,0.07005232679467781,MYD88,1
CAFFAREL_RESPONSE_TO_THC_UP,CAFFAREL_RESPONSE_TO_THC_UP,1/25,32/21728,0.036195080196174456,0.11162097162793905,0.0701922719738236,HERPUD1,1
CHO_NR4A1_TARGETS,CHO_NR4A1_TARGETS,1/25,32/21728,0.036195080196174456,0.11162097162793905,0.0701922719738236,HERPUD1,1
PID_WNT_NONCANONICAL_PATHWAY,PID_WNT_NONCANONICAL_PATHWAY,1/25,32/21728,0.036195080196174456,0.11162097162793905,0.0701922719738236,PPARG,1
REACTOME_DNA_STRAND_ELONGATION,REACTOME_DNA_STRAND_ELONGATION,1/25,32/21728,0.036195080196174456,0.11162097162793905,0.0701922719738236,POLD4,1
REACTOME_PERK_REGULATES_GENE_EXPRESSION,REACTOME_PERK_REGULATES_GENE_EXPRESSION,1/25,32/21728,0.036195080196174456,0.11162097162793905,0.0701922719738236,HERPUD1,1
REACTOME_TERMINATION_OF_TRANSLESION_DNA_SYNTHESIS,REACTOME_TERMINATION_OF_TRANSLESION_DNA_SYNTHESIS,1/25,32/21728,0.036195080196174456,0.11162097162793905,0.0701922719738236,POLD4,1
WP_TOLLLIKE_RECEPTOR_SIGNALING_RELATED_TO_MYD88,WP_TOLLLIKE_RECEPTOR_SIGNALING_RELATED_TO_MYD88,1/25,32/21728,0.036195080196174456,0.11162097162793905,0.0701922719738236,MYD88,1
BOQUEST_STEM_CELL_UP,BOQUEST_STEM_CELL_UP,2/25,262/21728,0.03621601452422655,0.11162097162793905,0.0701922719738236,IGF1/ATP8B4,2
MCLACHLAN_DENTAL_CARIES_UP,MCLACHLAN_DENTAL_CARIES_UP,2/25,265/21728,0.03697451574222802,0.11162097162793905,0.0701922719738236,HLA-DRB1/ACSL1,2
RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN,RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN,2/25,265/21728,0.03697451574222802,0.11162097162793905,0.0701922719738236,ACSL1/HERPUD1,2
BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_UP,BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_UP,1/25,33/21728,0.03730565924277729,0.11162097162793905,0.0701922719738236,IGF1,1
CUI_TCF21_TARGETS_DN,CUI_TCF21_TARGETS_DN,1/25,33/21728,0.03730565924277729,0.11162097162793905,0.0701922719738236,MERTK,1
FRIDMAN_IMMORTALIZATION_DN,FRIDMAN_IMMORTALIZATION_DN,1/25,33/21728,0.03730565924277729,0.11162097162793905,0.0701922719738236,HTATIP2,1
PID_INTEGRIN_A4B1_PATHWAY,PID_INTEGRIN_A4B1_PATHWAY,1/25,33/21728,0.03730565924277729,0.11162097162793905,0.0701922719738236,ITGA4,1
WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_INTERFERON_INDUCTION,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_INTERFERON_INDUCTION,1/25,33/21728,0.03730565924277729,0.11162097162793905,0.0701922719738236,MYD88,1
WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA,WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA,1/25,33/21728,0.03730565924277729,0.11162097162793905,0.0701922719738236,CRTAP,1
WP_WHITE_FAT_CELL_DIFFERENTIATION,WP_WHITE_FAT_CELL_DIFFERENTIATION,1/25,33/21728,0.03730565924277729,0.11162097162793905,0.0701922719738236,PPARG,1
HOLLMANN_APOPTOSIS_VIA_CD40_DN,HOLLMANN_APOPTOSIS_VIA_CD40_DN,2/25,268/21728,0.03773920545931927,0.11162097162793905,0.0701922719738236,MGST2/MYD88,2
BIOCARTA_NUCLEARRS_PATHWAY,BIOCARTA_NUCLEARRS_PATHWAY,1/25,34/21728,0.038415009716108894,0.11162097162793905,0.0701922719738236,PPARG,1
GROSS_HYPOXIA_VIA_ELK3_ONLY_UP,GROSS_HYPOXIA_VIA_ELK3_ONLY_UP,1/25,34/21728,0.038415009716108894,0.11162097162793905,0.0701922719738236,HERPUD1,1
MIKKELSEN_MCV6_ICP_WITH_H3K4ME3_AND_H3K27ME3,MIKKELSEN_MCV6_ICP_WITH_H3K4ME3_AND_H3K27ME3,1/25,34/21728,0.038415009716108894,0.11162097162793905,0.0701922719738236,IGF1,1
PID_IL1_PATHWAY,PID_IL1_PATHWAY,1/25,34/21728,0.038415009716108894,0.11162097162793905,0.0701922719738236,MYD88,1
REACTOME_KERATAN_SULFATE_KERATIN_METABOLISM,REACTOME_KERATAN_SULFATE_KERATIN_METABOLISM,1/25,34/21728,0.038415009716108894,0.11162097162793905,0.0701922719738236,HEXA,1
REACTOME_TELOMERE_C_STRAND_LAGGING_STRAND_SYNTHESIS,REACTOME_TELOMERE_C_STRAND_LAGGING_STRAND_SYNTHESIS,1/25,34/21728,0.038415009716108894,0.11162097162793905,0.0701922719738236,POLD4,1
VALK_AML_CLUSTER_6,VALK_AML_CLUSTER_6,1/25,34/21728,0.038415009716108894,0.11162097162793905,0.0701922719738236,HLA-DRB1,1
WP_FATTY_ACID_BETAOXIDATION,WP_FATTY_ACID_BETAOXIDATION,1/25,34/21728,0.038415009716108894,0.11162097162793905,0.0701922719738236,ACSL1,1
WP_PURINERGIC_SIGNALING,WP_PURINERGIC_SIGNALING,1/25,34/21728,0.038415009716108894,0.11162097162793905,0.0701922719738236,P2RX4,1
ABE_VEGFA_TARGETS_2HR,ABE_VEGFA_TARGETS_2HR,1/25,35/21728,0.03952313291870402,0.11306307992842884,0.07109913433640092,HERPUD1,1
KEGG_REGULATION_OF_AUTOPHAGY,KEGG_REGULATION_OF_AUTOPHAGY,1/25,35/21728,0.03952313291870402,0.11306307992842884,0.07109913433640092,ATG7,1
LIU_LIVER_CANCER,LIU_LIVER_CANCER,1/25,35/21728,0.03952313291870402,0.11306307992842884,0.07109913433640092,DOK1,1
WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY,WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY,1/25,35/21728,0.03952313291870402,0.11306307992842884,0.07109913433640092,PPARG,1
WP_SIGNAL_TRANSDUCTION_THROUGH_IL1R,WP_SIGNAL_TRANSDUCTION_THROUGH_IL1R,1/25,35/21728,0.03952313291870402,0.11306307992842884,0.07109913433640092,MYD88,1
WP_IL18_SIGNALING_PATHWAY,WP_IL18_SIGNALING_PATHWAY,2/25,279/21728,0.04059524195786034,0.11445776786658854,0.07197617664884585,MYD88/PTPN7,2
HU_GENOTOXIC_DAMAGE_24HR,HU_GENOTOXIC_DAMAGE_24HR,1/25,36/21728,0.04063003015177602,0.11445776786658854,0.07197617664884585,HERPUD1,1
KEGG_DNA_REPLICATION,KEGG_DNA_REPLICATION,1/25,36/21728,0.04063003015177602,0.11445776786658854,0.07197617664884585,POLD4,1
KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_UP,KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_UP,1/25,36/21728,0.04063003015177602,0.11445776786658854,0.07197617664884585,ACSL1,1
REACTOME_GLUTATHIONE_CONJUGATION,REACTOME_GLUTATHIONE_CONJUGATION,1/25,36/21728,0.04063003015177602,0.11445776786658854,0.07197617664884585,MGST2,1
BILANGES_RAPAMYCIN_SENSITIVE_GENES,BILANGES_RAPAMYCIN_SENSITIVE_GENES,1/25,37/21728,0.04173570271521909,0.11546044703252227,0.07260670626788825,ACSL1,1
GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_DN,GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_DN,1/25,37/21728,0.04173570271521909,0.11546044703252227,0.07260670626788825,HTATIP2,1
KEGG_ALLOGRAFT_REJECTION,KEGG_ALLOGRAFT_REJECTION,1/25,37/21728,0.04173570271521909,0.11546044703252227,0.07260670626788825,HLA-DRB1,1
REACTOME_FATTY_ACYL_COA_BIOSYNTHESIS,REACTOME_FATTY_ACYL_COA_BIOSYNTHESIS,1/25,37/21728,0.04173570271521909,0.11546044703252227,0.07260670626788825,ACSL1,1
VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1,VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1,1/25,37/21728,0.04173570271521909,0.11546044703252227,0.07260670626788825,ITGA4,1
WP_FACTORS_AND_PATHWAYS_AFFECTING_INSULINLIKE_GROWTH_FACTOR_IGF1AKT_SIGNALING,WP_FACTORS_AND_PATHWAYS_AFFECTING_INSULINLIKE_GROWTH_FACTOR_IGF1AKT_SIGNALING,1/25,37/21728,0.04173570271521909,0.11546044703252227,0.07260670626788825,IGF1,1
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4,SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4,2/25,287/21728,0.04272288012077977,0.11746083193658793,0.07386463799156588,IGF1/ACSL1,2
SMID_BREAST_CANCER_RELAPSE_IN_LUNG_DN,SMID_BREAST_CANCER_RELAPSE_IN_LUNG_DN,1/25,38/21728,0.04284015190760837,0.11746083193658793,0.07386463799156588,IGF1,1
VALK_AML_CLUSTER_11,VALK_AML_CLUSTER_11,1/25,38/21728,0.04284015190760837,0.11746083193658793,0.07386463799156588,GIMAP5,1
LEE_CALORIE_RESTRICTION_MUSCLE_UP,LEE_CALORIE_RESTRICTION_MUSCLE_UP,1/25,39/21728,0.04394337902620271,0.1180411551896346,0.07422957127441138,PPARG,1
PID_RET_PATHWAY,PID_RET_PATHWAY,1/25,39/21728,0.04394337902620271,0.1180411551896346,0.07422957127441138,DOK1,1
REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES,REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES,1/25,39/21728,0.04394337902620271,0.1180411551896346,0.07422957127441138,HLA-DRB1,1
REACTOME_TRANSLESION_SYNTHESIS_BY_Y_FAMILY_DNA_POLYMERASES_BYPASSES_LESIONS_ON_DNA_TEMPLATE,REACTOME_TRANSLESION_SYNTHESIS_BY_Y_FAMILY_DNA_POLYMERASES_BYPASSES_LESIONS_ON_DNA_TEMPLATE,1/25,39/21728,0.04394337902620271,0.1180411551896346,0.07422957127441138,POLD4,1
RUAN_RESPONSE_TO_TNF_TROGLITAZONE_DN,RUAN_RESPONSE_TO_TNF_TROGLITAZONE_DN,1/25,39/21728,0.04394337902620271,0.1180411551896346,0.07422957127441138,PPARG,1
WP_NUCLEAR_RECEPTORS,WP_NUCLEAR_RECEPTORS,1/25,39/21728,0.04394337902620271,0.1180411551896346,0.07422957127441138,PPARG,1
IVANOVA_HEMATOPOIESIS_MATURE_CELL,IVANOVA_HEMATOPOIESIS_MATURE_CELL,2/25,292/21728,0.044073807944181746,0.1180411551896346,0.07422957127441138,ACSL1/HTATIP2,2
POOLA_INVASIVE_BREAST_CANCER_UP,POOLA_INVASIVE_BREAST_CANCER_UP,2/25,292/21728,0.044073807944181746,0.1180411551896346,0.07422957127441138,HLA-DRB1/ITGA4,2
HELLER_HDAC_TARGETS_DN,HELLER_HDAC_TARGETS_DN,2/25,293/21728,0.044345922184185045,0.11842668236470226,0.07447200804889002,FMNL1/HERPUD1,2
REACTOME_RET_SIGNALING,REACTOME_RET_SIGNALING,1/25,40/21728,0.045045385366944246,0.1196032645949899,0.0752118957125022,DOK1,1
WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING,WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING,1/25,40/21728,0.045045385366944246,0.1196032645949899,0.0752118957125022,PPARG,1
SABATES_COLORECTAL_ADENOMA_DN,SABATES_COLORECTAL_ADENOMA_DN,2/25,299/21728,0.045991965532518816,0.12079054712578502,0.07595851220486824,IGF1/ITGA4,2
BLANCO_MELO_INFLUENZA_A_INFECTION_A594_CELLS_UP,BLANCO_MELO_INFLUENZA_A_INFECTION_A594_CELLS_UP,1/25,41/21728,0.04614617222446116,0.12079054712578502,0.07595851220486824,HERPUD1,1
KEGG_GRAFT_VERSUS_HOST_DISEASE,KEGG_GRAFT_VERSUS_HOST_DISEASE,1/25,41/21728,0.04614617222446116,0.12079054712578502,0.07595851220486824,HLA-DRB1,1
REACTOME_DISEASES_ASSOCIATED_WITH_GLYCOSAMINOGLYCAN_METABOLISM,REACTOME_DISEASES_ASSOCIATED_WITH_GLYCOSAMINOGLYCAN_METABOLISM,1/25,41/21728,0.04614617222446116,0.12079054712578502,0.07595851220486824,HEXA,1
REACTOME_DUAL_INCISION_IN_GG_NER,REACTOME_DUAL_INCISION_IN_GG_NER,1/25,41/21728,0.04614617222446116,0.12079054712578502,0.07595851220486824,POLD4,1
REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION,REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION,2/25,301/21728,0.04654569480378782,0.12149215253870042,0.07639971314805495,ITGA4/CRTAP,2
KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION,KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION,1/25,42/21728,0.04724574089206812,0.12194152118511437,0.07668229630232758,IGF1,1
KEGG_FATTY_ACID_METABOLISM,KEGG_FATTY_ACID_METABOLISM,1/25,42/21728,0.04724574089206812,0.12194152118511437,0.07668229630232758,ACSL1,1
VARELA_ZMPSTE24_TARGETS_DN,VARELA_ZMPSTE24_TARGETS_DN,1/25,42/21728,0.04724574089206812,0.12194152118511437,0.07668229630232758,VNN1,1
WP_DNA_REPLICATION,WP_DNA_REPLICATION,1/25,42/21728,0.04724574089206812,0.12194152118511437,0.07668229630232758,POLD4,1
REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS,REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS,2/25,307/21728,0.04822183890960683,0.12305769041177163,0.07738419356037587,PPARG/MYD88,2
KEGG_TYPE_I_DIABETES_MELLITUS,KEGG_TYPE_I_DIABETES_MELLITUS,1/25,43/21728,0.048344092661767424,0.12305769041177163,0.07738419356037587,HLA-DRB1,1
LUI_THYROID_CANCER_CLUSTER_2,LUI_THYROID_CANCER_CLUSTER_2,1/25,43/21728,0.048344092661767424,0.12305769041177163,0.07738419356037587,PPARG,1
REACTOME_NEGATIVE_REGULATION_OF_MAPK_PATHWAY,REACTOME_NEGATIVE_REGULATION_OF_MAPK_PATHWAY,1/25,43/21728,0.048344092661767424,0.12305769041177163,0.07738419356037587,PTPN7,1
RIZ_ERYTHROID_DIFFERENTIATION_CCNE1,RIZ_ERYTHROID_DIFFERENTIATION_CCNE1,1/25,43/21728,0.048344092661767424,0.12305769041177163,0.07738419356037587,MBD4,1
WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING_PATHWAY,WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING_PATHWAY,2/25,309/21728,0.048785494532696816,0.12313664537360641,0.07743384398066842,IGF1/ITGA4,2
BIOCARTA_TCR_PATHWAY,BIOCARTA_TCR_PATHWAY,1/25,44/21728,0.04944122882425106,0.12313664537360641,0.07743384398066842,PTPN7,1
KEGG_AMINO_SUGAR_AND_NUCLEOTIDE_SUGAR_METABOLISM,KEGG_AMINO_SUGAR_AND_NUCLEOTIDE_SUGAR_METABOLISM,1/25,44/21728,0.04944122882425106,0.12313664537360641,0.07743384398066842,HEXA,1
KEGG_NUCLEOTIDE_EXCISION_REPAIR,KEGG_NUCLEOTIDE_EXCISION_REPAIR,1/25,44/21728,0.04944122882425106,0.12313664537360641,0.07743384398066842,POLD4,1
PID_INSULIN_PATHWAY,PID_INSULIN_PATHWAY,1/25,44/21728,0.04944122882425106,0.12313664537360641,0.07743384398066842,DOK1,1
WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING_PATHWAY,WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING_PATHWAY,1/25,44/21728,0.04944122882425106,0.12313664537360641,0.07743384398066842,MYD88,1
WP_NEURODEGENERATION_WITH_BRAIN_IRON_ACCUMULATION_NBIA_SUBTYPES_PATHWAY,WP_NEURODEGENERATION_WITH_BRAIN_IRON_ACCUMULATION_NBIA_SUBTYPES_PATHWAY,1/25,44/21728,0.04944122882425106,0.12313664537360641,0.07743384398066842,ATG7,1
WP_NUCLEOTIDE_EXCISION_REPAIR,WP_NUCLEOTIDE_EXCISION_REPAIR,1/25,44/21728,0.04944122882425106,0.12313664537360641,0.07743384398066842,POLD4,1
CHANDRAN_METASTASIS_DN,CHANDRAN_METASTASIS_DN,2/25,313/21728,0.049920137503529846,0.12320930664396965,0.07747953664555848,HEXA/ITGA4,2
FAELT_B_CLL_WITH_VH3_21_UP,FAELT_B_CLL_WITH_VH3_21_UP,1/25,45/21728,0.050537150668900965,0.12320930664396965,0.07747953664555848,PTPN7,1
PID_NFAT_TFPATHWAY,PID_NFAT_TFPATHWAY,1/25,45/21728,0.050537150668900965,0.12320930664396965,0.07747953664555848,PPARG,1
REACTOME_GLYCOSPHINGOLIPID_METABOLISM,REACTOME_GLYCOSPHINGOLIPID_METABOLISM,1/25,45/21728,0.050537150668900965,0.12320930664396965,0.07747953664555848,HEXA,1
ROVERSI_GLIOMA_LOH_REGIONS,ROVERSI_GLIOMA_LOH_REGIONS,1/25,45/21728,0.050537150668900965,0.12320930664396965,0.07747953664555848,HTATIP2,1
SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_DN,SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_DN,1/25,45/21728,0.050537150668900965,0.12320930664396965,0.07747953664555848,IGF1,1
SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_DN,SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_DN,1/25,45/21728,0.050537150668900965,0.12320930664396965,0.07747953664555848,ITGA4,1
WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION,WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION,1/25,45/21728,0.050537150668900965,0.12320930664396965,0.07747953664555848,PPARG,1
BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN,BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN,1/25,46/21728,0.0516318594837919,0.1245635461175554,0.0783311431497956,IGF1,1
GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN,GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN,1/25,46/21728,0.0516318594837919,0.1245635461175554,0.0783311431497956,VNN1,1
JAEGER_METASTASIS_UP,JAEGER_METASTASIS_UP,1/25,46/21728,0.0516318594837919,0.1245635461175554,0.0783311431497956,MERTK,1
KLEIN_TARGETS_OF_BCR_ABL1_FUSION,KLEIN_TARGETS_OF_BCR_ABL1_FUSION,1/25,46/21728,0.0516318594837919,0.1245635461175554,0.0783311431497956,MYD88,1
WP_NUCLEAR_RECEPTORS_METAPATHWAY,WP_NUCLEAR_RECEPTORS_METAPATHWAY,2/25,321/21728,0.05221838165974361,0.12565048086875805,0.07901465645882257,SLC2A9/MGST2,2
FIGUEROA_AML_METHYLATION_CLUSTER_5_DN,FIGUEROA_AML_METHYLATION_CLUSTER_5_DN,1/25,47/21728,0.05272535655569022,0.12588689782288826,0.07916332604036719,GIMAP5,1
MCDOWELL_ACUTE_LUNG_INJURY_DN,MCDOWELL_ACUTE_LUNG_INJURY_DN,1/25,47/21728,0.05272535655569022,0.12588689782288826,0.07916332604036719,HLA-DRB1,1
SMITH_LIVER_CANCER,SMITH_LIVER_CANCER,1/25,47/21728,0.05272535655569022,0.12588689782288826,0.07916332604036719,HTATIP2,1
KEGG_PATHWAYS_IN_CANCER,KEGG_PATHWAYS_IN_CANCER,2/25,325/21728,0.05338177372641121,0.12653308470517477,0.07956967732656241,PPARG/IGF1,2
POMEROY_MEDULLOBLASTOMA_PROGNOSIS_UP,POMEROY_MEDULLOBLASTOMA_PROGNOSIS_UP,1/25,48/21728,0.053817643170058105,0.12653308470517477,0.07956967732656241,ACSL1,1
REACTOME_DNA_DAMAGE_BYPASS,REACTOME_DNA_DAMAGE_BYPASS,1/25,48/21728,0.053817643170058105,0.12653308470517477,0.07956967732656241,POLD4,1
WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS,WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS,1/25,48/21728,0.053817643170058105,0.12653308470517477,0.07956967732656241,ACSL1,1
WP_ENERGY_METABOLISM,WP_ENERGY_METABOLISM,1/25,48/21728,0.053817643170058105,0.12653308470517477,0.07956967732656241,PPARG,1
WP_PLURIPOTENT_STEM_CELL_DIFFERENTIATION_PATHWAY,WP_PLURIPOTENT_STEM_CELL_DIFFERENTIATION_PATHWAY,1/25,48/21728,0.053817643170058105,0.12653308470517477,0.07956967732656241,IGF1,1
REACTOME_DNA_REPAIR,REACTOME_DNA_REPAIR,2/25,330/21728,0.05484918542140308,0.12747652724777003,0.08016295630071664,POLD4/MBD4,2
ASTON_MAJOR_DEPRESSIVE_DISORDER_UP,ASTON_MAJOR_DEPRESSIVE_DISORDER_UP,1/25,49/21728,0.05490872061105245,0.12747652724777003,0.08016295630071664,HEXA,1
GUILLAUMOND_KLF10_TARGETS_UP,GUILLAUMOND_KLF10_TARGETS_UP,1/25,49/21728,0.05490872061105245,0.12747652724777003,0.08016295630071664,ITGA4,1
PID_ARF6_TRAFFICKING_PATHWAY,PID_ARF6_TRAFFICKING_PATHWAY,1/25,49/21728,0.05490872061105245,0.12747652724777003,0.08016295630071664,ITGA4,1
WP_EXERCISEINDUCED_CIRCADIAN_REGULATION,WP_EXERCISEINDUCED_CIRCADIAN_REGULATION,1/25,49/21728,0.05490872061105245,0.12747652724777003,0.08016295630071664,HERPUD1,1
KEGG_GLUTATHIONE_METABOLISM,KEGG_GLUTATHIONE_METABOLISM,1/25,50/21728,0.05599859016152575,0.1280759834387371,0.08053992123283538,MGST2,1
LIU_SMARCA4_TARGETS,LIU_SMARCA4_TARGETS,1/25,50/21728,0.05599859016152575,0.1280759834387371,0.08053992123283538,IGF1,1
MARTINEZ_RESPONSE_TO_TRABECTEDIN,MARTINEZ_RESPONSE_TO_TRABECTEDIN,1/25,50/21728,0.05599859016152575,0.1280759834387371,0.08053992123283538,PPARG,1
REACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM,REACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM,1/25,50/21728,0.05599859016152575,0.1280759834387371,0.08053992123283538,HEXA,1
WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY,WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY,1/25,50/21728,0.05599859016152575,0.1280759834387371,0.08053992123283538,MYD88,1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_8,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_8,1/25,50/21728,0.05599859016152575,0.1280759834387371,0.08053992123283538,MYD88,1
KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN,KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN,2/25,336/21728,0.05662913311207699,0.1286551752858569,0.08090414303690252,TRIM38/HEXA,2
APPIERTO_RESPONSE_TO_FENRETINIDE_DN,APPIERTO_RESPONSE_TO_FENRETINIDE_DN,1/25,51/21728,0.057087253103031754,0.1286551752858569,0.08090414303690252,FMNL1,1
BIOCARTA_NFAT_PATHWAY,BIOCARTA_NFAT_PATHWAY,1/25,51/21728,0.057087253103031754,0.1286551752858569,0.08090414303690252,IGF1,1
FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN,FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN,1/25,51/21728,0.057087253103031754,0.1286551752858569,0.08090414303690252,MYD88,1
REACTOME_EXTENSION_OF_TELOMERES,REACTOME_EXTENSION_OF_TELOMERES,1/25,51/21728,0.057087253103031754,0.1286551752858569,0.08090414303690252,POLD4,1
TAVOR_CEBPA_TARGETS_UP,TAVOR_CEBPA_TARGETS_UP,1/25,51/21728,0.057087253103031754,0.1286551752858569,0.08090414303690252,ACSL1,1
KEGG_AUTOIMMUNE_THYROID_DISEASE,KEGG_AUTOIMMUNE_THYROID_DISEASE,1/25,52/21728,0.058174710715820366,0.12890511439188973,0.08106131595388828,HLA-DRB1,1
KEGG_MTOR_SIGNALING_PATHWAY,KEGG_MTOR_SIGNALING_PATHWAY,1/25,52/21728,0.058174710715820366,0.12890511439188973,0.08106131595388828,IGF1,1
PID_KIT_PATHWAY,PID_KIT_PATHWAY,1/25,52/21728,0.058174710715820366,0.12890511439188973,0.08106131595388828,DOK1,1
PID_PTP1B_PATHWAY,PID_PTP1B_PATHWAY,1/25,52/21728,0.058174710715820366,0.12890511439188973,0.08106131595388828,DOK1,1
PRAMOONJAGO_SOX4_TARGETS_UP,PRAMOONJAGO_SOX4_TARGETS_UP,1/25,52/21728,0.058174710715820366,0.12890511439188973,0.08106131595388828,MYD88,1
WANG_BARRETTS_ESOPHAGUS_UP,WANG_BARRETTS_ESOPHAGUS_UP,1/25,52/21728,0.058174710715820366,0.12890511439188973,0.08106131595388828,POLD4,1
WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER,WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER,1/25,52/21728,0.058174710715820366,0.12890511439188973,0.08106131595388828,IGF1,1
BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN,BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN,1/25,53/21728,0.05926096427884442,0.1290734211214247,0.08116715477218779,GIMAP5,1
GENTILE_RESPONSE_CLUSTER_D3,GENTILE_RESPONSE_CLUSTER_D3,1/25,53/21728,0.05926096427884442,0.1290734211214247,0.08116715477218779,HERPUD1,1
REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY,REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY,1/25,53/21728,0.05926096427884442,0.1290734211214247,0.08116715477218779,PPARG,1
SCHEIDEREIT_IKK_INTERACTING_PROTEINS,SCHEIDEREIT_IKK_INTERACTING_PROTEINS,1/25,53/21728,0.05926096427884442,0.1290734211214247,0.08116715477218779,DOK1,1
WP_CARDIAC_PROGENITOR_DIFFERENTIATION,WP_CARDIAC_PROGENITOR_DIFFERENTIATION,1/25,53/21728,0.05926096427884442,0.1290734211214247,0.08116715477218779,IGF1,1
WP_WNT_SIGNALING_PATHWAY,WP_WNT_SIGNALING_PATHWAY,1/25,53/21728,0.05926096427884442,0.1290734211214247,0.08116715477218779,PPARG,1
WP_PI3KAKT_SIGNALING_PATHWAY,WP_PI3KAKT_SIGNALING_PATHWAY,2/25,345/21728,0.05933731325076015,0.1290734211214247,0.08116715477218779,IGF1/ITGA4,2
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN,1/25,54/21728,0.06034601506975701,0.1290734211214247,0.08116715477218779,CRTAP,1
HENDRICKS_SMARCA4_TARGETS_UP,HENDRICKS_SMARCA4_TARGETS_UP,1/25,54/21728,0.06034601506975701,0.1290734211214247,0.08116715477218779,PTPN7,1
IKEDA_MIR1_TARGETS_UP,IKEDA_MIR1_TARGETS_UP,1/25,54/21728,0.06034601506975701,0.1290734211214247,0.08116715477218779,IGF1,1
LEE_LIVER_CANCER_MYC_UP,LEE_LIVER_CANCER_MYC_UP,1/25,54/21728,0.06034601506975701,0.1290734211214247,0.08116715477218779,HTATIP2,1
MORI_PLASMA_CELL_UP,MORI_PLASMA_CELL_UP,1/25,54/21728,0.06034601506975701,0.1290734211214247,0.08116715477218779,HTATIP2,1
REACTOME_SIGNALING_BY_PTK6,REACTOME_SIGNALING_BY_PTK6,1/25,54/21728,0.06034601506975701,0.1290734211214247,0.08116715477218779,DOK1,1
REACTOME_SIGNALING_BY_TYPE_1_INSULIN_LIKE_GROWTH_FACTOR_1_RECEPTOR_IGF1R,REACTOME_SIGNALING_BY_TYPE_1_INSULIN_LIKE_GROWTH_FACTOR_1_RECEPTOR_IGF1R,1/25,54/21728,0.06034601506975701,0.1290734211214247,0.08116715477218779,IGF1,1
ROVERSI_GLIOMA_COPY_NUMBER_DN,ROVERSI_GLIOMA_COPY_NUMBER_DN,1/25,54/21728,0.06034601506975701,0.1290734211214247,0.08116715477218779,HERPUD1,1
NAGASHIMA_NRG1_SIGNALING_DN,NAGASHIMA_NRG1_SIGNALING_DN,1/25,55/21728,0.061429864364915265,0.13048550499582,0.0820551364293605,MBD4,1
REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES,REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES,1/25,55/21728,0.061429864364915265,0.13048550499582,0.0820551364293605,ATP8B4,1
RICKMAN_HEAD_AND_NECK_CANCER_F,RICKMAN_HEAD_AND_NECK_CANCER_F,1/25,55/21728,0.061429864364915265,0.13048550499582,0.0820551364293605,IGF1,1
SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP,SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP,2/25,353/21728,0.061782307962422414,0.1309331480671521,0.08233663446464794,HLA-DRB1/MERTK,2
CAFFAREL_RESPONSE_TO_THC_24HR_5_DN,CAFFAREL_RESPONSE_TO_THC_24HR_5_DN,1/25,56/21728,0.06251251343937958,0.13217748837067902,0.08311913144294239,HERPUD1,1
AMIT_SERUM_RESPONSE_240_MCF10A,AMIT_SERUM_RESPONSE_240_MCF10A,1/25,57/21728,0.06359396356691838,0.13294303695889725,0.08360054272193128,HERPUD1,1
JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP,JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP,1/25,57/21728,0.06359396356691838,0.13294303695889725,0.08360054272193128,HLA-DRB1,1
WIEDERSCHAIN_TARGETS_OF_BMI1_AND_PCGF2,WIEDERSCHAIN_TARGETS_OF_BMI1_AND_PCGF2,1/25,57/21728,0.06359396356691838,0.13294303695889725,0.08360054272193128,ITGA4,1
WP_CARDIAC_HYPERTROPHIC_RESPONSE,WP_CARDIAC_HYPERTROPHIC_RESPONSE,1/25,57/21728,0.06359396356691838,0.13294303695889725,0.08360054272193128,IGF1,1
WP_IL1_SIGNALING_PATHWAY,WP_IL1_SIGNALING_PATHWAY,1/25,57/21728,0.06359396356691838,0.13294303695889725,0.08360054272193128,MYD88,1
LIM_MAMMARY_LUMINAL_PROGENITOR_UP,LIM_MAMMARY_LUMINAL_PROGENITOR_UP,1/25,58/21728,0.06467421602000478,0.13459228739298293,0.0846376653462367,ACSL1,1
LUCAS_HNF4A_TARGETS_UP,LUCAS_HNF4A_TARGETS_UP,1/25,58/21728,0.06467421602000478,0.13459228739298293,0.0846376653462367,MGST2,1
BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_DN,BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_DN,1/25,59/21728,0.06575327206981985,0.13516895687021102,0.08500030097101445,GIMAP5,1
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_UP,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_UP,1/25,59/21728,0.06575327206981985,0.13516895687021102,0.08500030097101445,POLD4,1
CORRE_MULTIPLE_MYELOMA_DN,CORRE_MULTIPLE_MYELOMA_DN,1/25,59/21728,0.06575327206981985,0.13516895687021102,0.08500030097101445,IGF1,1
GALE_APL_WITH_FLT3_MUTATED_UP,GALE_APL_WITH_FLT3_MUTATED_UP,1/25,59/21728,0.06575327206981985,0.13516895687021102,0.08500030097101445,HTATIP2,1
SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN,SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN,1/25,59/21728,0.06575327206981985,0.13516895687021102,0.08500030097101445,HTATIP2,1
GOLDRATH_ANTIGEN_RESPONSE,GOLDRATH_ANTIGEN_RESPONSE,2/25,366/21728,0.06582903743679108,0.13516895687021102,0.08500030097101445,HLA-DRB1/ITGA4,2
LEE_LIVER_CANCER_CIPROFIBRATE_UP,LEE_LIVER_CANCER_CIPROFIBRATE_UP,1/25,60/21728,0.06683113298625609,0.13571860852593545,0.08534594657816857,VNN1,1
PID_FCER1_PATHWAY,PID_FCER1_PATHWAY,1/25,60/21728,0.06683113298625609,0.13571860852593545,0.08534594657816857,DOK1,1
WP_KIT_RECEPTOR_SIGNALING_PATHWAY,WP_KIT_RECEPTOR_SIGNALING_PATHWAY,1/25,60/21728,0.06683113298625609,0.13571860852593545,0.08534594657816857,DOK1,1
WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES,WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES,1/25,60/21728,0.06683113298625609,0.13571860852593545,0.08534594657816857,PPARG,1
ZHENG_GLIOBLASTOMA_PLASTICITY_DN,ZHENG_GLIOBLASTOMA_PLASTICITY_DN,1/25,60/21728,0.06683113298625609,0.13571860852593545,0.08534594657816857,MERTK,1
YAGI_AML_WITH_T_8_21_TRANSLOCATION,YAGI_AML_WITH_T_8_21_TRANSLOCATION,2/25,371/21728,0.06740914542800598,0.13581560007583016,0.08540693921378247,HEXA/HLA-DRB1,2
LEE_LIVER_CANCER_MYC_TGFA_UP,LEE_LIVER_CANCER_MYC_TGFA_UP,1/25,61/21728,0.06790780003791508,0.13581560007583016,0.08540693921378247,HTATIP2,1
LINDSTEDT_DENDRITIC_CELL_MATURATION_A,LINDSTEDT_DENDRITIC_CELL_MATURATION_A,1/25,61/21728,0.06790780003791508,0.13581560007583016,0.08540693921378247,P2RX4,1
MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_UP,MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_UP,1/25,61/21728,0.06790780003791508,0.13581560007583016,0.08540693921378247,MBD4,1
REACTOME_BASE_EXCISION_REPAIR_AP_SITE_FORMATION,REACTOME_BASE_EXCISION_REPAIR_AP_SITE_FORMATION,1/25,61/21728,0.06790780003791508,0.13581560007583016,0.08540693921378247,MBD4,1
REACTOME_REGULATION_OF_PTEN_GENE_TRANSCRIPTION,REACTOME_REGULATION_OF_PTEN_GENE_TRANSCRIPTION,1/25,61/21728,0.06790780003791508,0.13581560007583016,0.08540693921378247,PPARG,1
YU_MYC_TARGETS_DN,YU_MYC_TARGETS_DN,1/25,61/21728,0.06790780003791508,0.13581560007583016,0.08540693921378247,HLA-DRB1,1
DIRMEIER_LMP1_RESPONSE_EARLY,DIRMEIER_LMP1_RESPONSE_EARLY,1/25,62/21728,0.06898327449211028,0.1364318215737298,0.08579444692264622,HERPUD1,1
STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN,STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN,1/25,62/21728,0.06898327449211028,0.1364318215737298,0.08579444692264622,ATG7,1
REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,2/25,377/21728,0.06932223858996818,0.1364318215737298,0.08579444692264622,MYD88/ATG7,2
ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN,ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN,2/25,377/21728,0.06932223858996818,0.1364318215737298,0.08579444692264622,MBD4/DOK1,2
BLANCO_MELO_BETA_INTERFERON_TREATED_BRONCHIAL_EPITHELIAL_CELLS_UP,BLANCO_MELO_BETA_INTERFERON_TREATED_BRONCHIAL_EPITHELIAL_CELLS_UP,2/25,378/21728,0.06964286578125928,0.1364318215737298,0.08579444692264622,TRIM38/MYD88,2
BURTON_ADIPOGENESIS_PEAK_AT_0HR,BURTON_ADIPOGENESIS_PEAK_AT_0HR,1/25,63/21728,0.07005755761486898,0.1364318215737298,0.08579444692264622,IGF1,1
HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP,HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP,1/25,63/21728,0.07005755761486898,0.1364318215737298,0.08579444692264622,VNN1,1
PID_BCR_5PATHWAY,PID_BCR_5PATHWAY,1/25,63/21728,0.07005755761486898,0.1364318215737298,0.08579444692264622,DOK1,1
REACTOME_TRANSCRIPTIONAL_REGULATION_BY_MECP2,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_MECP2,1/25,63/21728,0.07005755761486898,0.1364318215737298,0.08579444692264622,PPARG,1
RIZKI_TUMOR_INVASIVENESS_2D_DN,RIZKI_TUMOR_INVASIVENESS_2D_DN,1/25,63/21728,0.07005755761486898,0.1364318215737298,0.08579444692264622,DOK1,1
WP_LUNG_FIBROSIS,WP_LUNG_FIBROSIS,1/25,63/21728,0.07005755761486898,0.1364318215737298,0.08579444692264622,IGF1,1
WP_MIRNAS_INVOLVEMENT_IN_THE_IMMUNE_RESPONSE_IN_SEPSIS,WP_MIRNAS_INVOLVEMENT_IN_THE_IMMUNE_RESPONSE_IN_SEPSIS,1/25,63/21728,0.07005755761486898,0.1364318215737298,0.08579444692264622,MYD88,1
GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP,GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP,1/25,64/21728,0.07113065067093338,0.1364318215737298,0.08579444692264622,VNN1,1
PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP,PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP,1/25,64/21728,0.07113065067093338,0.1364318215737298,0.08579444692264622,HERPUD1,1
REACTOME_CYTOSOLIC_SENSORS_OF_PATHOGEN_ASSOCIATED_DNA,REACTOME_CYTOSOLIC_SENSORS_OF_PATHOGEN_ASSOCIATED_DNA,1/25,64/21728,0.07113065067093338,0.1364318215737298,0.08579444692264622,MYD88,1
STEIN_ESRRA_TARGETS_UP,STEIN_ESRRA_TARGETS_UP,2/25,385/21728,0.07190128984690815,0.1364318215737298,0.08579444692264622,MGST2/HTATIP2,2
GUO_HEX_TARGETS_DN,GUO_HEX_TARGETS_DN,1/25,65/21728,0.0722025549237596,0.1364318215737298,0.08579444692264622,IGF1,1
KEGG_GLIOMA,KEGG_GLIOMA,1/25,65/21728,0.0722025549237596,0.1364318215737298,0.08579444692264622,IGF1,1
LEE_LIVER_CANCER_ACOX1_UP,LEE_LIVER_CANCER_ACOX1_UP,1/25,65/21728,0.0722025549237596,0.1364318215737298,0.08579444692264622,HTATIP2,1
LEE_LIVER_CANCER_MYC_TGFA_DN,LEE_LIVER_CANCER_MYC_TGFA_DN,1/25,65/21728,0.0722025549237596,0.1364318215737298,0.08579444692264622,IGF1,1
PID_CD8_TCR_DOWNSTREAM_PATHWAY,PID_CD8_TCR_DOWNSTREAM_PATHWAY,1/25,65/21728,0.0722025549237596,0.1364318215737298,0.08579444692264622,PTPN7,1
PID_RB_1PATHWAY,PID_RB_1PATHWAY,1/25,65/21728,0.0722025549237596,0.1364318215737298,0.08579444692264622,PPARG,1
REACTOME_DUAL_INCISION_IN_TC_NER,REACTOME_DUAL_INCISION_IN_TC_NER,1/25,65/21728,0.0722025549237596,0.1364318215737298,0.08579444692264622,POLD4,1
REACTOME_SIGNALING_BY_BRAF_AND_RAF1_FUSIONS,REACTOME_SIGNALING_BY_BRAF_AND_RAF1_FUSIONS,1/25,65/21728,0.0722025549237596,0.1364318215737298,0.08579444692264622,ATG7,1
WP_ENDOCHONDRAL_OSSIFICATION,WP_ENDOCHONDRAL_OSSIFICATION,1/25,65/21728,0.0722025549237596,0.1364318215737298,0.08579444692264622,IGF1,1
WP_ENDOCHONDRAL_OSSIFICATION_WITH_SKELETAL_DYSPLASIAS,WP_ENDOCHONDRAL_OSSIFICATION_WITH_SKELETAL_DYSPLASIAS,1/25,65/21728,0.0722025549237596,0.1364318215737298,0.08579444692264622,IGF1,1
WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP,WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP,1/25,65/21728,0.0722025549237596,0.1364318215737298,0.08579444692264622,HLA-DRB1,1
CHYLA_CBFA2T3_TARGETS_UP,CHYLA_CBFA2T3_TARGETS_UP,2/25,387/21728,0.07255102071054692,0.13650101409520587,0.08583795828269954,MGST2/ATP8B4,2
HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP,HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP,1/25,66/21728,0.07327327163552178,0.13650101409520587,0.08583795828269954,HLA-DRB1,1
MIKKELSEN_ES_HCP_WITH_H3_UNMETHYLATED,MIKKELSEN_ES_HCP_WITH_H3_UNMETHYLATED,1/25,66/21728,0.07327327163552178,0.13650101409520587,0.08583795828269954,SLC2A9,1
PID_HDAC_CLASSI_PATHWAY,PID_HDAC_CLASSI_PATHWAY,1/25,66/21728,0.07327327163552178,0.13650101409520587,0.08583795828269954,PPARG,1
PID_INTEGRIN1_PATHWAY,PID_INTEGRIN1_PATHWAY,1/25,66/21728,0.07327327163552178,0.13650101409520587,0.08583795828269954,ITGA4,1
WESTON_VEGFA_TARGETS_3HR,WESTON_VEGFA_TARGETS_3HR,1/25,66/21728,0.07327327163552178,0.13650101409520587,0.08583795828269954,HEXA,1
WP_AGERAGE_PATHWAY,WP_AGERAGE_PATHWAY,1/25,66/21728,0.07327327163552178,0.13650101409520587,0.08583795828269954,MYD88,1
BEIER_GLIOMA_STEM_CELL_DN,BEIER_GLIOMA_STEM_CELL_DN,1/25,67/21728,0.0743428020671123,0.13683814563747362,0.08604996171324385,HLA-DRB1,1
BROWNE_INTERFERON_RESPONSIVE_GENES,BROWNE_INTERFERON_RESPONSIVE_GENES,1/25,67/21728,0.0743428020671123,0.13683814563747362,0.08604996171324385,MYD88,1
KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY,KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY,1/25,67/21728,0.0743428020671123,0.13683814563747362,0.08604996171324385,ACSL1,1
REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES,REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES,1/25,67/21728,0.0743428020671123,0.13683814563747362,0.08604996171324385,CRTAP,1
REACTOME_HDR_THROUGH_HOMOLOGOUS_RECOMBINATION_HRR,REACTOME_HDR_THROUGH_HOMOLOGOUS_RECOMBINATION_HRR,1/25,67/21728,0.0743428020671123,0.13683814563747362,0.08604996171324385,POLD4,1
SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES,SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES,1/25,67/21728,0.0743428020671123,0.13683814563747362,0.08604996171324385,IGF1,1
KEGG_P53_SIGNALING_PATHWAY,KEGG_P53_SIGNALING_PATHWAY,1/25,68/21728,0.07541114747814226,0.13825377037659414,0.08694017002492592,IGF1,1
PID_P75_NTR_PATHWAY,PID_P75_NTR_PATHWAY,1/25,68/21728,0.07541114747814226,0.13825377037659414,0.08694017002492592,MYD88,1
LU_EZH2_TARGETS_DN,LU_EZH2_TARGETS_DN,2/25,400/21728,0.07682162368196514,0.14021706920158128,0.08817478035916253,ACSL1/MBD4,2
OSMAN_BLADDER_CANCER_UP,OSMAN_BLADDER_CANCER_UP,2/25,401/21728,0.07715347756076762,0.14021706920158128,0.08817478035916253,MBD4/CRTAP,2
KEGG_LONG_TERM_DEPRESSION,KEGG_LONG_TERM_DEPRESSION,1/25,70/21728,0.07754428827057147,0.14021706920158128,0.08817478035916253,IGF1,1
KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450,KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450,1/25,70/21728,0.07754428827057147,0.14021706920158128,0.08817478035916253,MGST2,1
KEGG_VIRAL_MYOCARDITIS,KEGG_VIRAL_MYOCARDITIS,1/25,70/21728,0.07754428827057147,0.14021706920158128,0.08817478035916253,HLA-DRB1,1
SESTO_RESPONSE_TO_UV_C7,SESTO_RESPONSE_TO_UV_C7,1/25,70/21728,0.07754428827057147,0.14021706920158128,0.08817478035916253,ACSL1,1
TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP,TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP,1/25,70/21728,0.07754428827057147,0.14021706920158128,0.08817478035916253,IGF1,1
KEGG_MELANOMA,KEGG_MELANOMA,1/25,71/21728,0.078609086164802,0.14158829554829833,0.08903706897090531,IGF1,1
LIN_APC_TARGETS,LIN_APC_TARGETS,1/25,71/21728,0.078609086164802,0.14158829554829833,0.08903706897090531,DOK1,1
KUMAR_TARGETS_OF_MLL_AF9_FUSION,KUMAR_TARGETS_OF_MLL_AF9_FUSION,2/25,407/21728,0.07915443920321673,0.14184313424584072,0.08919732297072691,IGF1/ATG7,2
REN_ALVEOLAR_RHABDOMYOSARCOMA_DN,REN_ALVEOLAR_RHABDOMYOSARCOMA_DN,2/25,407/21728,0.07915443920321673,0.14184313424584072,0.08919732297072691,PRR13/DOK1,2
CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN,CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN,2/25,408/21728,0.07948955935624642,0.14184313424584072,0.08919732297072691,SLC2A9/TRIM38,2
KEGG_DRUG_METABOLISM_CYTOCHROME_P450,KEGG_DRUG_METABOLISM_CYTOCHROME_P450,1/25,72/21728,0.07967270406413585,0.14184313424584072,0.08919732297072691,MGST2,1
KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN,KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN,1/25,72/21728,0.07967270406413585,0.14184313424584072,0.08919732297072691,MGST2,1
WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME,WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME,1/25,72/21728,0.07967270406413585,0.14184313424584072,0.08919732297072691,IGF1,1
SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN,SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN,2/25,409/21728,0.07982514048467226,0.14184313424584072,0.08919732297072691,IGF1/ITGA4,2
CASTELLANO_NRAS_TARGETS_UP,CASTELLANO_NRAS_TARGETS_UP,1/25,73/21728,0.08073514322180075,0.14226895886339835,0.08946510058395522,VNN1,1
GAURNIER_PSMD4_TARGETS,GAURNIER_PSMD4_TARGETS,1/25,73/21728,0.08073514322180075,0.14226895886339835,0.08946510058395522,HLA-DRB1,1
LEE_AGING_CEREBELLUM_DN,LEE_AGING_CEREBELLUM_DN,1/25,73/21728,0.08073514322180075,0.14226895886339835,0.08946510058395522,MERTK,1
WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING,WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING,1/25,73/21728,0.08073514322180075,0.14226895886339835,0.08946510058395522,PPARG,1
RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP,RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP,2/25,412/21728,0.08083463571783997,0.14226895886339835,0.08946510058395522,MYD88/VNN1,2
KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC,KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC,1/25,74/21728,0.08179640488975093,0.14314370855706413,0.09001518241455844,ITGA4,1
LEE_LIVER_CANCER_DENA_DN,LEE_LIVER_CANCER_DENA_DN,1/25,74/21728,0.08179640488975093,0.14314370855706413,0.09001518241455844,ACSL1,1
REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY,REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY,1/25,74/21728,0.08179640488975093,0.14314370855706413,0.09001518241455844,HLA-DRB1,1
ANDERSEN_LIVER_CANCER_KRT19_DN,ANDERSEN_LIVER_CANCER_KRT19_DN,1/25,75/21728,0.08285649031866726,0.1439086410797905,0.09049620628394209,MGST2,1
JAIN_NFKB_SIGNALING,JAIN_NFKB_SIGNALING,1/25,75/21728,0.08285649031866726,0.1439086410797905,0.09049620628394209,PTPN7,1
MCCLUNG_COCAINE_REWARD_5D,MCCLUNG_COCAINE_REWARD_5D,1/25,75/21728,0.08285649031866726,0.1439086410797905,0.09049620628394209,FMNL1,1
OUILLETTE_CLL_13Q14_DELETION_UP,OUILLETTE_CLL_13Q14_DELETION_UP,1/25,75/21728,0.08285649031866726,0.1439086410797905,0.09049620628394209,TRIM38,1
BRUECKNER_TARGETS_OF_MIRLET7A3_DN,BRUECKNER_TARGETS_OF_MIRLET7A3_DN,1/25,76/21728,0.08391540075796133,0.14412236115307858,0.09063060304909933,PPARG,1
SANA_RESPONSE_TO_IFNG_UP,SANA_RESPONSE_TO_IFNG_UP,1/25,76/21728,0.08391540075796133,0.14412236115307858,0.09063060304909933,HLA-DRB1,1
WP_16P112_PROXIMAL_DELETION_SYNDROME,WP_16P112_PROXIMAL_DELETION_SYNDROME,1/25,76/21728,0.08391540075796133,0.14412236115307858,0.09063060304909933,PPARG,1
WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY,WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY,1/25,76/21728,0.08391540075796133,0.14412236115307858,0.09063060304909933,ITGA4,1
WP_NUCLEOTIDE_EXCISION_REPAIR_IN_XERODERMA_PIGMENTOSUM,WP_NUCLEOTIDE_EXCISION_REPAIR_IN_XERODERMA_PIGMENTOSUM,1/25,76/21728,0.08391540075796133,0.14412236115307858,0.09063060304909933,POLD4,1
YAMASHITA_LIVER_CANCER_STEM_CELL_DN,YAMASHITA_LIVER_CANCER_STEM_CELL_DN,1/25,76/21728,0.08391540075796133,0.14412236115307858,0.09063060304909933,ACSL1,1
FRIDMAN_SENESCENCE_UP,FRIDMAN_SENESCENCE_UP,1/25,77/21728,0.0849731374557745,0.14479315907631599,0.09105243086138803,HTATIP2,1
KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_UP,KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_UP,1/25,77/21728,0.0849731374557745,0.14479315907631599,0.09105243086138803,MYD88,1
MAHAJAN_RESPONSE_TO_IL1A_UP,MAHAJAN_RESPONSE_TO_IL1A_UP,1/25,77/21728,0.0849731374557745,0.14479315907631599,0.09105243086138803,MERTK,1
MORI_SMALL_PRE_BII_LYMPHOCYTE_UP,MORI_SMALL_PRE_BII_LYMPHOCYTE_UP,1/25,77/21728,0.0849731374557745,0.14479315907631599,0.09105243086138803,HERPUD1,1
OSMAN_BLADDER_CANCER_DN,OSMAN_BLADDER_CANCER_DN,2/25,427/21728,0.08594284120083327,0.14479315907631599,0.09105243086138803,TRIM38/FMNL1,2
BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE,BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE,1/25,78/21728,0.08602970165897994,0.14479315907631599,0.09105243086138803,ITGA4,1
DUAN_PRDM5_TARGETS,DUAN_PRDM5_TARGETS,1/25,78/21728,0.08602970165897994,0.14479315907631599,0.09105243086138803,MYD88,1
KEGG_PEROXISOME,KEGG_PEROXISOME,1/25,78/21728,0.08602970165897994,0.14479315907631599,0.09105243086138803,ACSL1,1
REACTOME_TRANSCRIPTION_COUPLED_NUCLEOTIDE_EXCISION_REPAIR_TC_NER,REACTOME_TRANSCRIPTION_COUPLED_NUCLEOTIDE_EXCISION_REPAIR_TC_NER,1/25,78/21728,0.08602970165897994,0.14479315907631599,0.09105243086138803,POLD4,1
WOO_LIVER_CANCER_RECURRENCE_DN,WOO_LIVER_CANCER_RECURRENCE_DN,1/25,78/21728,0.08602970165897994,0.14479315907631599,0.09105243086138803,SLC2A9,1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16,1/25,78/21728,0.08602970165897994,0.14479315907631599,0.09105243086138803,CRTAP,1
GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN,GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN,1/25,79/21728,0.08708509461318448,0.14630295895014991,0.09200186072053175,HERPUD1,1
BURTON_ADIPOGENESIS_8,BURTON_ADIPOGENESIS_8,1/25,80/21728,0.0881393175627283,0.14737370925278845,0.09267519652260107,PRR13,1
SCHUHMACHER_MYC_TARGETS_UP,SCHUHMACHER_MYC_TARGETS_UP,1/25,80/21728,0.0881393175627283,0.14737370925278845,0.09267519652260107,ACSL1,1
ODONNELL_TFRC_TARGETS_UP,ODONNELL_TFRC_TARGETS_UP,2/25,434/21728,0.0883604274091394,0.14737370925278845,0.09267519652260107,POLD4/VNN1,2
RIGGI_EWING_SARCOMA_PROGENITOR_UP,RIGGI_EWING_SARCOMA_PROGENITOR_UP,2/25,434/21728,0.0883604274091394,0.14737370925278845,0.09267519652260107,IGF1/ITGA4,2
GAVIN_FOXP3_TARGETS_CLUSTER_P2,GAVIN_FOXP3_TARGETS_CLUSTER_P2,1/25,81/21728,0.08919237175068695,0.14796005654871588,0.09304391799372426,ITGA4,1
MORI_PRE_BI_LYMPHOCYTE_UP,MORI_PRE_BI_LYMPHOCYTE_UP,1/25,81/21728,0.08919237175068695,0.14796005654871588,0.09304391799372426,MGST2,1
SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN,SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN,1/25,81/21728,0.08919237175068695,0.14796005654871588,0.09304391799372426,MGST2,1
WP_VEGFAVEGFR2_SIGNALING_PATHWAY,WP_VEGFAVEGFR2_SIGNALING_PATHWAY,2/25,438/21728,0.08975129146895235,0.14862041813138346,0.09345918296710375,HERPUD1/DOK1,2
ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP,ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP,1/25,82/21728,0.09024425841887307,0.1486376021016733,0.09346998901814042,POLD4,1
REACTOME_ONCOGENIC_MAPK_SIGNALING,REACTOME_ONCOGENIC_MAPK_SIGNALING,1/25,82/21728,0.09024425841887307,0.1486376021016733,0.09346998901814042,ATG7,1
RIZ_ERYTHROID_DIFFERENTIATION,RIZ_ERYTHROID_DIFFERENTIATION,1/25,82/21728,0.09024425841887307,0.1486376021016733,0.09346998901814042,MBD4,1
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP,1/25,83/21728,0.09129497880783832,0.14983403271481815,0.09422235823488222,MERTK,1
NGUYEN_NOTCH1_TARGETS_DN,NGUYEN_NOTCH1_TARGETS_DN,1/25,83/21728,0.09129497880783832,0.14983403271481815,0.09422235823488222,HERPUD1,1
COATES_MACROPHAGE_M1_VS_M2_DN,COATES_MACROPHAGE_M1_VS_M2_DN,1/25,84/21728,0.09234453415687038,0.15022244641012014,0.09446661018271395,MGST2,1
KEGG_ECM_RECEPTOR_INTERACTION,KEGG_ECM_RECEPTOR_INTERACTION,1/25,84/21728,0.09234453415687038,0.15022244641012014,0.09446661018271395,ITGA4,1
REACTOME_GLOBAL_GENOME_NUCLEOTIDE_EXCISION_REPAIR_GG_NER,REACTOME_GLOBAL_GENOME_NUCLEOTIDE_EXCISION_REPAIR_GG_NER,1/25,84/21728,0.09234453415687038,0.15022244641012014,0.09446661018271395,POLD4,1
REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION,REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION,1/25,84/21728,0.09234453415687038,0.15022244641012014,0.09446661018271395,PPARG,1
WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE,WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE,1/25,84/21728,0.09234453415687038,0.15022244641012014,0.09446661018271395,IGF1,1
WP_MALIGNANT_PLEURAL_MESOTHELIOMA,WP_MALIGNANT_PLEURAL_MESOTHELIOMA,2/25,446/21728,0.09255309223665803,0.15029711287640074,0.0945135638047086,IGF1/ITGA4,2
BURTON_ADIPOGENESIS_9,BURTON_ADIPOGENESIS_9,1/25,85/21728,0.09339292570400026,0.1503398316210736,0.09454042726684055,DOK1,1
HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN,HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN,1/25,85/21728,0.09339292570400026,0.1503398316210736,0.09454042726684055,MERTK,1
KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION,KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION,1/25,85/21728,0.09339292570400026,0.1503398316210736,0.09454042726684055,IGF1,1
KIM_GLIS2_TARGETS_UP,KIM_GLIS2_TARGETS_UP,1/25,85/21728,0.09339292570400026,0.1503398316210736,0.09454042726684055,HLA-DRB1,1
REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS,REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS,1/25,85/21728,0.09339292570400026,0.1503398316210736,0.09454042726684055,ITGA4,1
COLDREN_GEFITINIB_RESISTANCE_UP,COLDREN_GEFITINIB_RESISTANCE_UP,1/25,86/21728,0.09444015468599931,0.15071278571651703,0.09477495752508248,CRTAP,1
LEIN_MEDULLA_MARKERS,LEIN_MEDULLA_MARKERS,1/25,86/21728,0.09444015468599931,0.15071278571651703,0.09477495752508248,HLA-DRB1,1
REACTOME_PLATELET_HOMEOSTASIS,REACTOME_PLATELET_HOMEOSTASIS,1/25,86/21728,0.09444015468599931,0.15071278571651703,0.09477495752508248,P2RX4,1
WP_APOPTOSIS,WP_APOPTOSIS,1/25,86/21728,0.09444015468599931,0.15071278571651703,0.09477495752508248,IGF1,1
WP_PYRIMIDINE_METABOLISM,WP_PYRIMIDINE_METABOLISM,1/25,86/21728,0.09444015468599931,0.15071278571651703,0.09477495752508248,POLD4,1
KEGG_APOPTOSIS,KEGG_APOPTOSIS,1/25,87/21728,0.09548622233838111,0.1515966828877391,0.09533079169974022,MYD88,1
MARTIN_VIRAL_GPCR_SIGNALING_UP,MARTIN_VIRAL_GPCR_SIGNALING_UP,1/25,87/21728,0.09548622233838111,0.1515966828877391,0.09533079169974022,HTATIP2,1
REACTOME_POTENTIAL_THERAPEUTICS_FOR_SARS,REACTOME_POTENTIAL_THERAPEUTICS_FOR_SARS,1/25,87/21728,0.09548622233838111,0.1515966828877391,0.09533079169974022,ITGA4,1
BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN,BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN,1/25,88/21728,0.09653112989540436,0.15220949492039867,0.09571615538398277,PPARG,1
KANG_IMMORTALIZED_BY_TERT_UP,KANG_IMMORTALIZED_BY_TERT_UP,1/25,88/21728,0.09653112989540436,0.15220949492039867,0.09571615538398277,PPARG,1
KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION,KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION,1/25,88/21728,0.09653112989540436,0.15220949492039867,0.09571615538398277,HLA-DRB1,1
RICKMAN_HEAD_AND_NECK_CANCER_E,RICKMAN_HEAD_AND_NECK_CANCER_E,1/25,88/21728,0.09653112989540436,0.15220949492039867,0.09571615538398277,VNN1,1
BAELDE_DIABETIC_NEPHROPATHY_UP,BAELDE_DIABETIC_NEPHROPATHY_UP,1/25,89/21728,0.09757487859007241,0.15281218274106256,0.0960951525097591,HLA-DRB1,1
KEGG_PROSTATE_CANCER,KEGG_PROSTATE_CANCER,1/25,89/21728,0.09757487859007241,0.15281218274106256,0.0960951525097591,IGF1,1
WP_ALLOGRAFT_REJECTION,WP_ALLOGRAFT_REJECTION,1/25,89/21728,0.09757487859007241,0.15281218274106256,0.0960951525097591,HLA-DRB1,1
WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_PART_3_OF_3,WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_PART_3_OF_3,1/25,89/21728,0.09757487859007241,0.15281218274106256,0.0960951525097591,IGF1,1
REACTOME_SIGNALING_BY_INTERLEUKINS,REACTOME_SIGNALING_BY_INTERLEUKINS,2/25,463/21728,0.09859307818042817,0.15366364580172043,0.09663059066136898,MYD88/PTPN7,2
REACTOME_COLLAGEN_FORMATION,REACTOME_COLLAGEN_FORMATION,1/25,90/21728,0.09861746965413443,0.15366364580172043,0.09663059066136898,CRTAP,1
REACTOME_SPHINGOLIPID_METABOLISM,REACTOME_SPHINGOLIPID_METABOLISM,1/25,90/21728,0.09861746965413443,0.15366364580172043,0.09663059066136898,HEXA,1
REACTOME_PEPTIDE_HORMONE_METABOLISM,REACTOME_PEPTIDE_HORMONE_METABOLISM,1/25,91/21728,0.0996589043180891,0.15476441611750308,0.09732280439378185,IGF1,1
WP_APOPTOSIS_MODULATION_AND_SIGNALING,WP_APOPTOSIS_MODULATION_AND_SIGNALING,1/25,91/21728,0.0996589043180891,0.15476441611750308,0.09732280439378185,MYD88,1
GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN,GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN,2/25,467/21728,0.10003075358362874,0.15508123542159893,0.09752203457817567,GIMAP5/ITGA4,2
ELVIDGE_HIF1A_TARGETS_DN,ELVIDGE_HIF1A_TARGETS_DN,1/25,92/21728,0.10069918381118181,0.15559539438383277,0.09784536078819286,HLA-DRB1,1
REACTOME_UNFOLDED_PROTEIN_RESPONSE_UPR,REACTOME_UNFOLDED_PROTEIN_RESPONSE_UPR,1/25,92/21728,0.10069918381118181,0.15559539438383277,0.09784536078819286,HERPUD1,1
DE_YY1_TARGETS_DN,DE_YY1_TARGETS_DN,1/25,93/21728,0.10173830936140893,0.15667699641656976,0.09852552064473287,ITGA4,1
MORI_MATURE_B_LYMPHOCYTE_UP,MORI_MATURE_B_LYMPHOCYTE_UP,1/25,93/21728,0.10173830936140893,0.15667699641656976,0.09852552064473287,HLA-DRB1,1
ONDER_CDH1_TARGETS_2_DN,ONDER_CDH1_TARGETS_2_DN,2/25,473/21728,0.10219870886421512,0.15670839067435577,0.0985452627617275,SLC2A9/MGST2,2
GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN,GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN,1/25,94/21728,0.10277628219551904,0.15670839067435577,0.0985452627617275,VNN1,1
RASHI_RESPONSE_TO_IONIZING_RADIATION_6,RASHI_RESPONSE_TO_IONIZING_RADIATION_6,1/25,94/21728,0.10277628219551904,0.15670839067435577,0.0985452627617275,FMNL1,1
REACTOME_POST_TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS,REACTOME_POST_TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS,1/25,94/21728,0.10277628219551904,0.15670839067435577,0.0985452627617275,VNN1,1
REACTOME_TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,REACTOME_TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,1/25,94/21728,0.10277628219551904,0.15670839067435577,0.0985452627617275,MYD88,1
ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP,ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP,1/25,94/21728,0.10277628219551904,0.15670839067435577,0.0985452627617275,ACSL1,1
LIM_MAMMARY_LUMINAL_MATURE_DN,LIM_MAMMARY_LUMINAL_MATURE_DN,1/25,95/21728,0.10381310353901163,0.15750953640401763,0.0990490591194096,MERTK,1
WESTON_VEGFA_TARGETS,WESTON_VEGFA_TARGETS,1/25,95/21728,0.10381310353901163,0.15750953640401763,0.0990490591194096,HEXA,1
WP_THYROID_HORMONES_PRODUCTION_AND_PERIPHERAL_DOWNSTREAM_SIGNALING_EFFECTS,WP_THYROID_HORMONES_PRODUCTION_AND_PERIPHERAL_DOWNSTREAM_SIGNALING_EFFECTS,1/25,95/21728,0.10381310353901163,0.15750953640401763,0.0990490591194096,PPARG,1
REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3,1/25,96/21728,0.10484877461613962,0.15882011105789018,0.09987320722710798,ITGA4,1
ENK_UV_RESPONSE_KERATINOCYTE_DN,ENK_UV_RESPONSE_KERATINOCYTE_DN,2/25,481/21728,0.10511025159511016,0.15895560143024842,0.09995840964854993,TRIM38/MBD4,2
HOEBEKE_LYMPHOID_STEM_CELL_UP,HOEBEKE_LYMPHOID_STEM_CELL_UP,1/25,97/21728,0.10588329664991403,0.15934229007250905,0.10020157680567897,ITGA4,1
NAKAMURA_ADIPOGENESIS_LATE_UP,NAKAMURA_ADIPOGENESIS_LATE_UP,1/25,97/21728,0.10588329664991403,0.15934229007250905,0.10020157680567897,PPARG,1
REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING,REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING,1/25,97/21728,0.10588329664991403,0.15934229007250905,0.10020157680567897,MYD88,1
SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP,SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP,2/25,484/21728,0.10620813201887806,0.15957124225275338,0.10034555220268838,PTPN7/DOK1,2
BROWNE_HCMV_INFECTION_10HR_UP,BROWNE_HCMV_INFECTION_10HR_UP,1/25,98/21728,0.106916670862098,0.16011507921649684,0.10068754127079775,HERPUD1,1
KEGG_PYRIMIDINE_METABOLISM,KEGG_PYRIMIDINE_METABOLISM,1/25,98/21728,0.106916670862098,0.16011507921649684,0.10068754127079775,POLD4,1
REACTOME_SLC_TRANSPORTER_DISORDERS,REACTOME_SLC_TRANSPORTER_DISORDERS,1/25,99/21728,0.1079488984732141,0.16139932393082496,0.10149513193189266,SLC2A9,1
BENPORATH_ES_CORE_NINE_CORRELATED,BENPORATH_ES_CORE_NINE_CORRELATED,1/25,100/21728,0.10897998070254356,0.16215378771199718,0.10196957258717526,HTATIP2,1
PID_CXCR4_PATHWAY,PID_CXCR4_PATHWAY,1/25,100/21728,0.10897998070254356,0.16215378771199718,0.10196957258717526,ITGA4,1
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11,1/25,100/21728,0.10897998070254356,0.16215378771199718,0.10196957258717526,IGF1,1
GAVIN_FOXP3_TARGETS_CLUSTER_P4,GAVIN_FOXP3_TARGETS_CLUSTER_P4,1/25,101/21728,0.11000991876812727,0.16289930279126538,0.10243838589744644,ATP8B4,1
SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE,SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE,1/25,101/21728,0.11000991876812727,0.16289930279126538,0.10243838589744644,ITGA4,1
WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY,WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY,1/25,101/21728,0.11000991876812727,0.16289930279126538,0.10243838589744644,IGF1,1
KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY,KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY,1/25,102/21728,0.11103871388676612,0.16337543253403167,0.10273779762905615,MYD88,1
KOBAYASHI_EGFR_SIGNALING_24HR_UP,KOBAYASHI_EGFR_SIGNALING_24HR_UP,1/25,102/21728,0.11103871388676612,0.16337543253403167,0.10273779762905615,ACSL1,1
REACTOME_INTERLEUKIN_1_SIGNALING,REACTOME_INTERLEUKIN_1_SIGNALING,1/25,102/21728,0.11103871388676612,0.16337543253403167,0.10273779762905615,MYD88,1
TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA,TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA,1/25,102/21728,0.11103871388676612,0.16337543253403167,0.10273779762905615,SLC2A9,1
BASSO_CD40_SIGNALING_UP,BASSO_CD40_SIGNALING_UP,1/25,103/21728,0.1120663672740233,0.16436400533523418,0.10335945653343503,HLA-DRB1,1
REACTOME_TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,REACTOME_TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,1/25,103/21728,0.1120663672740233,0.16436400533523418,0.10335945653343503,MYD88,1
CADWELL_ATG16L1_TARGETS_UP,CADWELL_ATG16L1_TARGETS_UP,1/25,104/21728,0.11309288014422669,0.16508344589773374,0.10381187301839719,VNN1,1
WP_INTEGRINMEDIATED_CELL_ADHESION,WP_INTEGRINMEDIATED_CELL_ADHESION,1/25,104/21728,0.11309288014422669,0.16508344589773374,0.10381187301839719,ITGA4,1
WP_TOLLLIKE_RECEPTOR_SIGNALING_PATHWAY,WP_TOLLLIKE_RECEPTOR_SIGNALING_PATHWAY,1/25,104/21728,0.11309288014422669,0.16508344589773374,0.10381187301839719,MYD88,1
ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN,ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN,1/25,105/21728,0.1141182537104678,0.16605553768263345,0.10442316792072646,HLA-DRB1,1
STEIN_ESRRA_TARGETS_DN,STEIN_ESRRA_TARGETS_DN,1/25,105/21728,0.1141182537104678,0.16605553768263345,0.10442316792072646,MBD4,1
CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN,CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN,1/25,106/21728,0.11514248918460346,0.1667580877845981,0.10486496292674662,HERPUD1,1
REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION,REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION,1/25,106/21728,0.11514248918460346,0.1667580877845981,0.10486496292674662,MYD88,1
ROESSLER_LIVER_CANCER_METASTASIS_UP,ROESSLER_LIVER_CANCER_METASTASIS_UP,1/25,106/21728,0.11514248918460346,0.1667580877845981,0.10486496292674662,MYD88,1
BORCZUK_MALIGNANT_MESOTHELIOMA_DN,BORCZUK_MALIGNANT_MESOTHELIOMA_DN,1/25,107/21728,0.1161655877772586,0.16771406735341712,0.10546612574514269,HEXA,1
IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN,IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN,1/25,107/21728,0.1161655877772586,0.16771406735341712,0.10546612574514269,IGF1,1
AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53,AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53,1/25,108/21728,0.11718755069782505,0.16866245614453323,0.10606251514215354,ACSL1,1
BOUDOUKHA_BOUND_BY_IGF2BP2,BOUDOUKHA_BOUND_BY_IGF2BP2,1/25,108/21728,0.11718755069782505,0.16866245614453323,0.10606251514215354,CRTAP,1
REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS,REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS,1/25,109/21728,0.11820837915446503,0.16960332661292807,0.10665417668072033,MGST2,1
WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,1/25,109/21728,0.11820837915446503,0.16960332661292807,0.10665417668072033,MERTK,1
GROSS_HYPOXIA_VIA_HIF1A_DN,GROSS_HYPOXIA_VIA_HIF1A_DN,1/25,110/21728,0.11922807435411054,0.1700104023197502,0.1069101641381888,MERTK,1
LE_EGR2_TARGETS_UP,LE_EGR2_TARGETS_UP,1/25,110/21728,0.11922807435411054,0.1700104023197502,0.1069101641381888,P2RX4,1
REACTOME_NUCLEOTIDE_EXCISION_REPAIR,REACTOME_NUCLEOTIDE_EXCISION_REPAIR,1/25,110/21728,0.11922807435411054,0.1700104023197502,0.1069101641381888,POLD4,1
WP_BURN_WOUND_HEALING,WP_BURN_WOUND_HEALING,1/25,110/21728,0.11922807435411054,0.1700104023197502,0.1069101641381888,MYD88,1
REACTOME_TELOMERE_MAINTENANCE,REACTOME_TELOMERE_MAINTENANCE,1/25,111/21728,0.120246637502466,0.1711986025458838,0.10765735771853253,POLD4,1
MARKEY_RB1_CHRONIC_LOF_UP,MARKEY_RB1_CHRONIC_LOF_UP,1/25,112/21728,0.12126406980400806,0.17238153922908223,0.1084012413470647,DOK1,1
HOSHIDA_LIVER_CANCER_SURVIVAL_DN,HOSHIDA_LIVER_CANCER_SURVIVAL_DN,1/25,113/21728,0.12228037246198831,0.17302766333059294,0.10880755315389305,IGF1,1
KEGG_OOCYTE_MEIOSIS,KEGG_OOCYTE_MEIOSIS,1/25,113/21728,0.12228037246198831,0.17302766333059294,0.10880755315389305,IGF1,1
REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,1/25,113/21728,0.12228037246198831,0.17302766333059294,0.10880755315389305,MYD88,1
MATZUK_SPERMATOZOA,MATZUK_SPERMATOZOA,1/25,114/21728,0.1232955466784329,0.1736662883092561,0.10920914917601887,POLD4,1
SMIRNOV_RESPONSE_TO_IR_6HR_DN,SMIRNOV_RESPONSE_TO_IR_6HR_DN,1/25,114/21728,0.1232955466784329,0.1736662883092561,0.10920914917601887,ITGA4,1
WP_GASTRIN_SIGNALING_PATHWAY,WP_GASTRIN_SIGNALING_PATHWAY,1/25,114/21728,0.1232955466784329,0.1736662883092561,0.10920914917601887,PPARG,1
HOSHIDA_LIVER_CANCER_SUBCLASS_S2,HOSHIDA_LIVER_CANCER_SUBCLASS_S2,1/25,115/21728,0.12430959365414507,0.17456240811007606,0.10977266948822283,PPARG,1
MARZEC_IL2_SIGNALING_UP,MARZEC_IL2_SIGNALING_UP,1/25,115/21728,0.12430959365414507,0.17456240811007606,0.10977266948822283,PTPN7,1
ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN,ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN,1/25,116/21728,0.12532251458870491,0.17518608695909732,0.1101648667138548,POLD4,1
KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION,KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION,1/25,116/21728,0.12532251458870491,0.17518608695909732,0.1101648667138548,ITGA4,1
LENAOUR_DENDRITIC_CELL_MATURATION_UP,LENAOUR_DENDRITIC_CELL_MATURATION_UP,1/25,116/21728,0.12532251458870491,0.17518608695909732,0.1101648667138548,PPARG,1
ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP,ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP,1/25,118/21728,0.12734498312658749,0.17720898254362474,0.11143695416277156,HLA-DRB1,1
KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP,KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP,1/25,118/21728,0.12734498312658749,0.17720898254362474,0.11143695416277156,MYD88,1
OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP,OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP,1/25,118/21728,0.12734498312658749,0.17720898254362474,0.11143695416277156,HERPUD1,1
TSENG_IRS1_TARGETS_UP,TSENG_IRS1_TARGETS_UP,1/25,119/21728,0.1283545331229704,0.17807746036880578,0.11198309196124492,IGF1,1
WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES,WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES,1/25,119/21728,0.1283545331229704,0.17807746036880578,0.11198309196124492,PPARG,1
REACTOME_SYNTHESIS_OF_DNA,REACTOME_SYNTHESIS_OF_DNA,1/25,120/21728,0.12936296186432472,0.17920746141324745,0.11269368728652608,POLD4,1
KEGG_LYSOSOME,KEGG_LYSOSOME,1/25,121/21728,0.13037027054413752,0.1803325299143459,0.1134011808073809,HEXA,1
REACTOME_METABOLISM_OF_WATER_SOLUBLE_VITAMINS_AND_COFACTORS,REACTOME_METABOLISM_OF_WATER_SOLUBLE_VITAMINS_AND_COFACTORS,1/25,123/21728,0.13238153248701068,0.1822958808017852,0.11463582388082186,VNN1,1
TOOKER_GEMCITABINE_RESISTANCE_DN,TOOKER_GEMCITABINE_RESISTANCE_DN,1/25,123/21728,0.13238153248701068,0.1822958808017852,0.11463582388082186,MBD4,1
WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,1/25,123/21728,0.13238153248701068,0.1822958808017852,0.11463582388082186,ITGA4,1
KAYO_AGING_MUSCLE_DN,KAYO_AGING_MUSCLE_DN,1/25,124/21728,0.13338548813097395,0.182589912641511,0.11482072428584425,MERTK,1
REACTOME_GLYCOSAMINOGLYCAN_METABOLISM,REACTOME_GLYCOSAMINOGLYCAN_METABOLISM,1/25,124/21728,0.13338548813097395,0.182589912641511,0.11482072428584425,HEXA,1
REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1/25,124/21728,0.13338548813097395,0.182589912641511,0.11482072428584425,IGF1,1
REACTOME_TCR_SIGNALING,REACTOME_TCR_SIGNALING,1/25,124/21728,0.13338548813097395,0.182589912641511,0.11482072428584425,HLA-DRB1,1
CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_UP,CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_UP,1/25,125/21728,0.1343883284752031,0.183419225274871,0.11534223325555797,ACSL1,1
MISSIAGLIA_REGULATED_BY_METHYLATION_UP,MISSIAGLIA_REGULATED_BY_METHYLATION_UP,1/25,125/21728,0.1343883284752031,0.183419225274871,0.11534223325555797,POLD4,1
AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_UP,AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_UP,1/25,126/21728,0.13539005470712084,0.18370104339115959,0.11551945312362734,VNN1,1
EPPERT_HSC_R,EPPERT_HSC_R,1/25,126/21728,0.13539005470712084,0.18370104339115959,0.11551945312362734,ATP8B4,1
REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION,REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION,1/25,126/21728,0.13539005470712084,0.18370104339115959,0.11551945312362734,HLA-DRB1,1
WIERENGA_STAT5A_TARGETS_GROUP1,WIERENGA_STAT5A_TARGETS_GROUP1,1/25,126/21728,0.13539005470712084,0.18370104339115959,0.11551945312362734,P2RX4,1
MANNE_COVID19_ICU_VS_HEALTHY_DONOR_PLATELETS_UP,MANNE_COVID19_ICU_VS_HEALTHY_DONOR_PLATELETS_UP,1/25,128/21728,0.13739016957766814,0.18614152007296972,0.11705413429058932,P2RX4,1
PID_PDGFRB_PATHWAY,PID_PDGFRB_PATHWAY,1/25,129/21728,0.13838856058510107,0.1872196632220108,0.11773211904596717,DOK1,1
LENAOUR_DENDRITIC_CELL_MATURATION_DN,LENAOUR_DENDRITIC_CELL_MATURATION_DN,1/25,130/21728,0.13938584221783334,0.18829315527672225,0.11840717898467837,DOK1,1
BROWN_MYELOID_CELL_DEVELOPMENT_DN,BROWN_MYELOID_CELL_DEVELOPMENT_DN,1/25,131/21728,0.14038201565725128,0.18908598027303233,0.11890574289213245,HLA-DRB1,1
PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP,PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP,1/25,131/21728,0.14038201565725128,0.18908598027303233,0.11890574289213245,PPARG,1
REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,1/25,132/21728,0.1413770820835405,0.1901490885665086,0.11957427305617767,IGF1,1
ELVIDGE_HYPOXIA_BY_DMOG_UP,ELVIDGE_HYPOXIA_BY_DMOG_UP,1/25,133/21728,0.1423710426756829,0.19093010657812917,0.12006541220224118,HLA-DRB1,1
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN,1/25,133/21728,0.1423710426756829,0.19093010657812917,0.12006541220224118,HEXA,1
VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN,VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN,1/25,134/21728,0.14336389861146015,0.19198295987969446,0.1207274935675454,IGF1,1
KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP,KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP,1/25,136/21728,0.14534630121904468,0.19435598021186293,0.12221975515715237,HTATIP2,1
MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3,MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3,1/25,137/21728,0.14633585024041962,0.19539642430946202,0.12287403305858173,IGF1,1
REACTOME_CHROMOSOME_MAINTENANCE,REACTOME_CHROMOSOME_MAINTENANCE,1/25,138/21728,0.14732429930456614,0.19558570769744127,0.12299306294029115,POLD4,1
REACTOME_HOMOLOGY_DIRECTED_REPAIR,REACTOME_HOMOLOGY_DIRECTED_REPAIR,1/25,138/21728,0.14732429930456614,0.19558570769744127,0.12299306294029115,POLD4,1
RIEGE_DELTANP63_DIRECT_TARGETS_UP,RIEGE_DELTANP63_DIRECT_TARGETS_UP,1/25,138/21728,0.14732429930456614,0.19558570769744127,0.12299306294029115,SLC2A9,1
WP_MEASLES_VIRUS_INFECTION,WP_MEASLES_VIRUS_INFECTION,1/25,138/21728,0.14732429930456614,0.19558570769744127,0.12299306294029115,MYD88,1
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP,1/25,139/21728,0.1483116495832778,0.1960514509512857,0.12328594318194315,HERPUD1,1
KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS,KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS,1/25,139/21728,0.1483116495832778,0.1960514509512857,0.12328594318194315,HLA-DRB1,1
REACTOME_PTEN_REGULATION,REACTOME_PTEN_REGULATION,1/25,139/21728,0.1483116495832778,0.1960514509512857,0.12328594318194315,PPARG,1
HOLLERN_EMT_BREAST_TUMOR_UP,HOLLERN_EMT_BREAST_TUMOR_UP,1/25,140/21728,0.14929790224715356,0.19679209939567746,0.12375169613398719,DOK1,1
REACTOME_RHO_GTPASES_ACTIVATE_FORMINS,REACTOME_RHO_GTPASES_ACTIVATE_FORMINS,1/25,140/21728,0.14929790224715356,0.19679209939567746,0.12375169613398719,FMNL1,1
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN,1/25,141/21728,0.1502830584656002,0.19724651423610026,0.12403745256132075,CRTAP,1
REACTOME_DEATH_RECEPTOR_SIGNALLING,REACTOME_DEATH_RECEPTOR_SIGNALLING,1/25,141/21728,0.1502830584656002,0.19724651423610026,0.12403745256132075,MYD88,1
WELCSH_BRCA1_TARGETS_DN,WELCSH_BRCA1_TARGETS_DN,1/25,141/21728,0.1502830584656002,0.19724651423610026,0.12403745256132075,P2RX4,1
GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP,GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP,1/25,143/21728,0.1522500862378714,0.198980310726723,0.12512774153696868,MERTK,1
MANNE_COVID19_NONICU_VS_HEALTHY_DONOR_PLATELETS_UP,MANNE_COVID19_NONICU_VS_HEALTHY_DONOR_PLATELETS_UP,1/25,143/21728,0.1522500862378714,0.198980310726723,0.12512774153696868,P2RX4,1
REACTOME_DISEASES_OF_GLYCOSYLATION,REACTOME_DISEASES_OF_GLYCOSYLATION,1/25,143/21728,0.1522500862378714,0.198980310726723,0.12512774153696868,HEXA,1
BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_UP,BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_UP,1/25,144/21728,0.15323196012455442,0.19929031303766542,0.12532268489039794,VNN1,1
ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP,ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP,1/25,144/21728,0.15323196012455442,0.19929031303766542,0.12532268489039794,HLA-DRB1,1
WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,1/25,144/21728,0.15323196012455442,0.19929031303766542,0.12532268489039794,IGF1,1
IGLESIAS_E2F_TARGETS_UP,IGLESIAS_E2F_TARGETS_UP,1/25,145/21728,0.1542127422315268,0.19929031303766542,0.12532268489039794,CRTAP,1
JOHNSTONE_PARVB_TARGETS_2_UP,JOHNSTONE_PARVB_TARGETS_2_UP,1/25,145/21728,0.1542127422315268,0.19929031303766542,0.12532268489039794,HLA-DRB1,1
MIKKELSEN_ES_LCP_WITH_H3K4ME3,MIKKELSEN_ES_LCP_WITH_H3K4ME3,1/25,145/21728,0.1542127422315268,0.19929031303766542,0.12532268489039794,GIMAP5,1
SMITH_TERT_TARGETS_UP,SMITH_TERT_TARGETS_UP,1/25,145/21728,0.1542127422315268,0.19929031303766542,0.12532268489039794,HERPUD1,1
WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK,WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK,1/25,145/21728,0.1542127422315268,0.19929031303766542,0.12532268489039794,PPARG,1
BROWNE_HCMV_INFECTION_24HR_UP,BROWNE_HCMV_INFECTION_24HR_UP,1/25,146/21728,0.15519243372224656,0.19971839660077415,0.12559188302987848,MERTK,1
VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_DN,VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_DN,1/25,146/21728,0.15519243372224656,0.19971839660077415,0.12559188302987848,POLD4,1
WEI_MIR34A_TARGETS,WEI_MIR34A_TARGETS,1/25,146/21728,0.15519243372224656,0.19971839660077415,0.12559188302987848,CRTAP,1
LEE_NEURAL_CREST_STEM_CELL_UP,LEE_NEURAL_CREST_STEM_CELL_UP,1/25,147/21728,0.1561710357589874,0.20069824345104914,0.12620805466504803,ITGA4,1
GOZGIT_ESR1_TARGETS_UP,GOZGIT_ESR1_TARGETS_UP,1/25,149/21728,0.15812497611370058,0.2029270526792491,0.12760962984614435,PPARG,1
DARWICHE_PAPILLOMA_RISK_HIGH_UP,DARWICHE_PAPILLOMA_RISK_HIGH_UP,1/25,150/21728,0.15910031675029934,0.20333152514146138,0.1278639802666743,HEXA,1
DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP,DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP,1/25,150/21728,0.15910031675029934,0.20333152514146138,0.1278639802666743,HEXA,1
WHITFIELD_CELL_CYCLE_S,WHITFIELD_CELL_CYCLE_S,1/25,150/21728,0.15910031675029934,0.20333152514146138,0.1278639802666743,MBD4,1
LANDIS_ERBB2_BREAST_TUMORS_324_UP,LANDIS_ERBB2_BREAST_TUMORS_324_UP,1/25,151/21728,0.16007457257017288,0.20373127418022002,0.12811536038674126,DOK1,1
REACTOME_AUTOPHAGY,REACTOME_AUTOPHAGY,1/25,151/21728,0.16007457257017288,0.20373127418022002,0.12811536038674126,ATG7,1
SMID_BREAST_CANCER_ERBB2_UP,SMID_BREAST_CANCER_ERBB2_UP,1/25,151/21728,0.16007457257017288,0.20373127418022002,0.12811536038674126,ACSL1,1
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN,1/25,152/21728,0.16104774472968286,0.20384673442496842,0.1281879669658038,POLD4,1
HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP,HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP,1/25,152/21728,0.16104774472968286,0.20384673442496842,0.1281879669658038,HLA-DRB1,1
HUANG_GATA2_TARGETS_UP,HUANG_GATA2_TARGETS_UP,1/25,152/21728,0.16104774472968286,0.20384673442496842,0.1281879669658038,MGST2,1
LANDIS_ERBB2_BREAST_TUMORS_324_DN,LANDIS_ERBB2_BREAST_TUMORS_324_DN,1/25,152/21728,0.16104774472968286,0.20384673442496842,0.1281879669658038,ACSL1,1
LU_AGING_BRAIN_DN,LU_AGING_BRAIN_DN,1/25,153/21728,0.16201983438401024,0.20479661692315385,0.1287852956727967,TRIM38,1
FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP,FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP,1/25,154/21728,0.1629908426871569,0.2051819327560395,0.12902759954583481,MYD88,1
WP_HEPATITIS_B_INFECTION,WP_HEPATITIS_B_INFECTION,1/25,154/21728,0.1629908426871569,0.2051819327560395,0.12902759954583481,MYD88,1
WP_OREXIN_RECEPTOR_PATHWAY,WP_OREXIN_RECEPTOR_PATHWAY,1/25,154/21728,0.1629908426871569,0.2051819327560395,0.12902759954583481,PPARG,1
DESERT_PERIVENOUS_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP,DESERT_PERIVENOUS_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP,1/25,155/21728,0.16396077079195126,0.20556275741080457,0.12926707916468913,HEXA,1
REACTOME_CDC42_GTPASE_CYCLE,REACTOME_CDC42_GTPASE_CYCLE,1/25,155/21728,0.16396077079195126,0.20556275741080457,0.12926707916468913,FMNL1,1
REACTOME_TOLL_LIKE_RECEPTOR_CASCADES,REACTOME_TOLL_LIKE_RECEPTOR_CASCADES,1/25,155/21728,0.16396077079195126,0.20556275741080457,0.12926707916468913,MYD88,1
REACTOME_SARS_COV_INFECTIONS,REACTOME_SARS_COV_INFECTIONS,1/25,156/21728,0.16492961985004229,0.20593914694789062,0.12950376978267902,ITGA4,1
RUIZ_TNC_TARGETS_UP,RUIZ_TNC_TARGETS_UP,1/25,156/21728,0.16492961985004229,0.20593914694789062,0.12950376978267902,HERPUD1,1
WP_BREAST_CANCER_PATHWAY,WP_BREAST_CANCER_PATHWAY,1/25,156/21728,0.16492961985004229,0.20593914694789062,0.12950376978267902,IGF1,1
BROWNE_HCMV_INFECTION_14HR_UP,BROWNE_HCMV_INFECTION_14HR_UP,1/25,157/21728,0.16589739101190715,0.2068680017476413,0.13008787533002736,HERPUD1,1
NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON,NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON,1/25,158/21728,0.1668640854268485,0.20779301204098113,0.1306695632793593,POLD4,1
KEGG_PURINE_METABOLISM,KEGG_PURINE_METABOLISM,1/25,159/21728,0.16782970424299726,0.20815388821547579,0.13089649839934228,POLD4,1
SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP,SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP,1/25,159/21728,0.16782970424299726,0.20815388821547579,0.13089649839934228,GIMAP5,1
SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP,SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP,1/25,159/21728,0.16782970424299726,0.20815388821547579,0.13089649839934228,ACSL1,1
BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN,BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN,1/25,160/21728,0.16879424860731307,0.20878967297611417,0.13129630836502051,MYD88,1
SENGUPTA_EBNA1_ANTICORRELATED,SENGUPTA_EBNA1_ANTICORRELATED,1/25,160/21728,0.16879424860731307,0.20878967297611417,0.13129630836502051,FMNL1,1
REACTOME_S_PHASE,REACTOME_S_PHASE,1/25,162/21728,0.17072011856243507,0.2108895582241845,0.1326168103665412,POLD4,1
BROWNE_HCMV_INFECTION_6HR_DN,BROWNE_HCMV_INFECTION_6HR_DN,1/25,164/21728,0.1726417044445141,0.21212890280150404,0.1333961658081912,GIMAP5,1
DARWICHE_PAPILLOMA_RISK_LOW_UP,DARWICHE_PAPILLOMA_RISK_LOW_UP,1/25,164/21728,0.1726417044445141,0.21212890280150404,0.1333961658081912,HEXA,1
PHONG_TNF_RESPONSE_VIA_P38_PARTIAL,PHONG_TNF_RESPONSE_VIA_P38_PARTIAL,1/25,164/21728,0.1726417044445141,0.21212890280150404,0.1333961658081912,HERPUD1,1
VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP,VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP,1/25,164/21728,0.1726417044445141,0.21212890280150404,0.1333961658081912,IGF1,1
FOSTER_TOLERANT_MACROPHAGE_UP,FOSTER_TOLERANT_MACROPHAGE_UP,1/25,167/21728,0.17551607060540675,0.21395362696490217,0.13454363418161996,ACSL1,1
GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN,GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN,1/25,167/21728,0.17551607060540675,0.21395362696490217,0.13454363418161996,IGF1,1
KIM_WT1_TARGETS_12HR_UP,KIM_WT1_TARGETS_12HR_UP,1/25,167/21728,0.17551607060540675,0.21395362696490217,0.13454363418161996,ACSL1,1
REACTOME_DNA_DOUBLE_STRAND_BREAK_REPAIR,REACTOME_DNA_DOUBLE_STRAND_BREAK_REPAIR,1/25,167/21728,0.17551607060540675,0.21395362696490217,0.13454363418161996,POLD4,1
SERVITJA_LIVER_HNF1A_TARGETS_DN,SERVITJA_LIVER_HNF1A_TARGETS_DN,1/25,167/21728,0.17551607060540675,0.21395362696490217,0.13454363418161996,IGF1,1
YAMAZAKI_TCEB3_TARGETS_UP,YAMAZAKI_TCEB3_TARGETS_UP,1/25,167/21728,0.17551607060540675,0.21395362696490217,0.13454363418161996,HERPUD1,1
IWANAGA_CARCINOGENESIS_BY_KRAS_UP,IWANAGA_CARCINOGENESIS_BY_KRAS_UP,1/25,171/21728,0.17933364965543086,0.21831922566748105,0.1372889183965021,IGF1,1
ELVIDGE_HYPOXIA_UP,ELVIDGE_HYPOXIA_UP,1/25,172/21728,0.1802853896358838,0.219189078978364,0.13783592116206078,HLA-DRB1,1
BLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_UP,BLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_UP,1/25,173/21728,0.18123606996892816,0.2197665730331885,0.13819907531820466,TRIM38,1
MOHANKUMAR_HOXA1_TARGETS_DN,MOHANKUMAR_HOXA1_TARGETS_DN,1/25,173/21728,0.18123606996892816,0.2197665730331885,0.13819907531820466,SLC2A9,1
CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP,CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP,1/25,175/21728,0.1831342562143734,0.22177726440639717,0.13946348821181503,MERTK,1
MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN,MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN,1/25,176/21728,0.18408176438468105,0.22263291922964043,0.1400015623316946,MBD4,1
REACTOME_DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS,REACTOME_DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS,1/25,177/21728,0.18502821742339604,0.22319330665694248,0.14035395907340198,SLC2A9,1
REACTOME_FATTY_ACID_METABOLISM,REACTOME_FATTY_ACID_METABOLISM,1/25,177/21728,0.18502821742339604,0.22319330665694248,0.14035395907340198,ACSL1,1
KEGG_CALCIUM_SIGNALING_PATHWAY,KEGG_CALCIUM_SIGNALING_PATHWAY,1/25,178/21728,0.18597361645659216,0.22404122764783724,0.14088716981272062,P2RX4,1
MANNE_COVID19_COMBINED_COHORT_VS_HEALTHY_DONOR_PLATELETS_UP,MANNE_COVID19_COMBINED_COHORT_VS_HEALTHY_DONOR_PLATELETS_UP,1/25,179/21728,0.1869179626091949,0.22488567376418764,0.14141819539511458,P2RX4,1
BROWNE_HCMV_INFECTION_48HR_UP,BROWNE_HCMV_INFECTION_48HR_UP,1/25,180/21728,0.18786125700497958,0.2257266599123552,0.14194704519437237,MBD4,1
FERNANDEZ_BOUND_BY_MYC,FERNANDEZ_BOUND_BY_MYC,1/25,181/21728,0.18880350076657615,0.22656420091989138,0.14247372853472323,HERPUD1,1
BROWNE_HCMV_INFECTION_18HR_DN,BROWNE_HCMV_INFECTION_18HR_DN,1/25,182/21728,0.1897446950154662,0.22680995885419244,0.14262827214344298,POLD4,1
KEGG_HUNTINGTONS_DISEASE,KEGG_HUNTINGTONS_DISEASE,1/25,182/21728,0.1897446950154662,0.22680995885419244,0.14262827214344298,PPARG,1
OKUMURA_INFLAMMATORY_RESPONSE_LPS,OKUMURA_INFLAMMATORY_RESPONSE_LPS,1/25,182/21728,0.1897446950154662,0.22680995885419244,0.14262827214344298,ACSL1,1
GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP,GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP,1/25,183/21728,0.19068484087198734,0.227000666739396,0.14274819781288062,ATP8B4,1
REACTOME_ION_CHANNEL_TRANSPORT,REACTOME_ION_CHANNEL_TRANSPORT,1/25,183/21728,0.19068484087198734,0.227000666739396,0.14274819781288062,ATP8B4,1
DOANE_RESPONSE_TO_ANDROGEN_UP,DOANE_RESPONSE_TO_ANDROGEN_UP,1/25,184/21728,0.1916239394553343,0.227000666739396,0.14274819781288062,POLD4,1
GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN,GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN,1/25,184/21728,0.1916239394553343,0.227000666739396,0.14274819781288062,MBD4,1
REACTOME_RAC1_GTPASE_CYCLE,REACTOME_RAC1_GTPASE_CYCLE,1/25,184/21728,0.1916239394553343,0.227000666739396,0.14274819781288062,FMNL1,1
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP,1/25,184/21728,0.1916239394553343,0.227000666739396,0.14274819781288062,VNN1,1
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP,1/25,184/21728,0.1916239394553343,0.227000666739396,0.14274819781288062,P2RX4,1
WANG_CISPLATIN_RESPONSE_AND_XPC_UP,WANG_CISPLATIN_RESPONSE_AND_XPC_UP,1/25,185/21728,0.19256199188355616,0.22752849168849856,0.1430801178082151,MGST2,1
WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II,WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II,1/25,185/21728,0.19256199188355616,0.22752849168849856,0.1430801178082151,MGST2,1
ALCALAY_AML_BY_NPM1_LOCALIZATION_DN,ALCALAY_AML_BY_NPM1_LOCALIZATION_DN,1/25,186/21728,0.19349899927356284,0.2280523920009848,0.14340956981606698,HLA-DRB1,1
WP_VITAMIN_D_RECEPTOR_PATHWAY,WP_VITAMIN_D_RECEPTOR_PATHWAY,1/25,186/21728,0.19349899927356284,0.2280523920009848,0.14340956981606698,HLA-DRB1,1
LEE_LIVER_CANCER_SURVIVAL_UP,LEE_LIVER_CANCER_SURVIVAL_UP,1/25,187/21728,0.19443496274112193,0.22857239894757844,0.14373657350086957,ACSL1,1
REACTOME_SUMOYLATION,REACTOME_SUMOYLATION,1/25,187/21728,0.19443496274112193,0.22857239894757844,0.14373657350086957,PPARG,1
DARWICHE_SKIN_TUMOR_PROMOTER_DN,DARWICHE_SKIN_TUMOR_PROMOTER_DN,1/25,189/21728,0.19630376236627467,0.22989185858864106,0.14456630888691033,HEXA,1
REACTOME_DNA_REPLICATION,REACTOME_DNA_REPLICATION,1/25,189/21728,0.19630376236627467,0.22989185858864106,0.14456630888691033,POLD4,1
REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS,REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS,1/25,189/21728,0.19630376236627467,0.22989185858864106,0.14456630888691033,VNN1,1
REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1/25,191/21728,0.1981683996623893,0.23178177378233888,0.14575477230331632,ITGA4,1
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN,1/25,193/21728,0.20002888351466164,0.2336620586188968,0.1469371797193336,ACSL1,1
RAMALHO_STEMNESS_UP,RAMALHO_STEMNESS_UP,1/25,197/21728,0.20373742633777459,0.23769366406073703,0.1494724339958155,CRTAP,1
MCBRYAN_PUBERTAL_BREAST_4_5WK_DN,MCBRYAN_PUBERTAL_BREAST_4_5WK_DN,1/25,199/21728,0.2055855029884277,0.23924559793615516,0.1504483596044175,ACSL1,1
XU_GH1_AUTOCRINE_TARGETS_UP,XU_GH1_AUTOCRINE_TARGETS_UP,1/25,199/21728,0.2055855029884277,0.23924559793615516,0.1504483596044175,P2RX4,1
GRUETZMANN_PANCREATIC_CANCER_DN,GRUETZMANN_PANCREATIC_CANCER_DN,1/25,200/21728,0.20650799648210094,0.2400168411942909,0.15093335194719593,HERPUD1,1
WELCSH_BRCA1_TARGETS_UP,WELCSH_BRCA1_TARGETS_UP,1/25,201/21728,0.20742946155493436,0.2404828387412288,0.15122639209974745,HLA-DRB1,1
WIERENGA_STAT5A_TARGETS_UP,WIERENGA_STAT5A_TARGETS_UP,1/25,201/21728,0.20742946155493436,0.2404828387412288,0.15122639209974745,P2RX4,1
FOSTER_KDM1A_TARGETS_DN,FOSTER_KDM1A_TARGETS_DN,1/25,202/21728,0.20834989930571812,0.24094531534228228,0.15151721812364985,MYD88,1
KIM_MYC_AMPLIFICATION_TARGETS_UP,KIM_MYC_AMPLIFICATION_TARGETS_UP,1/25,202/21728,0.20834989930571812,0.24094531534228228,0.15151721812364985,ITGA4,1
BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_UP,BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_UP,1/25,204/21728,0.2101876972306902,0.24246371066311825,0.15247205318528287,TRIM38,1
PROVENZANI_METASTASIS_UP,PROVENZANI_METASTASIS_UP,1/25,204/21728,0.2101876972306902,0.24246371066311825,0.15247205318528287,PRR13,1
MANALO_HYPOXIA_UP,MANALO_HYPOXIA_UP,1/25,205/21728,0.21110505959685055,0.24321829808913953,0.15294657159399072,PPARG,1
WP_CIRCADIAN_RHYTHM_GENES,WP_CIRCADIAN_RHYTHM_GENES,1/25,207/21728,0.21293671660804991,0.2450230711654273,0.15408149382925027,PPARG,1
SANSOM_APC_TARGETS,SANSOM_APC_TARGETS,1/25,211/21728,0.21658779031611564,0.2489143261841926,0.15652848946647793,VNN1,1
MCBRYAN_PUBERTAL_BREAST_3_4WK_UP,MCBRYAN_PUBERTAL_BREAST_3_4WK_UP,1/25,212/21728,0.2174980150334137,0.249649895516614,0.1569910484451708,HLA-DRB1,1
KEGG_REGULATION_OF_ACTIN_CYTOSKELETON,KEGG_REGULATION_OF_ACTIN_CYTOSKELETON,1/25,213/21728,0.21840722444148986,0.25038247566245236,0.15745172768930707,ITGA4,1
TIEN_INTESTINE_PROBIOTICS_24HR_DN,TIEN_INTESTINE_PROBIOTICS_24HR_DN,1/25,215/21728,0.22022260167041663,0.2521507855557186,0.15856372024009652,HERPUD1,1
LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER,LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER,1/25,216/21728,0.22112877165871403,0.25287498145130166,0.1590191270917277,POLD4,1
BROWNE_HCMV_INFECTION_1HR_DN,BROWNE_HCMV_INFECTION_1HR_DN,1/25,218/21728,0.2229380797932824,0.25431455028270733,0.15992439252227666,PPARG,1
WONG_MITOCHONDRIA_GENE_MODULE,WONG_MITOCHONDRIA_GENE_MODULE,1/25,218/21728,0.2229380797932824,0.25431455028270733,0.15992439252227666,GIMAP5,1
AMUNDSON_RESPONSE_TO_ARSENITE,AMUNDSON_RESPONSE_TO_ARSENITE,1/25,219/21728,0.22384122010035656,0.25502994743863067,0.16037426633187984,HEXA,1
REACTOME_BIOLOGICAL_OXIDATIONS,REACTOME_BIOLOGICAL_OXIDATIONS,1/25,222/21728,0.22654459892236445,0.2577921298082078,0.16211125046039043,MGST2,1
CAIRO_LIVER_DEVELOPMENT_DN,CAIRO_LIVER_DEVELOPMENT_DN,1/25,224/21728,0.22834182715032614,0.25919883081928913,0.1629958471317471,ACSL1,1
THUM_SYSTOLIC_HEART_FAILURE_DN,THUM_SYSTOLIC_HEART_FAILURE_DN,1/25,224/21728,0.22834182715032614,0.25919883081928913,0.1629958471317471,MBD4,1
BENPORATH_MYC_TARGETS_WITH_EBOX,BENPORATH_MYC_TARGETS_WITH_EBOX,1/25,230/21728,0.23370948951891846,0.26496634149138726,0.1666227164539141,HERPUD1,1
HOSHIDA_LIVER_CANCER_SUBCLASS_S1,HOSHIDA_LIVER_CANCER_SUBCLASS_S1,1/25,235/21728,0.23815514326241505,0.2696756769294994,0.1695841577410386,HEXA,1
GAL_LEUKEMIC_STEM_CELL_DN,GAL_LEUKEMIC_STEM_CELL_DN,1/25,236/21728,0.23904129789036055,0.2703478081403833,0.17000682398438322,GIMAP5,1
CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP,CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP,1/25,238/21728,0.24081063951307824,0.27168379842501134,0.17084695458032156,DOK1,1
MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED,MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED,1/25,238/21728,0.24081063951307824,0.27168379842501134,0.17084695458032156,SLC2A9,1
ALFANO_MYC_TARGETS,ALFANO_MYC_TARGETS,1/25,239/21728,0.24169382862485878,0.2723476800602067,0.17126443312056747,HERPUD1,1
DESERT_STEM_CELL_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP,DESERT_STEM_CELL_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP,1/25,242/21728,0.2443374818412013,0.2749912706714616,0.17292684143386514,P2RX4,1
SENESE_HDAC1_AND_HDAC2_TARGETS_UP,SENESE_HDAC1_AND_HDAC2_TARGETS_UP,1/25,243/21728,0.2452167317227042,0.2753101580945063,0.17312737214418714,TRIM38,1
WINTER_HYPOXIA_METAGENE,WINTER_HYPOXIA_METAGENE,1/25,243/21728,0.2452167317227042,0.2753101580945063,0.17312737214418714,HERPUD1,1
UDAYAKUMAR_MED1_TARGETS_DN,UDAYAKUMAR_MED1_TARGETS_DN,1/25,244/21728,0.24609499943072977,0.275960897419896,0.17353658621073434,FMNL1,1
REACTOME_DISEASES_OF_METABOLISM,REACTOME_DISEASES_OF_METABOLISM,1/25,246/21728,0.24784859253119196,0.277590423634935,0.1745613053616816,HEXA,1
REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,1/25,249/21728,0.2504716421328258,0.27984981539387066,0.17598211220940604,SLC2A9,1
WP_MAPK_SIGNALING_PATHWAY,WP_MAPK_SIGNALING_PATHWAY,1/25,249/21728,0.2504716421328258,0.27984981539387066,0.17598211220940604,PTPN7,1
BILD_HRAS_ONCOGENIC_SIGNATURE,BILD_HRAS_ONCOGENIC_SIGNATURE,1/25,250/21728,0.25134403884341194,0.2804853766803293,0.1763817816444996,MYD88,1
DANG_REGULATED_BY_MYC_DN,DANG_REGULATED_BY_MYC_DN,1/25,251/21728,0.25221546071830336,0.28111831809856735,0.17677980358898288,ACSL1,1
PLASARI_TGFB1_TARGETS_10HR_DN,PLASARI_TGFB1_TARGETS_10HR_DN,1/25,254/21728,0.2548238877631046,0.2836834605941068,0.17839288020955454,IGF1,1
KAAB_HEART_ATRIUM_VS_VENTRICLE_UP,KAAB_HEART_ATRIUM_VS_VENTRICLE_UP,1/25,256/21728,0.25655798405867836,0.285270249422646,0.17939072417555318,POLD4,1
ONDER_CDH1_TARGETS_2_UP,ONDER_CDH1_TARGETS_2_UP,1/25,257/21728,0.2574235788052569,0.285888686076992,0.17977962487411667,PPARG,1
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1,SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1,1/25,259/21728,0.2591518666838146,0.2874625748089372,0.18076935668094482,HEXA,1
REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,1/25,261/21728,0.26087629264759826,0.2890284105592096,0.18175402441180644,IGF1,1
RICKMAN_METASTASIS_DN,RICKMAN_METASTASIS_DN,1/25,262/21728,0.2617370599967298,0.2892883294700698,0.18191747307755585,MYD88,1
RIZKI_TUMOR_INVASIVENESS_3D_DN,RIZKI_TUMOR_INVASIVENESS_3D_DN,1/25,262/21728,0.2617370599967298,0.2892883294700698,0.18191747307755585,DOK1,1
AFFAR_YY1_TARGETS_DN,AFFAR_YY1_TARGETS_DN,1/25,263/21728,0.2625968649673853,0.28989187960557233,0.1822970124655684,ITGA4,1
MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP,MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP,1/25,265/21728,0.26431359189700754,0.29109148857310485,0.18305138037406457,P2RX4,1
MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP,MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP,1/25,265/21728,0.26431359189700754,0.29109148857310485,0.18305138037406457,TRIM38,1
KOYAMA_SEMA3B_TARGETS_UP,KOYAMA_SEMA3B_TARGETS_UP,1/25,266/21728,0.26517051591520535,0.2913407333004159,0.1832081166345746,HTATIP2,1
SENESE_HDAC1_TARGETS_DN,SENESE_HDAC1_TARGETS_DN,1/25,266/21728,0.26517051591520535,0.2913407333004159,0.1832081166345746,DOK1,1
KEGG_MAPK_SIGNALING_PATHWAY,KEGG_MAPK_SIGNALING_PATHWAY,1/25,267/21728,0.26602648167338827,0.29193404877222184,0.1835812200071388,PTPN7,1
WANG_CLIM2_TARGETS_UP,WANG_CLIM2_TARGETS_UP,1/25,268/21728,0.2668814901985346,0.29252490740622294,0.18395277840992832,MERTK,1
MCBRYAN_PUBERTAL_BREAST_4_5WK_UP,MCBRYAN_PUBERTAL_BREAST_4_5WK_UP,1/25,269/21728,0.26773554251657017,0.2931133190584252,0.18432279804084156,HLA-DRB1,1
KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION,KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION,1/25,272/21728,0.27029197247149295,0.2955618728564018,0.18586255846062177,P2RX4,1
ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN,ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN,1/25,274/21728,0.27199149683390234,0.29636809324826147,0.18636954599343855,VNN1,1
KUMAR_PATHOGEN_LOAD_BY_MACROPHAGES,KUMAR_PATHOGEN_LOAD_BY_MACROPHAGES,1/25,274/21728,0.27199149683390234,0.29636809324826147,0.18636954599343855,ACSL1,1
OISHI_CHOLANGIOMA_STEM_CELL_LIKE_DN,OISHI_CHOLANGIOMA_STEM_CELL_LIKE_DN,1/25,274/21728,0.27199149683390234,0.29636809324826147,0.18636954599343855,MYD88,1
FORTSCHEGGER_PHF8_TARGETS_UP,FORTSCHEGGER_PHF8_TARGETS_UP,1/25,278/21728,0.2753791528167645,0.29970593310093097,0.18846852935943711,HERPUD1,1
ZHOU_INFLAMMATORY_RESPONSE_FIMA_DN,ZHOU_INFLAMMATORY_RESPONSE_FIMA_DN,1/25,280/21728,0.2770673007095177,0.30118845394775806,0.1894008049432245,DOK1,1
BHAT_ESR1_TARGETS_VIA_AKT1_UP,BHAT_ESR1_TARGETS_VIA_AKT1_UP,1/25,281/21728,0.27790995818258124,0.301395306761391,0.18953088326758694,HLA-DRB1,1
OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN,OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN,1/25,281/21728,0.27790995818258124,0.301395306761391,0.18953088326758694,POLD4,1
HELLER_SILENCED_BY_METHYLATION_UP,HELLER_SILENCED_BY_METHYLATION_UP,1/25,283/21728,0.2795924452437427,0.3028645010612172,0.19045477852106615,HLA-DRB1,1
NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP,NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP,1/25,285/21728,0.2812711685283895,0.30432618234219194,0.19137394925141257,HLA-DRB1,1
HUTTMANN_B_CLL_POOR_SURVIVAL_UP,HUTTMANN_B_CLL_POOR_SURVIVAL_UP,1/25,286/21728,0.2821091212769222,0.3048758222922528,0.19171958749752058,ITGA4,1
GABRIELY_MIR21_TARGETS,GABRIELY_MIR21_TARGETS,1/25,289/21728,0.28461735603006133,0.3065109988016045,0.19274785980688736,TRIM38,1
GENTILE_UV_HIGH_DOSE_DN,GENTILE_UV_HIGH_DOSE_DN,1/25,289/21728,0.28461735603006133,0.3065109988016045,0.19274785980688736,HERPUD1,1
HADDAD_B_LYMPHOCYTE_PROGENITOR,HADDAD_B_LYMPHOCYTE_PROGENITOR,1/25,289/21728,0.28461735603006133,0.3065109988016045,0.19274785980688736,TRIM38,1
BASAKI_YBX1_TARGETS_UP,BASAKI_YBX1_TARGETS_UP,1/25,293/21728,0.28794858504612975,0.3093773169565394,0.19455032918661397,HTATIP2,1
REACTOME_METABOLISM_OF_CARBOHYDRATES,REACTOME_METABOLISM_OF_CARBOHYDRATES,1/25,293/21728,0.28794858504612975,0.3093773169565394,0.19455032918661397,HEXA,1
DURAND_STROMA_S_UP,DURAND_STROMA_S_UP,1/25,300/21728,0.29374243460507343,0.3152357834786154,0.19823439562565018,IGF1,1
TARTE_PLASMA_CELL_VS_PLASMABLAST_DN,TARTE_PLASMA_CELL_VS_PLASMABLAST_DN,1/25,307/21728,0.29949101152823543,0.32079203497708086,0.20172841570670846,IGF1,1
JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_DN,JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_DN,1/25,308/21728,0.300308560882224,0.32079203497708086,0.20172841570670846,CRTAP,1
REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,1/25,308/21728,0.300308560882224,0.32079203497708086,0.20172841570670846,ATG7,1
REACTOME_LEISHMANIA_INFECTION,REACTOME_LEISHMANIA_INFECTION,1/25,308/21728,0.300308560882224,0.32079203497708086,0.20172841570670846,P2RX4,1
LIU_SOX4_TARGETS_DN,LIU_SOX4_TARGETS_DN,1/25,310/21728,0.3019409125087825,0.32216328309251163,0.20259071800759446,P2RX4,1
LI_INDUCED_T_TO_NATURAL_KILLER_UP,LI_INDUCED_T_TO_NATURAL_KILLER_UP,1/25,315/21728,0.30600581276590566,0.32612384197888905,0.20508129502431852,PRR13,1
DACOSTA_UV_RESPONSE_VIA_ERCC3_UP,DACOSTA_UV_RESPONSE_VIA_ERCC3_UP,1/25,317/21728,0.30762540191668086,0.3270953640633062,0.2056922316734393,MBD4,1
HELLER_HDAC_TARGETS_UP,HELLER_HDAC_TARGETS_UP,1/25,317/21728,0.30762540191668086,0.3270953640633062,0.2056922316734393,HLA-DRB1,1
SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12,SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12,1/25,319/21728,0.3092413622454476,0.32843565369516503,0.2065350658916964,HERPUD1,1
REACTOME_RHO_GTPASE_EFFECTORS,REACTOME_RHO_GTPASE_EFFECTORS,1/25,322/21728,0.3116585157393149,0.3302436565861548,0.20767201917926345,FMNL1,1
TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN,TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN,1/25,322/21728,0.3116585157393149,0.3302436565861548,0.20767201917926345,ATP8B4,1
GRESHOCK_CANCER_COPY_NUMBER_UP,GRESHOCK_CANCER_COPY_NUMBER_UP,1/25,323/21728,0.31246242759143616,0.3307162463854376,0.20796920483568188,PPARG,1
FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL,FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL,1/25,327/21728,0.31566907095294294,0.33296600634762474,0.20938395477772712,ACSL1,1
LINDGREN_BLADDER_CANCER_CLUSTER_3_UP,LINDGREN_BLADDER_CANCER_CLUSTER_3_UP,1/25,327/21728,0.31566907095294294,0.33296600634762474,0.20938395477772712,ACSL1,1
REACTOME_MAPK_FAMILY_SIGNALING_CASCADES,REACTOME_MAPK_FAMILY_SIGNALING_CASCADES,1/25,327/21728,0.31566907095294294,0.33296600634762474,0.20938395477772712,PTPN7,1
FARMER_BREAST_CANCER_APOCRINE_VS_BASAL,FARMER_BREAST_CANCER_APOCRINE_VS_BASAL,1/25,329/21728,0.3172670037413112,0.3342699104412447,0.21020390813803497,ACSL1,1
YANG_BCL3_TARGETS_UP,YANG_BCL3_TARGETS_UP,1/25,333/21728,0.32045213009778817,0.3372411938614536,0.2120723843831424,MERTK,1
MULLIGHAN_NPM1_SIGNATURE_3_UP,MULLIGHAN_NPM1_SIGNATURE_3_UP,1/25,335/21728,0.3220393390441637,0.33852599462662947,0.21288032471394333,TRIM38,1
PHONG_TNF_RESPONSE_NOT_VIA_P38,PHONG_TNF_RESPONSE_NOT_VIA_P38,1/25,341/21728,0.32677964089386435,0.3431186229385576,0.21576837532704923,PPARG,1
NABA_SECRETED_FACTORS,NABA_SECRETED_FACTORS,1/25,343/21728,0.328352658627146,0.34437895184050277,0.21656092665294777,IGF1,1
YOSHIMURA_MAPK8_TARGETS_DN,YOSHIMURA_MAPK8_TARGETS_DN,1/25,357/21728,0.3392654013257407,0.35542089662696646,0.22350459664853664,ACSL1,1
COLINA_TARGETS_OF_4EBP1_AND_4EBP2,COLINA_TARGETS_OF_4EBP1_AND_4EBP2,1/25,359/21728,0.3408104005610654,0.3558291639756208,0.2237613334638217,P2RX4,1
GRUETZMANN_PANCREATIC_CANCER_UP,GRUETZMANN_PANCREATIC_CANCER_UP,1/25,359/21728,0.3408104005610654,0.3558291639756208,0.2237613334638217,PRR13,1
PEREZ_TP63_TARGETS,PEREZ_TP63_TARGETS,1/25,359/21728,0.3408104005610654,0.3558291639756208,0.2237613334638217,ACSL1,1
DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP,DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP,1/25,367/21728,0.3469557870831056,0.36183650932820494,0.22753902158711453,MERTK,1
JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_DN,JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_DN,1/25,375/21728,0.35304615350156887,0.36777299417750803,0.23127214944860383,MBD4,1
LINDGREN_BLADDER_CANCER_CLUSTER_1_DN,LINDGREN_BLADDER_CANCER_CLUSTER_1_DN,1/25,378/21728,0.3553159525491011,0.3693047695785932,0.23223539850465197,ACSL1,1
MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP,MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP,1/25,378/21728,0.3553159525491011,0.3693047695785932,0.23223539850465197,DOK1,1
MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN,MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN,1/25,382/21728,0.358330461786027,0.372019490663246,0.23394253684906788,HTATIP2,1
RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN,RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN,1/25,383/21728,0.3590819720668925,0.3723813043656663,0.23417006152864872,MYD88,1
BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP,BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP,1/25,390/21728,0.3643189353229087,0.37738867291296824,0.23731891939844893,TRIM38,1
HSIAO_HOUSEKEEPING_GENES,HSIAO_HOUSEKEEPING_GENES,1/25,399/21728,0.3709918352770457,0.38387061119371807,0.24139505283542081,MGST2,1
BERENJENO_TRANSFORMED_BY_RHOA_DN,BERENJENO_TRANSFORMED_BY_RHOA_DN,1/25,400/21728,0.37172910397778525,0.3842032349837512,0.24160422158923522,P2RX4,1
JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_DN,JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_DN,1/25,402/21728,0.3732011533698889,0.3852937047081311,0.24228995784790203,ACSL1,1
MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP,MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP,1/25,408/21728,0.3775974617745309,0.389397382454985,0.2448705344214533,MYD88,1
ZHOU_INFLAMMATORY_RESPONSE_LPS_UP,ZHOU_INFLAMMATORY_RESPONSE_LPS_UP,1/25,409/21728,0.3783272958953394,0.3897150740326573,0.24507031313058428,ACSL1,1
MOHANKUMAR_HOXA1_TARGETS_UP,MOHANKUMAR_HOXA1_TARGETS_UP,1/25,410/21728,0.379056308400739,0.3900312126528762,0.24526911527043482,HTATIP2,1
IBRAHIM_NRF1_UP,IBRAHIM_NRF1_UP,1/25,419/21728,0.385580594217265,0.3963030801521166,0.24921314678055181,ACSL1,1
RUTELLA_RESPONSE_TO_HGF_UP,RUTELLA_RESPONSE_TO_HGF_UP,1/25,422/21728,0.38774069421430835,0.39808044606002324,0.25033083415941315,VNN1,1
SWEET_LUNG_CANCER_KRAS_DN,SWEET_LUNG_CANCER_KRAS_DN,1/25,423/21728,0.388459106053445,0.39837537624126884,0.2505162994818642,ACSL1,1
HAN_SATB1_TARGETS_UP,HAN_SATB1_TARGETS_UP,1/25,425/21728,0.38989350274096835,0.3989607935023862,0.2508844361053967,ATG7,1
PUJANA_BRCA2_PCC_NETWORK,PUJANA_BRCA2_PCC_NETWORK,1/25,425/21728,0.38989350274096835,0.3989607935023862,0.2508844361053967,ITGA4,1
MILI_PSEUDOPODIA_CHEMOTAXIS_DN,MILI_PSEUDOPODIA_CHEMOTAXIS_DN,1/25,428/21728,0.39203904338757845,0.4002696973371519,0.2517075335271222,P2RX4,1
SHEN_SMARCA2_TARGETS_UP,SHEN_SMARCA2_TARGETS_UP,1/25,428/21728,0.39203904338757845,0.4002696973371519,0.2517075335271222,MBD4,1
MOOTHA_HUMAN_MITODB_6_2002,MOOTHA_HUMAN_MITODB_6_2002,1/25,431/21728,0.3941773396714564,0.4020086775457238,0.2528010822570512,ACSL1,1
REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS,REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS,1/25,432/21728,0.3948884992952635,0.40228993754004794,0.25297795115300353,ATG7,1
CUI_TCF21_TARGETS_2_UP,CUI_TCF21_TARGETS_2_UP,1/25,433/21728,0.39559885746194345,0.4025697624392464,0.253153917596792,IGF1,1
BAELDE_DIABETIC_NEPHROPATHY_DN,BAELDE_DIABETIC_NEPHROPATHY_DN,1/25,437/21728,0.3984322928565145,0.40500708316767814,0.25468661415875865,PTPN7,1
GRYDER_PAX3FOXO1_ENHANCERS_KO_DOWN,GRYDER_PAX3FOXO1_ENHANCERS_KO_DOWN,1/25,438/21728,0.399138656704083,0.40527925142260735,0.25485776576131153,ATP8B4,1
RATTENBACHER_BOUND_BY_CELF1,RATTENBACHER_BOUND_BY_CELF1,1/25,445/21728,0.4040609560007653,0.409826919148965,0.2577175431422063,MYD88,1
MOOTHA_MITOCHONDRIA,MOOTHA_MITOCHONDRIA,1/25,450/21728,0.4075531586909058,0.41246343771127814,0.2593755042340232,ACSL1,1
REACTOME_RHO_GTPASE_CYCLE,REACTOME_RHO_GTPASE_CYCLE,1/25,450/21728,0.4075531586909058,0.41246343771127814,0.2593755042340232,FMNL1,1
SENESE_HDAC1_TARGETS_UP,SENESE_HDAC1_TARGETS_UP,1/25,451/21728,0.4082492377882234,0.41271585964586266,0.25953423846493073,TRIM38,1
MIKKELSEN_NPC_ICP_WITH_H3K4ME3,MIKKELSEN_NPC_ICP_WITH_H3K4ME3,1/25,452/21728,0.4089445317232375,0.4129669369533022,0.25969212713399725,POLD4,1
ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP,ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP,1/25,454/21728,0.410332767500614,0.41391645979319575,0.2602892296717294,ACSL1,1
HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP,HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP,1/25,461/21728,0.4151669845948499,0.41833619821771134,0.2630685593713564,HLA-DRB1,1
SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN,SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN,1/25,463/21728,0.4165411864221865,0.4192636778367106,0.2636518001433861,PRR13,1
CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN,CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN,1/25,466/21728,0.4185966784970565,0.42087413594263356,0.26466452841231913,CRTAP,1
GARY_CD5_TARGETS_UP,GARY_CD5_TARGETS_UP,1/25,474/21728,0.4240440608801507,0.42588773071006436,0.26781730160851625,POLD4,1
JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_UP,JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_UP,1/25,476/21728,0.42539823124649045,0.42678389323752136,0.26838084878914537,MBD4,1
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5,CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5,1/25,493/21728,0.43678592567237406,0.43725914986053477,0.2749681598576159,ACSL1,1
MEISSNER_NPC_HCP_WITH_H3K4ME2,MEISSNER_NPC_HCP_WITH_H3K4ME2,1/25,493/21728,0.43678592567237406,0.43725914986053477,0.2749681598576159,FMNL1,1
PILON_KLF1_TARGETS_UP,PILON_KLF1_TARGETS_UP,1/25,497/21728,0.43943372361841426,0.43943372361841426,0.27633562934309036,ITGA4,1
